| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Integra LifeSciences Holdings Corporation$20
+0.59 (+3.02%)
D 39Pipeline Score MedTech · Commercial
Market Cap
1.17 B
EPS
-6.46
P/E Ratio
-
Value Trade
12.12 M
SEC Financials
Q1 2026Dilution Risk
Revenue
391.92 M
R&D Expenses
23.50 M
Operating CF
9.80 M
Total Assets
3.58 B
Total Liabilities
2.54 B
Equity
1.04 B
D/E Ratio
12,345
5.3 %
Week
39.94 %
1 Month
25.83 %
3 Month
36.4 %
6 Month
-78.65 %
5 Year
115.56 %
All Time
Cash Data
Cash Position
265.50 M
Monthly Burn
-
Runway
12,345 mo
Burn Trend
StableSEC Filing
May 5, 2026
Overview
Volume
22.54 K
52 Week Range
8.70 - 16.49
% held by Insiders
14.43 %
% held by Institutions
96.71 %
Enterprise Value
2.95 B
Total Shares
77.90 M
Short %
9.29 %
Float Shares
66.76 M
Company Description
locked
Upcoming Catalyst
Catalyst Timeline
Dated clinical, regulatory & corporate events for Integra LifeSciences Holdings Corporation
1279Total events
2Upcoming
308Tier-1 (high impact)
2002 – 2026Coverage
Upcoming catalysts 2
TBD
T2Quarterly Update
Subscribe to view catalyst details
TBD
T2Product Launch
Subscribe to view catalyst details
Event history 2
TBD
◆Oral PresentationPresentation
Subscribe to view catalyst details
TBD
◆Oral PresentationPresentation
Subscribe to view catalyst details
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
D39
Pipeline Score $182M
Pipeline ValueValuation Signal
2
Drugs Scored0.5x
rNPV / MCap Top 57%
Micro Cap (rank 394 of 913)
Percentile RankIntegra LifeSciences Holdings Corporation faces pipeline headwinds (39/100), with $455M risk-adjusted pipeline value, led by NorLeu3-A in a formulation in Foot Ulcer, Diabetic (Phase 2).
Showing 1 of 1 assets
| Drug | Indication | Phase | NCT ID | PTRS | rNPV | Status | Enrollment | Velocity | Design | Completion | ML Signal | Last Change |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NorLeu3-A in a formulation Small molecule | Foot Ulcer, Diabetic | Phase 2 | NCT00796744 | 43% | $414M | COMPLETED | 78 | - | - | May 1, 2011 | - | Sep 27, 2012 |
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in IART
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
IART Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-08-21 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-08-21 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-08-21 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
IART▲ +5.7%on this news
Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026
Integra LifeSciences Holdings Corporation will announce its second quarter 2026 financial results on July 29, 2026. The management team will conduct a conference call at 8:30 a.m. ET, which will be accessible via a live webcast. Participants are encouraged to register in advance for dial-in details.
Read more →IARTIntegra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer
Integra LifeSciences has appointed Topaz Kirlew as Chief Regulatory Officer, following her interim leadership. Kirlew will oversee global regulatory affairs and has significant experience in the healthcare and medical technology sectors. Her leadership is expected to enhance the company's regulatory strategy and compliance efforts.
Read more →IARTIntegra LifeSciences to Present at the 2026 Truist Securities MedTech Conference
Integra LifeSciences Holdings Corporation announced that Bob Davis will present at the 2026 Truist Securities MedTech Conference on June 16, 2026. The presentation will focus on the company's advancements in neurosurgery and tissue reconstruction. A live webcast will be available for interested investors and stakeholders.
Read more →IARTIntegra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference
Integra LifeSciences Holdings Corporation announced that its CFO, Lea Knight, will present at the 2026 Jefferies Global Healthcare Conference on June 3, 2026. The presentation will be available via a live webcast on the company's investor relations website. Integra is known for its innovative technologies in neurosurgery and tissue reconstruction.
Read more →IARTIntegra LifeSciences to Present at the BofA Securities 2026 Health Care Conference
Integra LifeSciences Holdings Corporation will present at the BofA Securities 2026 Health Care Conference on May 12, 2026. CFO Lea Knight will lead the presentation, which will be available via a live webcast. The event underscores Integra's role as a leader in medical technology and its dedication to innovation in healthcare.
Read more →IART▲ +24.1%on this newsshared move
Integra LifeSciences Announces Leadership Transition
Integra LifeSciences has appointed Stuart M. Essig as its new president and chief executive officer, effective May 1, 2026, succeeding Mojdeh Poul. Essig, who has over thirty years of experience in the medical technology industry and has served as chairman of the board since June 2012, aims to enhance the company's operational resilience and customer focus. Additionally, Michael McBreen has been named chief commercial officer to further elevate the commercial organization and ensure market priorities are at the forefront of decision-making. This leadership shift is seen as pivotal for Integra's plans for 2026.
Read more →IART▲ +24.1%on this newsshared move
Document News Release Integra LifeSciences Reports First Quarter 2026 Financial Results PRINCETON, N.J.
Integra LifeSciences reported its financial results for the first quarter of 2026, revealing a revenue increase of 2.4% compared to the previous year. Adjusted earnings per diluted share also rose to $0.54, while the company reaffirmed its full-year revenue guidance. However, the company reported a GAAP net loss of $(4.6) million. Some segments faced challenges, with organic declines noted particularly in Specialty Surgery and Instruments.
Read more →IART▲ +24.1%on this newsshared move
Document Integra LifeSciences Announces Leadership Transition Stuart Essig Appointed as Integra's Next President and Chief Executive Officer Michael McBreen Appointed Chief Commercial Officer PRINCETON, N.J.
Integra LifeSciences announced a leadership transition with Stuart Essig being appointed as the new president and CEO, effective May 1, 2026. Essig succeeds Mojdeh Poul, who is leaving for other opportunities. Alongside him, Michael McBreen has been appointed as chief commercial officer, tasked with enhancing the company's commercial organization. Essig, who has a long history with Integra, promised to focus on execution and customer engagement to drive long-term value.
Read more →IART▲ +24.1%on this newsshared move
Integra LifeSciences Reports First Quarter 2026 Financial Results
Integra LifeSciences reported its first quarter 2026 financial results, showing a 2.4% increase in revenues to $391.9 million. The adjusted earnings per diluted share improved to $0.54, while GAAP earnings reflected a loss of $(0.06). The company reaffirmed its full-year revenue guidance and highlighted operational improvements despite some declines in specific product segments.
Read more →IART▼ -5.7%on this news
INTEGRA SHAREHOLDER ALERT: Kaskela Law Firm Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (IART) and Encourages Long-Term Integra Investors to Contact the Firm
Kaskela Law is investigating potential breach of fiduciary duty claims against Integra LifeSciences Holdings Corp. due to accusations of securities fraud. A complaint alleges that during a specified period, the company issued misleading statements regarding serious violations of Good Manufacturing Practices. Following the revelation of systemic deficiencies, Integra had to halt production on key product lines, leading to a significant drop in stock price. Long-term shareholders are encouraged to explore legal options to protect their rights.
Read more →IARTIntegra LifeSciences to Host First Quarter 2026 Financial Results Conference Call on May 5, 2026
Integra LifeSciences Holdings Corporation will announce its first quarter 2026 financial results on May 5, 2026. The management team will conduct a conference call at 8:30 a.m. ET to discuss the results. A live webcast will be available on the company's investor website, along with a replay after the call.
Read more →IARTIntegra LifeSciences Unveils New Real-World Evidence Highlighting PriMatrix Utilization
Integra LifeSciences Holdings Corporation is set to present new real-world evidence on its PriMatrix® Dermal Scaffold at three major medical conferences in April 2026. The data, derived from 985 cases, illustrates PriMatrix's utilization across various wound types, including surgical and traumatic wounds. Additionally, a specific case series highlights its efficacy in burn injuries among patients with significant comorbidities. This information is expected to aid clinical decision making in complex reconstruction cases.
Read more →IARTIntegra LifeSciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance
Integra LifeSciences reported its financial results for Q4 and full-year 2025, showing a GAAP net loss of $(516.5) million due to a significant goodwill impairment charge. Despite a 1.7% decrease in Q4 revenues, the company anticipates revenue growth for 2026, projecting earnings per diluted share between $2.30 and $2.40. Operational improvements and a simplified operating model were highlighted as key strategies moving forward.
Read more →IARTDocument News Release Integra LifeSciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance Princeton, New Jersey
Integra LifeSciences reported mixed financial results for Q4 and full-year 2025, showing both revenue decreases and operational challenges. For Q4, revenues fell by 1.7% year-over-year, with a GAAP net loss of $(1.7) million. Despite a slight overall revenue increase for the full year, the company faced a significant goodwill impairment leading to a net loss of $(516.5) million. Looking ahead, Integra has provided guidance for 2026, forecasting modest revenue growth and improved adjusted earnings per share driven by operational efficiencies.
Read more →IARTIntegra LifeSciences Announces Key Executive Leadership Appointments
Integra LifeSciences has announced key executive appointments, including Teshtar Elavia as the new chief technology officer, aimed at enhancing R&D and innovation. Michael Hutchinson joins as chief legal officer, while Kerri DiPietro takes on the role of chief quality officer. These appointments reflect the company's commitment to strategic growth and innovation.
Read more →IARTIntegra LifeSciences to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 26, 2026
Integra LifeSciences Holdings Corporation will announce its fourth quarter and full year 2025 financial results on February 26, 2026. A conference call hosted by the management team is scheduled for 8:30 a.m. ET, with a live webcast available for participants. A replay of the call will also be accessible on the company's website.
Read more →IARTIntegra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference
Integra LifeSciences Holdings Corporation will have its CEO Mojdeh Poul and CFO Lea Knight present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026. The presentation aims to highlight the company's advancements in medical technology and its commitment to improving patient outcomes. A live webcast will be available for interested investors.
Read more →IARTIntegra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference
Integra LifeSciences Holdings Corporation announced that CEO Mojdeh Poul and CFO Lea Knight will present at the Citi 2025 Global Healthcare Conference on December 3, 2025. The presentation will be available via a live webcast on the company's investor relations website. This event highlights Integra's commitment to innovation in medical technology.
Read more →IART▲ +6.2%on this news
Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access
Integra LifeSciences has praised new Medicare policies from the Centers for Medicare & Medicaid Services that include their dermal regenerative products in the 2026 Physician Fee Schedule. This change is expected to enhance access to their innovative wound reconstruction solutions, aligning reimbursement with care quality. Company leadership sees this as a significant opportunity to expand their commercial presence and impact patient outcomes positively. Integra continues to emphasize its commitment to improving healthcare through its diverse and scientifically backed product offerings.
Read more →IARTIntegra LifeSciences Receives FDA 510(k) Clearance for Use of the CUSA® Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries
Integra LifeSciences has received FDA 510(k) clearance for its CUSA Clarity Ultrasonic Surgical Aspirator System, allowing its use in cardiac surgeries, including valve replacement and repair. This clearance signifies an important expansion of the system's applications. The company will showcase the system at an upcoming thoracic surgery conference in December 2025.
Read more →IART▼ -23.5%on this news
Integra LifeSciences Reports Third Quarter 2025 Financial Results
Integra LifeSciences reported a 5.6% increase in revenue for Q3 2025, totaling $402.1 million. Despite facing supply interruptions, the company achieved a positive adjusted EBITDA of $78.5 million. However, it also reported a GAAP net loss of $(5.4) million. Looking ahead, Integra anticipates a decline in organic growth for Q4 2025.
Read more →IART▼ -23.5%on this newsshared move
Document News Release Integra LifeSciences Reports Third Quarter 2025 Financial Results PRINCETON, N.J.
Integra LifeSciences reported its financial results for Q3 2025, showing a 5.6% increase in revenues to $402.1 million. The adjusted earnings per diluted share rose to $0.54, marking an improvement from the previous year. Despite strong profitability, the company faced GAAP losses of $5.4 million and reported supply interruptions that affected revenue. Future guidance for Q4 expects reported revenues to range between $420 million and $440 million, reflecting potential challenges ahead.
Read more →IARTIntegra LifeSciences to Host Third Quarter 2025 Financial Results Conference Call on October 30, 2025
Integra LifeSciences Holdings Corporation will announce its third quarter 2025 financial results on October 30, 2025. A conference call will follow the earnings release at 8:30 a.m. ET, providing an opportunity for management to discuss results with investors. A live webcast will be available on the company's website.
Read more →IARTIntegra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons (CNS) Annual Meeting
Integra LifeSciences will exhibit its neurosurgical product portfolio at the CNS Annual Meeting from October 11 to 15, 2025, in Los Angeles. The company will highlight its latest innovations, including the Durepair Dura Regeneration Matrix and the Mayfield Ghost Base Unit. These products aim to improve surgical outcomes and patient care. Integra's booth will also feature other advanced medical technologies.
Read more →IARTIntegra LifeSciences Strengthens Leadership with Appointment of New Chief Medical Officer
Integra LifeSciences has appointed Dr. Raymond Turner as its new Chief Medical Officer. With over 20 years of experience in clinical operations, Dr. Turner will oversee medical affairs and clinical development at Integra. His previous roles include leadership positions at Siemens Healthineers and Cerenovus. Dr. Turner aims to improve patient outcomes through evidence-based practices.
Read more →IARTIntegra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences
Integra LifeSciences Holdings Corporation announced that CEO Mojdeh Poul and CFO Lea Knight will present at the Wells Fargo and Morgan Stanley Healthcare Investor Conferences. The presentations will be accessible via a live webcast on the company's investor relations website, highlighting their commitment to innovation in medical technology.
Read more →IART▲ +6.2%on this news
Document News Release Integra LifeSciences Reports Second Quarter 2025 Financial Results PRINCETON, N.J.
Integra LifeSciences reported mixed financial results for the second quarter of 2025, with revenues of $415.6 million, reflecting a slight decline year-on-year. The company experienced a significant GAAP net loss primarily due to a goodwill impairment charge amidst various operational challenges. However, adjusted earnings per share slightly exceeded the upper guidance range, and the firm updated its revenue guidance for the full year, indicating favorable expectations moving forward. The CEO emphasized progress in compliance and operational improvements to ensure sustained growth.
Read more →IART▲ +6.2%on this news
Integra LifeSciences Reports Second Quarter 2025 Financial Results
Integra LifeSciences Holdings Corporation reported its financial results for Q2 2025, showing second-quarter revenues of $415.6 million, reflecting a slight decline compared to the previous year. The company's GAAP earnings per diluted share reported a significant loss primarily due to a goodwill impairment charge. While the adjusted earnings per diluted share reached $0.45, there were challenges, including a decrease in organic sales and operational obstacles. Despite these issues, the company expressed commitment to compliance and operational excellence as it updates its revenue guidance for the year ahead.
Read more →IARTIntegra LifeSciences to Host Second Quarter 2025 Financial Results Conference Call on July 31, 2025
Integra LifeSciences Holdings Corporation, a global medical technology company, is scheduled to announce its second quarter 2025 financial results on July 31, 2025. Following this announcement, the management will conduct a conference call to discuss the results at 8:30 a.m. ET. A live webcast will be available for investors, reinforcing the company's commitment to transparency and communication. The announcement underscores Integra's ongoing efforts to innovate and improve patient care outcomes.
Read more →IARTIntegra LifeSciences Announces First Patient Enrolled in Acclarent AERA® Pediatric Registry
Integra LifeSciences has announced the enrollment of the first patient in the Acclarent AERA Pediatric Registry, which will evaluate the AERA Eustachian Tube Balloon Dilation System in children with obstructive Eustachian tube dysfunction. The registry aims to capture safety and efficacy outcomes for up to 300 pediatric patients. This initiative reflects a commitment to improving pediatric ENT care and understanding the clinical performance of the AERA system.
Read more →IART▼ -21.2%on this news
Document News Release Integra LifeSciences Reports First Quarter 2025 Financial Results PRINCETON, N.J.
Integra LifeSciences Holdings Corporation reported its first quarter 2025 financial results, with revenues of $382.7 million reflecting a 3.7% increase but a 3.5% decrease on an organic basis. The company posted a GAAP net loss of $25.3 million, resulting in a diluted loss per share of $(0.33), a significant decline from the previous year's loss. Despite these challenges, Integra is reaffirming its full-year revenue guidance and remains optimistic about long-term growth prospects, particularly following leadership changes and strategic initiatives aimed at operational improvements.
Read more →IART▼ -21.2%on this news
Integra LifeSciences Reports First Quarter 2025 Financial Results
Integra LifeSciences Holdings Corporation reported its financial results for the first quarter of 2025, revealing a 3.7% increase in revenues to $382.7 million but a net loss of $(25.3) million. The company reaffirmed its full-year revenue guidance while adjusting its earnings guidance due to impacts from new tariffs. Key segments showed varied performance, with significant growth in Instruments but a decline in Neurosurgery sales. The company is focusing on enhancing its compliance and operational processes moving forward.
Read more →IARTIntegra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025
Integra LifeSciences Holdings Corporation will announce its first quarter 2025 financial results on May 5, 2025, before market opening. A conference call led by the management team is scheduled for 8:30 a.m. ET to discuss these results, and a live webcast will be available on the company's investor website. Participants are advised to register in advance for dial-in details and are encouraged to join early. A replay of the call will be accessible on the website afterwards.
Read more →IARTIntegra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
Integra LifeSciences Holdings Corporation announced that its CEO, Mojdeh Poul, and CFO, Lea Knight, will present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference on March 17, 2025. The presentation aims to highlight the company's advancements in medical technology and its commitment to restoring patients' lives. A live webcast of the presentation will be available on their investor relations website, allowing broader access to their insights and strategies.
Read more →IARTINTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Integra LifeSciences Holdings Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. is investigating Integra LifeSciences Holdings Corp. due to potential claims from long-term stockholders linked to a class action complaint filed on September 12, 2023. The investigation concerns breaches of fiduciary duties in light of the company’s violations of federal manufacturing regulations, which resulted in multiple warnings from the FDA since 2018. Notably, Integra had to recall all products made at its Boston Facility due to high bacterial endotoxin levels. These compliance issues have led to significant declines in stock prices and lowered revenue expectations.
Read more →IART▲ +12.1%on this newsshared move
Document News Release Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 Financial Guidance Princeton, New Jersey
Integra LifeSciences Holdings Corporation reported financial results for Q4 2024, with revenues hitting $442.6 million, a growth of 11.5% year-over-year. Adjusted earnings per diluted share rose to $0.97, marking an improvement from the previous year. However, the company's full-year report showed a net loss of $(6.9) million, significantly lower than the previous year, primarily due to challenges in organic sales. For 2025, the company forecasts revenues between $1.65 billion and $1.72 billion while expecting ongoing operational improvements and the impacts of their Compliance Master Plan to influence results.
Read more →IART▲ +12.1%on this newsshared move
Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 Financial Guidance
Integra LifeSciences Holdings Corporation reported its fourth quarter and full-year financial results for 2024, highlighting a revenue increase of 11.5% in Q4. The company faced challenges, including a GAAP loss in earnings per share for the full year and decreased organic sales. Looking ahead to 2025, Integra anticipates modest revenue growth while addressing operational hurdles like production delays and supply chain issues. The recent acquisition of Acclarent was mentioned as a positive driver for future revenue.
Read more →IARTIntegra LifeSciences to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on February 25, 2025
Integra LifeSciences Holdings Corporation is set to announce its fourth quarter and full year financial results for 2024 on February 25, 2025. The company will hold a conference call at 8:30 a.m. ET following the release, with details available for participants. Investors can access the live webcast and subsequent replay on the company’s website. This initiative reflects Integra's commitment to transparency and stakeholder engagement.
Read more →IARTIntegra LifeSciences Launches Integra Institute for Healthcare Professionals (HCPs)
Integra LifeSciences has announced the launch of its new global medical education platform, the Integra Institute, aimed at enhancing professional development for healthcare providers. This platform features on-demand learning resources including webinars, surgical videos, and an events calendar tailored to various medical specialties. Integra positions this initiative as a way to strengthen partnerships with healthcare professionals and improve patient outcomes through accessible education.
Read more →IART▼ -6%on this news
Integra’s DuraSeal Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research
Integra LifeSciences has published an economic evaluation of its DuraSeal PEG dural sealant, demonstrating cost savings when used instead of fibrin glue in posterior fossa surgeries. The study, published in the Journal of Comparative Effectiveness Research, highlights savings of €419 to €1,279 per patient across five European countries. This analysis elaborates on the clinical effectiveness and financial benefits of DuraSeal, suggesting that it may lead to reduced hospital costs associated with managing complications from cerebrospinal fluid leaks.
Read more →IART▲ +25.1%on this news
Document News Release Integra LifeSciences Reports Third Quarter 2024 Financial Results PRINCETON, N.J.
Integra LifeSciences reported financial results for Q3 2024, revealing a slight decrease in revenues and a GAAP net loss compared to the previous year. Despite these challenges, the company updated its full-year revenue guidance upward and reported that issues with shipping holds were resolving. New leadership is set to take over starting in January 2025, which may influence future operational strategies. The company expects revenue growth in the upcoming fourth quarter, supported by improved production and integration efforts.
Read more →IART▲ +25.1%on this news
projecteaglep Integra LifeSciences Announces Appointment of Mojdeh Poul as President and Chief Executive Officer A proven healthcare executive with deep global expertise and a distinguished record in business strategy an
Integra LifeSciences has appointed Mojdeh Poul as its new president and CEO, effective January 6, 2025. Poul, a seasoned healthcare executive with significant experience at 3M, Medtronic, and Boston Scientific, is expected to strengthen the company's strategic initiatives. She aims to focus on operational excellence and compliance while maximizing the product portfolio. The transition is aimed at maintaining the momentum built under the outgoing president, Jan De Witte, who has been instrumental in the company's growth.
Read more →IART▲ +25.1%on this news
Integra LifeSciences Announces Appointment of Mojdeh Poul as President and Chief Executive Officer
Integra LifeSciences has appointed Mojdeh Poul as the new president and CEO, effective January 6, 2025. Poul, who previously served in senior positions at 3M, Medtronic, and Boston Scientific, will be succeeding Jan De Witte, who will remain in his role until the transition. The current executive chairman, Stuart Essig, expressed confidence in Poul's ability to lead the company and emphasized the importance of her experience in driving the company's strategic initiatives. The transition aims to maintain focus on operational and quality compliance priorities and maximize opportunities within Integra's product portfolio.
Read more →IART▲ +25.1%on this news
Integra LifeSciences Reports Third Quarter 2024 Financial Results
Integra LifeSciences reported a decline in financial performance for the third quarter of 2024, with revenues dropping 0.4% on a reported basis and 8.6% on an organic basis compared to the previous year. The company announced a GAAP net loss of $10.7 million, reflecting a significant decrease from the prior year's net income. However, shipping holds are releasing as expected, and production of Integra Skin is expected to meet historical run rates in the upcoming quarter. With the appointment of a new CEO and an updated revenue guidance for the full year, the company aims to address operational challenges.
Read more →IARTIntegra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024
Integra LifeSciences Holdings Corporation (NASDAQ: IART) will release its third-quarter 2024 financial results on November 4, 2024, before the market opens. The company's management will host a conference call at 8:30 a.m. ET to discuss the results. Interested participants can register for dial-in details, and a live webcast will be available on the company's Investor section of their website. A replay of the call will also be accessible following the event.
Read more →IARTIntegra LifeSciences to Present at the 22nd Annual Morgan Stanley Healthcare Conference
Integra LifeSciences Holdings Corporation (NASDAQ: IART) will be presenting at the 22nd Annual Morgan Stanley Healthcare Conference on September 6, 2024. The presentation will be led by CFO Lea Knight and will be available via a live webcast on the company's investor relations website. This event represents a strategic opportunity for Integra to share insights on their innovative medical technologies with investors and stakeholders. The conference highlights the company's ongoing commitment to advancing patient care through their product portfolio.
Read more →IARTIntegra LifeSciences to Present at the 2024 Wells Fargo Healthcare Conference
Integra LifeSciences Holdings Corporation will be presenting at the Wells Fargo Healthcare Conference on September 4, 2024. Lea Knight, the chief financial officer, is set to deliver the presentation at 1:30 PM ET. The event will be accessible via a live webcast on the company's investor relations website, highlighting Integra's focus on engaging with investors and stakeholders.
Read more →IARTIntegra LifeSciences Continues to Make Progress on Its ESG Strategy
Integra LifeSciences has released its latest Environmental, Social, and Governance (ESG) report, showcasing progress in ESG performance since establishing its strategy three years ago. The report includes efforts in reducing greenhouse gas emissions, promoting diversity and inclusion, and strengthening governance practices. CEO Jan De Witte emphasized the company's commitment to creating healthier environments for patients and employees alike. The report aligns with major external guidelines for transparency and accountability.
Read more →IART▼ -19.1%on this news
Document News Release Integra LifeSciences Reports Second Quarter 2024 Financial Results PRINCETON, N.J.
Integra LifeSciences reported its financial results for the second quarter of 2024, showing a 9.7% increase in revenues to $418.2 million. However, the company experienced a GAAP net loss of $12.4 million, and earnings per diluted share fell to $(0.16). Despite these challenges, Integra noted early integration success with its Acclarent acquisition and plans to enhance its manufacturing capabilities. The company also issued a revised revenue guidance for the full year, reflecting potential impacts from quality compliance efforts and temporary shipping holds.
Read more →IART▼ -19.1%on this news
Integra LifeSciences Reports Second Quarter 2024 Financial Results
Integra LifeSciences reported its second quarter 2024 financial results, showing a revenue increase of 9.7% year-over-year but lower earnings per diluted share at $(0.16). The company is focusing on the relaunch of key products and has received a PMA approvable notification for SurgiMend, pending GMP certification. However, it has announced temporary shipping holds on certain products, impacting future earnings, as the company invests heavily in compliance improvements to enhance operational reliability.
Read more →IARTIntegra LifeSciences Provides Updated Plans for Its Manufacturing Facility in Braintree, Massachusetts
Integra LifeSciences Holdings Corporation announced plans to restart the manufacture of PriMatrix and SurgiMend at a new facility in Braintree, Massachusetts, expected to be operational by mid-2026. The decision follows a reassessment of their Boston facility, where challenges prompted a shift to the new site, consolidating operations to mitigate risks. The Braintree facility aims to improve quality systems and support future growth, while temporary use of the Boston site will facilitate product development activities during this transition.
Read more →IARTIntegra LifeSciences to Host Second Quarter 2024 Financial Results Conference Call on July 29, 2024
Integra LifeSciences Holdings Corporation will announce its second quarter 2024 financial results on July 29, 2024, before the market opens. The company will host a conference call at 8:30 a.m. ET for discussion of these results, with a live webcast available for investors. Participants are encouraged to register in advance to receive dial-in information. A replay of the call will also be accessible after the event on the company’s investor relations website.
Read more →IARTIntegra LifeSciences to Present at the 2024 Bank of America Healthcare Conference
Integra LifeSciences Holdings Corporation (NASDAQ: IART) announced that its CFO, Lea Knight, will present at the 2024 Bank of America Healthcare Conference on May 14, 2024. This event highlights the company's commitment to sharing insights on their innovative medical technologies. A live webcast of the presentation will be available on their investor relations website. Integra is known for its extensive range of surgical and regenerative care products.
Read more →IART▼ -19.9%on this news
Document News Release Integra LifeSciences Reports First Quarter 2024 Financial Results PRINCETON, N.J.
Integra LifeSciences Holdings Corporation reported its financial results for the first quarter of 2024, revealing a 3.1% decline in total revenues compared to the previous year, with a GAAP earnings per share loss of $0.04. The company noted that organic growth of 1.6% was realized when excluding the impact of the Boston product recall. Despite these setbacks, Integra is optimistic about its full-year guidance, having updated revenue projections to between $1.672 billion and $1.687 billion following the acquisition of Acclarent, Inc. Overall, the performance reflects mixed results, with positive contributions from international sales balancing declines in some segments.
Read more →IART▼ -19.9%on this news
Integra LifeSciences Reports First Quarter 2024 Financial Results
Integra LifeSciences Holdings Corporation (IART) reported a decline in first quarter 2024 revenues, totaling $368.9 million, down 3.1% year over year. The company posted a GAAP net loss of $(3.3) million, compared to a net income of $24.2 million in the same quarter last year. Despite these setbacks, the company has updated its full-year guidance, increasing expectations due to the recent acquisition of Acclarent, which is anticipated to boost revenue. The Codman Specialty Surgical segment showed stronger performance, although the Tissue Technologies segment experienced a significant decline mainly due to a product recall.
Read more →IARTIntegra LifeSciences to Spotlight CereLink Intracranial Pressure (ICP) Monitoring System at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting
Integra LifeSciences Holdings Corporation (IART) announced that it will feature its CereLink ICP Monitoring System at the AANS Annual Scientific Meeting from May 3 to 6, 2024, in Chicago. This follows a successful relaunch of the product in Q1 2024, emphasizing its advanced monitoring capabilities for conditions like traumatic brain injuries and strokes. The CereLink system will be highlighted in booth #655, showcasing its innovative features important for clinician use.
Read more →IARTIntegra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024
Integra LifeSciences Holdings Corporation announced that it will reschedule the release of its first quarter 2024 financial results to May 6, 2024. Alongside the earnings release, a conference call will be held at 8:30 a.m. EDT, which will also be available via webcast. Participants are encouraged to register in advance for dial-in details. A replay of the call will be accessible on the Investors section of the company’s website afterward.
Read more →IARTIntegra LifeSciences Completes the Acquisition of Acclarent, Inc.
Integra LifeSciences has completed its acquisition of Acclarent, Inc., a company specializing in ENT surgical interventions. This deal not only enhances Integra's product lineup but also adds significantly to its addressable market, estimated at $1 billion. The acquisition aims to leverage Acclarent’s commercial capabilities and innovation to improve patient care. However, the company faces risks related to the integration process and potential geopolitical impacts, specifically concerning its operations in Israel.
Read more →IARTIntegra LifeSciences Launches MicroMatrix Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases
Integra LifeSciences has announced the commercial launch of MicroMatrix Flex, a dual-syringe system tailored for efficient mixing and delivery of their MicroMatrix paste. This innovative product is designed to address complex wound management, particularly in hard-to-reach areas. Coupled with strong support from clinical research, MicroMatrix Flex aims to expand treatment options for various wound types. However, the company has cautioned that uncertainties regarding commercial success and potential market challenges may impact outcomes.
Read more →IART▼ -12.6%on this news
pressreleasex Integra LifeSciences Announces Leadership Transition Plan Jan De Witte to retire as CEO by the end of 2024 Stuart Essig appointed executive chairman of the Board PRINCETON, N.J.
Integra LifeSciences has announced a leadership transition plan as CEO Jan De Witte intends to retire by the end of 2024. The Board has initiated a formal search for his successor while Stuart Essig has been appointed as executive chairman. De Witte's departure follows his significant contributions to the company's growth and innovation. The company is focused on ensuring a smooth transition and maintaining operational execution during this period.
Read more →IART▼ -12.6%on this news
Integra LifeSciences Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
Integra LifeSciences reported its fourth-quarter and full-year financial results for 2023, revealing a slight revenue decrease of 1.0% year-over-year. Despite this decline, the company stated that organic sales, excluding Boston products, showed a 5.5% increase. Adjusted earnings per share dropped from $3.36 to $3.10. The company is initiating a guidance for 2024, expecting revenue growth of 4.0% to 5.0% and remains optimistic about the relaunch of its Boston product line in Q2 2024.
Read more →IART▼ -12.6%on this news
Integra LifeSciences Announces Leadership Transition Plan
Integra LifeSciences has announced that CEO Jan De Witte will retire by the end of 2024, with Stuart Essig stepping in as executive chairman. The Board is conducting a search for a new CEO with the assistance of Heidrick & Struggles. De Witte highlighted significant accomplishments during his tenure and emphasized the company's continued focus on operational execution and innovation. The leadership transition will be discussed during the upcoming financial results conference call.
Read more →IART▼ -12.6%on this news
Document News Release Integra LifeSciences Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance Princeton, New Jersey
Integra LifeSciences reported its fourth quarter and full-year 2023 financial results, revealing slight revenue decreases compared to 2022. Despite these declines, the company maintains a positive outlook for 2024, expecting modest growth driven by key product relaunches and expansions. Notable achievements include successful acquisitions and product integrations. However, adjusted earnings and revenues for the first quarter of 2024 are projected to decline, highlighting ongoing market challenges.
Read more →IARTIntegra LifeSciences to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024
Integra LifeSciences Holdings Corporation is set to announce its financial results for the fourth quarter and full year of 2023 on February 28, 2024, before the market opens. The company's management will conduct a conference call at 8:30 a.m. ET to discuss these results. A live webcast will be available, and a replay will be accessible on the company's website afterwards. Integra emphasizes its mission of restoring patients' lives through innovative medical technology solutions.
Read more →IARTIntegra LifeSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Integra LifeSciences Holdings Corporation announced that its CEO, Jan De Witte, will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024. The event will feature a live webcast available on their investor relations website. This presentation underscores Integra's dedication to innovation in medical technology and its proactive engagement with investors and analysts.
Read more →IARTIntegra LifeSciences Announces Definitive Agreement to Acquire Acclarent
Integra LifeSciences has announced a definitive agreement to acquire Acclarent for $275 million, aiming to enhance its position in the ear, nose, and throat (ENT) market. This acquisition is strategically aligned with Integra's Codman Specialty Surgical division and is intended to leverage Acclarent's established brand and innovative products. With the ENT devices market growing significantly, Integra expects the transaction to be financially beneficial. However, the acquisition is subject to regulatory approvals and other customary closing conditions, and integration challenges may arise from geopolitical factors affecting Acclarent's operations.
Read more →IARTIntegra LifeSciences Appoints Jeff Graves, Ph.D., to Board of Directors
Integra LifeSciences has appointed Jeff Graves, Ph.D., as a new member of its Board of Directors. Dr. Graves brings a wealth of expertise from his leadership roles at 3D Systems and other organizations. His appointment marks the fourth addition to the board since 2021, reflecting strategic efforts to enhance the company’s capabilities. The chairman expressed confidence in Dr. Graves' ability to contribute to shareholder value through improved operational efficiencies.
Read more →IARTINTEGRA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Integra LifeSciences Holdings Corp. and Encourages Investors to Contact the Firm
Integra LifeSciences Holdings Corp. is facing a class action lawsuit following allegations of violations of federal manufacturing regulations at its Boston Facility. The lawsuit pertains to securities purchased between March 2019 and May 2023. These violations have led to significant FDA scrutiny, including recalls of products due to elevated endotoxin levels and a notable decline in stock prices. The company's guidance has also shifted downward in light of these events, indicating serious operational challenges.
Read more →IARTINTEGRA LIFESCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Integra LifeSciences Holdings Corporation - IART
Integra LifeSciences Holdings Corporation is facing a class action lawsuit filed by investors who purchased shares between March 11, 2019 and May 22, 2023. The lawsuit alleges that the company failed to disclose material information, particularly related to a significant recall of medical devices. Following the recall announcement and a lowered revenue guidance, Integra's shares dropped by 20%, resulting in substantial financial losses for investors. The deadline to file lead plaintiff applications in this class action lawsuit is November 13, 2023.
Read more →IARTINTEGRA LIFESCIENCES HOLDINGS CORPORATION (NASDAQ: IART) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is currently under scrutiny as Bernstein Liebhard LLP reminds investors of a deadline to file a lead plaintiff motion in a securities class action lawsuit. The lawsuit pertains to allegations of violations of the Securities Exchange Act based on events occurring within a specified class period. Additionally, the company recently recalled products manufactured at its Boston Facility due to concerns about bacterial endotoxins, leading to an adjustment in its revenue guidance and a notable decrease in its stock price. The outcome of the lawsuit and the ongoing production issues could have severe implications for Integra's financial stability.
Read more →IARTINTEGRA LIFESCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Integra LifeSciences Holdings Corporation - IART
Integra LifeSciences Holdings Corporation is currently facing a class action lawsuit initiated by investors who incurred losses exceeding $100,000. The suit pertains to allegations that the company failed to disclose critical information during a specified class period. A significant factor contributing to investor losses was the company's announcement of a substantial product recall due to violations in good manufacturing practices, resulting in lowered revenue guidance and earnings adjustments. The deadline for potential plaintiffs to file their applications is November 13, 2023.
Read more →IARTDocument News Release Integra LifeSciences Reports Third Quarter 2023 Financial Results PRINCETON, N.J.
Integra LifeSciences reported its financial results for the third quarter of 2023, revealing a revenue decline of 0.7% year-over-year. The company has successfully prepared to restart its Boston manufacturing facility and relaunched its CereLink ICP Monitor in select international markets. Despite the challenges posed by the Boston product recall, Integra achieved organic growth in its Codman Specialty Surgical and Tissue Technologies segments. The company has also updated its full-year revenue and adjusted earnings guidance amid these developments.
Read more →IARTIntegra LifeSciences Reports Third Quarter 2023 Financial Results
Integra LifeSciences reported its financial results for the third quarter of 2023, noting a slight decline in revenues by 0.7% year-over-year, with total revenues reaching $382.4 million. The company saw a substantial decrease in GAAP earnings per diluted share, falling from $0.60 to $0.24. Positive developments included the successful completion of external inspections related to the Boston manufacturing facility, alongside the relaunch of the CereLink ICP Monitor in international markets. Despite challenges, the company is optimistic about its long-term growth trajectory, particularly in its Codman Specialty Surgical and Tissue Technologies segments excluding the impact of the Boston product recall.
Read more →IARTIntegra LifeSciences Holdings Corporation Investors: Please contact the Portnoy Law Firm to recover your losses; November 13, 2023 deadline
Integra LifeSciences Holdings Corporation is facing a lawsuit filed by investors due to alleged misleading statements and uncovered information regarding FDA violations. These violations relate to issues dating back to 2018, resulting in potential product recalls and a lack of progress in obtaining premarket approval for the SurgiMend product. The lawsuit claims that investors suffered financial losses as a result of these inadequate actions and the subsequent shutdown of the Boston Facility for necessary corrections.
Read more →IARTIntegra Lifesciences Holdings Corporation (IART) Shareholders Should Contact Robbins LLP for Information About the Class Action Allegations Against Integra Lifesciences Holdings Corporation
Integra Lifesciences Holdings Corporation (IART) has been hit with a class action lawsuit alleging that the company misled investors regarding remediation efforts at its Boston Facility. The lawsuit claims that Integra assured investors of improvements to the facility's compliance with FDA regulations, but failed to adequately address violations. Recent disclosures included a pause in production and recalls of products due to unsafe testing practices. The company's stock has significantly declined in value following these revelations.
Read more →IARTIntegra LifeSciences to Host Third Quarter 2023 Financial Results Conference Call on October 25, 2023
Integra LifeSciences Holdings Corporation is set to release its third quarter 2023 financial results on October 25, 2023. A conference call will be held at 8:30 a.m. ET where management will discuss the results. Participants can access a live webcast through the company's investor relations website and are encouraged to register in advance. A replay of the call will also be available afterward.
Read more →IARTINTEGRA LIFESCIENCES HOLDING CORPORATION (NASDAQ: IART) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Integra LifeSciences Holding Corporation
Integra LifeSciences Holding Corporation is involved in a securities class action lawsuit following alleged violations of the Securities Exchange Act. The lawsuit pertains to the company's activities between March 11, 2019, and May 22, 2023. Compounding this issue, Integra announced a recall of products from its Boston Facility due to deviations from good manufacturing practices, resulting in a significant drop in stock price and lowered revenue expectations. Investors are reminded of the deadline to file a lead plaintiff motion by November 13, 2023.
Read more →IARTIntegra Lifesciences Holdings Corporation (IART) Investor Alert: Robbins LLP Reminds Investors of Class Action Filed Against Integra Lifesciences Holdings Corporation
Integra Lifesciences Holdings Corporation (IART) is facing a class action lawsuit filed by shareholders, alleging that the company misled them regarding the remediation of violations at its Boston Facility. The lawsuit claims that despite assurances of progress, Integra had not adequately addressed issues noted by the FDA, leading to potential safety risks with its products. Following the announcement of a recall of all products from the Boston Facility and a pause in production, the company's stock price saw steep declines. Shareholders are encouraged to participate in the class action to seek recovery for their losses.
Read more →IARTINTEGRA LIFESCIENCES HOLDING CORPORATION SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Integra LifeSciences Holding Corporation (NASDAQ: IART)
Integra LifeSciences Holding Corporation is the subject of a securities class action lawsuit filed by Bernstein Liebhard LLP on behalf of investors who owned shares between March 11, 2019, and May 22, 2023. The lawsuit alleges violations of the Securities Exchange Act and comes on the heels of a recall of all products from the company's Boston Facility, which was found to have deviated from good manufacturing practices. As a result of the recall, Integra lowered its revenue expectations and announced an impairment charge due to inventory write-offs. Following this negative news, the company's stock price dropped significantly.
Read more →IARTIntegra LifeSciences to Present at the 2023 Wells Fargo Healthcare Conference
Integra LifeSciences Holdings Corporation (NASDAQ: IART) announced that CFO Lea Knight will present at the upcoming 2023 Wells Fargo Healthcare Conference on September 6, 2023. The live webcast of the presentation will be accessible on the company's investor relations website. This event highlights Integra's ongoing efforts in advancing medical technology and improving patient outcomes.
Read more →IARTDocument News Release Integra LifeSciences Reports Second Quarter 2023 Financial Results PRINCETON, N.J.
Integra LifeSciences reported its financial results for the second quarter of 2023, revealing a revenue decline of 4.2% year-over-year, totaling $381.3 million. The company's GAAP earnings per diluted share fell from $0.54 in the previous year to $0.05, highlighting significant challenges. Despite the ongoing impact of the Boston recall affecting its Tissue Technologies segment, there is optimism surrounding the recovery of the Codman Specialty Surgical segment. The company has also announced a $125 million share repurchase plan and is confident in upcoming product launches and operational strategies.
Read more →IARTIntegra LifeSciences Reports Second Quarter 2023 Financial Results
Integra LifeSciences reported a decline in financial performance for the second quarter of 2023, with total revenues of $381.3 million, down 4.2% year-over-year. GAAP earnings per share fell to $0.05 from $0.54 in the previous year, while adjusted earnings per diluted share also decreased. The company remains optimistic about its product segments, particularly in the Codman Specialty Surgical area, and plans a significant share repurchase and updated full-year guidance, despite ongoing challenges such as the Boston recall.
Read more →IARTIntegra LifeSciences to Host Second Quarter 2023 Financial Results Conference Call on July 27, 2023
Integra LifeSciences Holdings Corporation will release its financial results for the second quarter of 2023 on July 27, 2023. Following the earnings announcement, the company's management will conduct a conference call at 8:30 a.m. ET, which will also be available via a live webcast on their investor relations website. This announcement reflects the company's commitment to transparency and keeps the investors informed about their performance and developments.
Read more →IARTIntegra LifeSciences Announces Complete Enrollment in DuraSorb Monofilament Mesh U.S. IDE Study
Integra LifeSciences has completed patient enrollment for the DuraSorb U.S. IDE clinical study, aimed at evaluating the safety and effectiveness of the DuraSorb Monofilament Mesh in two-stage breast reconstruction. This study marks a significant step towards gaining pre-market approval for this bioabsorbable surgical matrix. The enrollment was achieved sooner than expected, with participation from several major academic hospitals across the nation. Integra aims to enhance patient outcomes in breast reconstruction and innovates treatment pathways for women's health.
Read more →IARTIntegra LifeSciences Appoints Lea Daniels Knight, Executive Vice President and Chief Financial Officer
Integra LifeSciences has appointed Lea Daniels Knight as the new executive vice president and chief financial officer, effective June 28, 2023. Ms. Knight has over 30 years of experience in financial leadership roles within the healthcare industry, including her previous position at Booz Allen Hamilton. Her extensive background at Johnson & Johnson positions her well to contribute to Integra's mission of advancing patient outcomes. The CEO of Integra expressed confidence in her ability to drive growth and create shareholder value.
Read more →IARTIntegra LifeSciences Opens New Center of Innovation and Learning
Integra LifeSciences Holdings Corporation has inaugurated its new center of innovation and learning in Plainsboro, New Jersey, honoring its late founder, Dr. Richard E. Caruso. This advanced 14,000 square foot facility aims to enhance research and development in treatment pathways and provide educational programs for medical professionals. Integra's commitment to regenerative medicine is reinforced by the facility's dedication to developing innovative technologies. The opening ceremony was attended by notable guests, emphasizing the company's influence and stature in the medical field.
Read more →IARTIntegra LifeSciences To Host Investor Day On May 4, 2023
Integra LifeSciences Holdings Corporation (IART) will conduct an Investor Day on May 4, 2023, in New York, NY. The event, hosted by CEO Jan DeWitte and the executive team, aims to engage and update investors. A live webcast of the meeting will be available, along with a replay on the company’s website for those unable to attend.
Read more →IART▼ -7.9%on this news
Integra LifeSciences Reports First Quarter 2023 Financial Results
Integra LifeSciences Holdings Corporation (NASDAQ: IART) reported its financial results for the first quarter of 2023, showing a 1.1% increase in revenues year-over-year. The company maintained adjusted earnings per diluted share at $0.74, despite a drop in GAAP earnings from $0.39 to $0.29. Integra reiterated its full-year revenue guidance within the range of $1,602 million to $1,620 million, signaling confidence in continued performance. Additionally, the company highlighted growth in various product lines and upcoming product launches which are expected to support their market position.
Read more →IART▼ -7.9%on this news
Document News Release Integra LifeSciences Reports First Quarter 2023 Financial Results PRINCETON, N.J.
Integra LifeSciences reported its first quarter 2023 financial results, showcasing a 1.1% increase in revenue to $380.8 million, with a 4.6% increase on an organic basis. The company reaffirmed its full-year guidance for revenue and adjusted earnings per share, indicating ongoing confidence in its financial outlook. Notable product performance, particularly in the Codman Specialty Surgical segment, contributed to positive growth, despite challenges such as a decrease in GAAP earnings. Overall, the results demonstrate a steady performance amidst market pressures.
Read more →IARTIntegra LifeSciences to Host First Quarter 2023 Financial Results Conference Call on April 26, 2023
Integra LifeSciences Holdings Corporation (NASDAQ: IART) will announce its first quarter 2023 financial results on April 26, 2023, before the market opens. Accompanying the earnings release, a conference call is scheduled for 8:30 a.m. ET, which will be accessible via live webcast. Participants are encouraged to register in advance for call details. The replay of the call will be available afterward on the company's investor website.
Read more →IARTIntegra LifeSciences Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides 2023 Financial Guidance Princeton, New Jersey
Integra LifeSciences Holdings Corporation reported Q4 and full-year 2022 financial results, showing a slight revenue decrease of 1.8% in Q4 compared to the previous year. The company, however, realized organic growth of 2.9% and exceeded adjusted earnings per share expectations, leading to a positive outlook for 2023. Expected revenue growth of approximately 2.9% to 4.0% for 2023 includes a gradual recovery from COVID-19 impacts and plans for new product launches. The company is also undertaking share repurchase to strengthen its stock value.
Read more →IARTIntegra LifeSciences Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides 2023 Financial Guidance
Integra LifeSciences Holdings Corporation reported financial results for Q4 and full year 2022, showing a slight revenue decrease in Q4 but demonstrating overall organic growth throughout the year. The company achieved adjusted earnings per share of $3.36 for the full year and expects revenues in 2023 to grow between 2.9% to 4.0%. The successful launches of new products and strategic acquisitions are central to their positive outlook, despite some challenges such as a recent revenue decline and ongoing supply chain issues. Their guidance reflects anticipated improvements in the market post-COVID.
Read more →IARTIntegra LifeSciences to Host Fourth Quarter 2022 Financial Results Conference Call on February 22, 2023
Integra LifeSciences Holdings Corporation (IART) will release its fourth quarter 2022 financial results on February 22, 2023, before the market opens. Following the release, the company will host a conference call at 8:30 a.m. ET to discuss the results. A live webcast of the call will be accessible on the company's Investors website, and a replay will also be available after the event. This announcement highlights Integra's ongoing commitment to transparency with its stakeholders.
Read more →IARTIntegra LifeSciences Reports Select Preliminary Fourth Quarter and Full-Year 2022 Financials
Integra LifeSciences announced preliminary financial results for the fourth quarter and full year of 2022, projecting revenues of approximately $397 million to $398 million for Q4 and $1,557 million to $1,558 million for the full year. Despite a reported revenue decrease of around 2% for Q4, organic growth is expected to rise by 3%. Adjusted earnings per diluted share are projected to be above previous guidance. The company also plans to initiate a $150 million share repurchase in 2023 and is set to present at the 41st Annual J.P. Morgan Healthcare Conference.
Read more →IARTIntegra LifeSciences to Present at 41st Annual J.P. Morgan Healthcare Conference
PRINCETON, N.J., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president and chief executive officer will present at the 41st Annual J.P. Morgan Healthcar
Read more →IARTIntegra LifeSciences Completes the Acquisition of Surgical Innovation Associates
PRINCETON, N.J., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has successfully completed its acquisition of Surgical Innovation Associates (SIA). “This acquisition is a
Read more →IARTIntegra LifeSciences Announces Definitive Agreement to Acquire Surgical Innovation Associates (SIA) and Plans for $150 Million Share Repurchase
Acquisition will add distinct new product solution for plastic and reconstructive surgery to address clinical needs and improve patient outcomes Deploys capital to support strong profitable growth and greater returns for our shareholders PRINCETON, N.J., Dec. 01, 2022 (GLOBE NE
Read more →IART▲ +5.9%on this news
Document News Release Integra LifeSciences Reports Third Quarter 2022 Financial Results PRINCETON, N.J.
Integra LifeSciences Reports Third Quarter 2022 Financial Results PRINCETON, N.J., October 26, 2022 - Integra LifeSciences Holdings Corporation (NASDAQ IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30,
Read more →IART▲ +5.9%on this news
Integra LifeSciences Reports Third Quarter 2022 Financial Results
PRINCETON, N.J., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2022. Third Quarter 2022 Highlights Third quarte
Read more →IARTIntegra LifeSciences to Host Third Quarter 2022 Financial Results Conference Call on October 26, 2022
PRINCETON, N.J., Oct. 07, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2022 financial results on Wednesday, October 26, 2022, prior to the market open. In conjunction wit
Read more →IARTIntegra LifeSciences Announces Key Executive Appointment
PRINCETON, N.J., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today announced the appointment of Harvinder Singh as executive vice president and president of Integra’s international business. Mr. Singh brings a wealth of global healt
Read more →IARTIntegra LifeSciences Publishes Its Inaugural ESG Report
PRINCETON, N.J., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today issued its inaugural Environmental, Social and Governance (ESG) report. The report includes 2021 performance highlights
Read more →IARTIntegra LifeSciences Announces Participation in Upcoming Investor Conferences
PRINCETON, N.J., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it is participating in the following investor conferences: On September 7, 2022, Jan De Witte, chief exe
Read more →IARTIntegra LifeSciences Announces the Passing of Dr. Richard Caruso, Founder and Former Chairman and CEO
PRINCETON, N.J., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that Dr. Richard Caruso, founder and former chairman and CEO of Integra LifeSciences passed away over the past
Read more →IARTDocument News Release Integra LifeSciences Reports Second Quarter 2022 Financial Results PRINCETON, N.J.
Integra LifeSciences Reports Second Quarter 2022 Financial Results PRINCETON, N.J., July 27, 2022 - Integra LifeSciences Holdings Corporation (NASDAQ IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2022.
Read more →IARTIntegra LifeSciences Reports Second Quarter 2022 Financial Results
PRINCETON, N.J., July 27, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2022. Second Quarter 2022 Highlights Second quarter
Read more →IARTIntegra LifeSciences Appoints Renee Lo as Director
PRINCETON, N.J., July 19, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced the appointment of Renee Lo to its board of directors as an independent director to fill an existing vacancy,
Read more →IARTIntegra LifeSciences to Host Second Quarter 2022 Financial Results Conference Call on July 27, 2022
PRINCETON, N.J., July 01, 2022 (GLOBE NEWSWIRE) -- )Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2022 financial results on Wednesday, July 27, 2022, prior to the market open. In conjunction with
Read more →IARTDocument News Release Integra LifeSciences Reports First Quarter 2022 Financial Results PRINCETON, N.J.
Integra LifeSciences Reports First Quarter 2022 Financial Results PRINCETON, N.J., April 27, 2022 - Integra LifeSciences Holdings Corporation (NASDAQ IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2022.
Read more →IARTIntegra LifeSciences Reports First Quarter 2022 Financial Results
PRINCETON, N.J., April 27, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2022. First Quarter 2022 Highlights Revenues of $37
Read more →IARTIntegra LifeSciences to Host First Quarter 2022 Financial Results Conference Call on April 27, 2022
PRINCETON, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2022 financial results on Wednesday, April 27, 2022, prior to the market open. In conjunction with
Read more →IARTIntegra LifeSciences Launches NeuraGen 3D Nerve Guide Matrix
PRINCETON, N.J., March 22, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company and pioneers in nerve repair, today announced the launch of NeuraGen® 3D Nerve Guide Matrix, a resorbable implant for the repai
Read more →IARTIntegra LifeSciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides 2022 Financial Guidance
PRINCETON, N.J., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2021, consistent with its preliminary revenue results announced on January 11, 2022
Read more →IARTDocument News Release Integra LifeSciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides 2022 Financial Guidance Princeton, New Jersey
Integra LifeSciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides 2022 Financial Guidance Princeton, New Jersey, February 23, 2022 - Integra LifeSciences Holdings Corporation (NASDAQ IART) today reported financial results for the fourth quarter and fu
Read more →IARTIntegra LifeSciences Reports Preliminary Fourth Quarter and Full-Year 2021 Revenue and Plans $125 Million Share Repurchase
Fourth quarter 2021 revenue is expected to be in a range of $404 million to $406 million, representing an increase of approximately 4% on a reported basis and an increase of approximately 8% on an organic basis compared to the prior year. Full-year 2021 revenue is expected to be
Read more →IART▲ +9%on this news
Document News Release Integra LifeSciences Reports Third Quarter 2021 Financial Results Third Quarter 2021 Highlights Revenues of $386.9 million increased 4.5% on a reported basis and 6.7% on an organic basis compared to
Integra LifeSciences Reports Third Quarter 2021 Financial Results Third Quarter 2021 Highlights Revenues of $386.9 million increased 4.5% on a reported basis and 6.7% on an organic basis compared to the prior year GAAP earnings per diluted share of $0.51, compared to $0.38 in
Read more →IART▲ +9%on this news
Integra LifeSciences Reports Third Quarter 2021 Financial Results
Third Quarter 2021 Highlights Revenues of $386.9 million increased 4.5% on a reported basis and 6.7% on an organic basis compared to the prior year; GAAP earnings per diluted share of $0.51, compared to $0.38 in the third quarter of 2020; adjusted earnings per diluted share of
Read more →IARTIntegra LifeSciences Announces Jan De Witte as President and Chief Executive Officer
PRINCETON, N.J., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced that it has appointed Jan D. De Witte as its next President and Chief Executive Officer. Mr. De Witte succeeds
Read more →IARTDocument Integra LifeSciences Announces Jan De Witte as President and Chief Executive Officer 30-year healthcare and technology veteran with extensive global executive experience and diverse expertise in R D, commerciali
Integra LifeSciences Announces Jan De Witte as President and Chief Executive Officer 30-year healthcare and technology veteran with extensive global executive experience and diverse expertise in R D, commercialization, product management, digital innovation and operations PRINC
Read more →IARTIntegra LifeSciences to Host Third Quarter 2021 Financial Results Conference Call on November 2, 2021
PRINCETON, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2021 financial results on Tuesday, November 2, 2021, prior to the market open. In conjunction with
Read more →IARTDocument News Release Integra LifeSciences Reports Second Quarter 2021 Financial Results Raises Full-Year 2021 Guidance Second Quarter 2021 Highlights Revenues of $390.0 million increased 50.8% on a reported basis and 48
Integra LifeSciences Reports Second Quarter 2021 Financial Results Raises Full-Year 2021 Guidance Second Quarter 2021 Highlights Revenues of $390.0 million increased 50.8% on a reported basis and 48.7% on an organic basis compared to the prior year GAAP earnings per diluted s
Read more →IARTIntegra LifeSciences Reports Second Quarter 2021 Financial Results
Second Quarter 2021 Highlights Revenues of $390.0 million increased 50.8% on a reported basis and 48.7% on an organic basis compared to the prior year; GAAP earnings per diluted share of $0.41, compared to $(0.00) in the second quarter of 2020; adjusted earnings per diluted sha
Read more →IARTIntegra LifeSciences Announces Positive Clinical Outcomes for PriMatrix Dermal Repair Scaffold for the Management of Diabetic Foot Ulcers
PRINCETON, N.J., July 19, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, today announced positive clinical outcomes for PriMatrix® Dermal Repair Scaffold for the management of hard to heal diabetic fo
Read more →IARTIntegra LifeSciences Receives Innovative Technology Contract from Vizient for SurgiMend Collagen Matrix for Soft Tissue Reconstruction
PRINCETON, N.J., July 14, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, announced its SurgiMend® Collagen Matrix for Soft Tissue Reconstruction has received an Innovative Technology contract from Viz
Read more →IARTIntegra LifeSciences to Host Second Quarter 2021 Financial Results Conference Call on July 28, 2021
PRINCETON, N.J., July 08, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2021 financial results on Wednesday, July 28, 2021 prior to market open. In conjunction with the e
Read more →IARTIntegra LifeSciences Announces CEO Succession Plan
PRINCETON, N.J., June 24, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced that Peter Arduini will step down as Chief Executive Officer at the end of 2021 to accept the role of Presiden
Read more →IARTDocument Integra LifeSciences Hosts Virtual Investor Day PRINCETON, New Jersey
Integra LifeSciences Hosts Virtual Investor Day PRINCETON, New Jersey, May 20, 2021 -- Integra LifeSciences Holdings Corporation (NASDAQ IART), a leading global medical technology company, will host an Investor Day meeting from 8 30 a.m. to approximately 12 30 p.m. ET, today May
Read more →IARTIntegra LifeSciences Hosts Virtual Investor Day
PRINCETON, N.J., May 20, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will host an Investor Day meeting from 8:30 a.m. to approximately 12:30 p.m. ET, today May 20, 2021. Highlights of today’s pre
Read more →IARTIntegra LifeSciences to Host Virtual Investor Day on May 20, 2021
PRINCETON, N.J., May 07, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will host an Investor Day meeting from 8:30 a.m. to approximately 12:30 p.m., U.S. eastern time on May 20, 2021. The event wil
Read more →IARTDocument News Release Investor Relations Contacts Michael Beaulieu Director, Investor Relations (609) 529-4812 michael.beaulieu integralife.com Media Contact Laurene Isip Vice President, Global Corporate Communications a
Investor Relations Contacts Michael Beaulieu Director, Investor Relations (609) 529-4812 michael.beaulieu integralife.com Media Contact Laurene Isip Vice President, Global Corporate Communications and Public Relations (609) 208-8121 laurene.isip integralife.com Integra
Read more →IARTIntegra LifeSciences Reports First Quarter 2021 Financial Results
PRINCETON, N.J., April 28, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2021. First Quarter 2021 Financial Summary Reported
Read more →IARTIntegra LifeSciences Statement on the U.S. FDA Safety Communication on Acellular Dermal Matrix (ADM) Products Used in Implant-Based Breast Reconstruction
PRINCETON, N.J., April 19, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company and manufacturer of SurgiMend Collagen Matrix, today issued the following statement regarding the U.S. FDA safety communication
Read more →IARTIntegra LifeSciences to Host First Quarter 2021 Financial Results Conference Call on April 28, 2021
PRINCETON, N.J., April 08, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2021 financial results on Wednesday, April 28, 2021 prior to market open. In conjunction with the
Read more →IARTIntegra LifeSciences Appoints Shaundra Clay as Director
PRINCETON, N.J., April 01, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced the appointment of Shaundra Clay to its board of directors, effective today. “We are delighted to welcome Sha
Read more →IARTDocument News Release Contact Investor Relations Michael Beaulieu Director, Investor Relations (609) 750-2827 michael.beaulieu integralife.com Media Laurene Isip Vice President, Global Corporate Communications and Public
Contact Investor Relations Michael Beaulieu Director, Investor Relations (609) 750-2827 michael.beaulieu integralife.com Media Laurene Isip Vice President, Global Corporate Communications and Public Relations (609) 750-7984 laurene.isip integralife.com Integra LifeSciences Repor
Read more →IARTIntegra LifeSciences Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides 2021 Financial Guidance
PRINCETON, N.J., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full-year ended December 31, 2020, consistent with its preliminary revenue results announced on January 14, 2021
Read more →IARTIntegra LifeSciences Completes the Acquisition of ACell, Inc.
PRINCETON, N.J., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it completed the previously-disclosed acquisition of ACell, Inc. “Acquiring ACell and its proprietary MatriSte
Read more →IARTIntegra LifeSciences Announces Preliminary Fourth Quarter and Full-Year 2020 Revenue Results; Will Host Fourth Quarter Financial Results Conference Call on February 18, 2021
PRINCETON, N.J., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today certain unaudited preliminary fourth quarter and full-year 2020 revenue results. Preliminary Fourth Quarter a
Read more →IARTIntegra LifeSciences Completes the Sale of its Extremity Orthopedics Business to Smith+Nephew
PRINCETON, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has completed its previously announced divestiture of its Extremity Orthopedics business to Smith+Nephew (LS
Read more →IARTIntegra LifeSciences to Present at 39th Annual J.P. Morgan Healthcare Conference
PRINCETON, N.J., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Peter Arduini, president and chief executive officer will present virtually at the 39th Annual J.P. Morga
Read more →IARTIntegra LifeSciences Announces Definitive Agreement to Acquire ACell, Inc.
PRINCETON, N.J., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) a leading global medical technology company, today announced it has entered into a definitive agreement to acquire ACell, Inc. (“ACell”) for an upfront cash payment of $300
Read more →IARTIntegra LifeSciences Reports Third Quarter 2020 Financial Results
PRINCETON, N.J., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2020. Third Quarter 2020 Financial Summary Repor
Read more →IARTIntegra LifeSciences Announces Preliminary Third Quarter Revenue Results; Will Host Third Quarter 2020 Financial Results Conference Call on October 28, 2020
PRINCETON, N.J., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today certain unaudited preliminary third quarter financial results. The company also announced that it will release
Read more →IARTIntegra LifeSciences Announces Definitive Agreement to Divest its Extremity Orthopedics Business to Smith+Nephew for $240 Million
PRINCETON, N.J., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has entered into a definitive agreement to sell its Extremity Orthopedics business to Smith+Nephew (LSE:SN,
Read more →IARTIntegra LifeSciences Announces September 2020 Investor Conference Schedule
PRINCETON, N.J., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it will participate in two investor conferences in September. On September 10, 2020, Carrie Anderson, c
Read more →IARTIntegra LifeSciences Reports Second Quarter 2020 Financial Results
Investor Relations Contacts: Michael Beaulieu Director, Investor Relations (609) 529-4812 michael.beaulieu@integralife.com Media Contact: Laurene Isip Senior Director, Global Corporate Communications (609) 750-7984 laurene.isip@integralife.com Integra LifeSciences Repor
Read more →IARTIntegra LifeSciences Receives FDA Clearance for Specific Neurosurgery Indication for CUSA Clarity
PRINCETON, N.J., July 22, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, announced today that it has received FDA clearance for a specific indication for neurosurgery for its CUSA® Clarity Ultrasonic
Read more →IARTIntegra LifeSciences Announces Preliminary Second Quarter Revenue Results; Will Host Second Quarter 2020 Financial Results Conference Call on August 10, 2020
PRINCETON, N.J., July 09, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today certain unaudited preliminary second quarter financial results. The company also announced that it will releas
Read more →IARTIntegra LifeSciences Announces Key Executive Leadership Changes
PRINCETON, N.J., May 21, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced changes to its executive leadership team. Michael McBreen, who is currently the corporate vice president and president of the international business, has been
Read more →IARTIntegra LifeSciences Announces Positive Clinical Results for Integra Bilayer Wound Matrix (IBWM)
PRINCETON, N.J., May 15, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, today announced positive clinical and economic data on Integra® Bilayer Wound Matrix (IBWM) in complex lower extremity reconstru
Read more →IARTIntegra LifeSciences Announces May 2020 Investor Conference Schedule
PRINCETON, N.J., May 11, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it will participate in two investor conferences in May. On May 12, 2020, Glenn Coleman, chief operating o
Read more →IARTIntegra LifeSciences Reports First Quarter 2020 Financial Results
Investor Relations Contacts: Michael Beaulieu Director, Investor Relations (609) 750-2827 michael.beaulieu@integralife.com Media Contact: Laurene Isip Senior Director, Global Corporate Communications (609) 750-7984 laurene.isip@integralife.com Integra LifeSciences Repor
Read more →IARTIntegra LifeSciences Holdings Corporation Announces Virtual-Only Format for Its 2020 Annual Meeting of Stockholders
PRINCETON, N.J., April 23, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that its 2020 Annual Meeting of Stockholders (the “Meeting”) location will change from its headquarters to a
Read more →IARTIntegra LifeSciences Announces Preliminary First Quarter Revenue Results and Provides an Update on COVID-19 Impact; Will Host First Quarter 2020 Financial Results Conference Call on May 7, 2020
PRINCETON, N.J., April 07, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today certain unaudited preliminary first quarter financial results. The company also announced that it will relea
Read more →IARTIntegra LifeSciences Launches AmnioExcel Plus Placental Allograft Membrane
PRINCETON, N.J., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq:IART), a leading global medical technology company, today announced the launch of AmnioExcel® Plus Placental Allograft Membrane, its latest wound care offering to support soft tiss
Read more →IARTInvestor Relations: Sravan Emany Sr. Vice President, Strategy, Treasury, Investor Relations (609) 936-2488 sravan.emany@integralife.com Michael Beaulieu Director, Investor Relations (609) 750-2827 m
Contact: Investor Relations: Sravan Emany Sr. Vice President, Strategy, Treasury, Investor Relations (609) 936-2488 sravan.emany@integralife.com Michael Beaulieu Director, Investor Relations (609) 750-2827 michael.beaulieu@integralife.com Media: Laurene Isip Sr. Director, Global
Read more →IARTIntegra LifeSciences Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides 2020 Financial Guidance
PRINCETON, N.J., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2019 and issued its financial guidance for 2020, consistent with the preliminary re
Read more →IARTIntegra LifeSciences to Host Fourth Quarter and Full-Year 2019 Financial Results Conference Call on February 19, 2020
PRINCETON, N.J., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full-year 2019 financial results on Wednesday, February 19, 2020 prior to market open. In con
Read more →IARTIntegra Announces Pricing of Convertible Senior Notes PRINCETON, N.J.
Integra Announces Pricing of Convertible Senior Notes PRINCETON, N.J., February 4, 2020 Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced the pricing of $500,000,000 aggregate principal amount of 0.50% convertible senior notes due 2025 (the Notes ). The No
Read more →IARTIntegra Announces Amendment and Extension of Credit Facility and Private Placement of Convertible Senior Notes PRINCETON, N.J.
Integra Announces Amendment and Extension of Credit Facility and Private Placement of Convertible Senior Notes PRINCETON, N.J., February 3, 2020 Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has amended and extended its credit facility and comm
Read more →IARTIntegra LifeSciences Announces Preliminary Fourth Quarter and Full-Year 2019 Revenue Results and 2020 Financial Guidance
Fourth quarter 2019 reported revenue is expected to be at or near the low end of the previously communicated guidance range of $395 to $400 million, representing organic revenue growth of slightly less than 5% and reported growth of approximately 3%; For the full-year 2020, the
Read more →IARTIntegra LifeSciences to Present at the 38th Annual J.P. Morgan Healthcare Conference
PLAINSBORO, N.J., Dec. 16, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced President and Chief Executive Officer Peter Arduini will speak at the 38th Annual J.P. Morgan Healthcare Conf
Read more →IARTIntegra LifeSciences to participate in the Piper Jaffray 31st Annual Healthcare Conference
PRINCETON, N.J., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Carrie Anderson, chief financial officer, will present at the Piper Jaffray 31st Annual Healthcare Confer
Read more →IARTIntegra LifeSciences to participate in the 28th Annual Credit Suisse Healthcare Conference
PLAINSBORO, NJ, Nov. 06, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the 28th Annual Credit Suisse Healthcare Conference in Scottsdale, Arizona on Tuesday, November 12, 2019 at 1:1
Read more →IARTIntegra LifeSciences Reports Third Quarter 2019 Financial Results
Investor Relations Contacts: Sravan Emany Senior Vice President, Strategy, Treasury & Investor Relations (609) 936-2488 sravan.emany@integralife.com Michael Beaulieu Director, Investor Relations (609) 750-2827 michael.beaulieu@integralife.com Media Contact: Laurene Isip
Read more →IARTIntegra LifeSciences to Host Third Quarter 2019 Earnings Results Conference Call on October 24, 2019
PLAINSBORO, N.J., Oct. 09, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2019 financial results on Thursday, October 24, 2019, prior to market open. In conjunction with t
Read more →IARTIntegra LifeSciences Supports the European Burns Association’s “Share your Care” Educational Program
PLAINSBORO, N.J., Sept. 23, 2019 (GLOBE NEWSWIRE) -- During the 18th European Burns Association (EBA) Congress, which took place in Helsinki, Finland, from 4 to 7 September 2019, Integra LifeSciences announced its support for EBA through an educational grant for their “Share your
Read more →IARTIntegra LifeSciences Presents Cadence Total Ankle System Retrospective Study Abstract at AOFAS
PLAINSBORO, N.J., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced positive findings from its Cadence® Total Ankle System retrospective study. Tim Daniels, MD, FRCSC, Professor
Read more →IARTIntegra LifeSciences Acquires Rebound Therapeutics Corporation
PLAINSBORO, N.J., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, announced today that it has acquired Rebound Therapeutics, developers of single-use medical devices that enable minimally in
Read more →IARTIntegra LifeSciences to participate in the Wells Fargo 2019 Healthcare Conference and the Morgan Stanley 17th Annual Global Healthcare Conference in September 2019
PLAINSBORO, N.J., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conferences in September: On Thursday, September 5, 2019 at 1:55 p.m. ET, Glenn Col
Read more →IARTIntegra LifeSciences Acquires Arkis Biosciences Inc.
PLAINSBORO, N.J., July 29, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that it has acquired Arkis Biosciences Inc. a privately-held company that offers a portfolio of neurosurgical
Read more →IARTIntegra LifeSciences Reports Second Quarter 2019 Financial Results
Investor Relations Contacts: Sravan Emany Senior Vice President, Strategy, Treasury & Investor Relations (609) 936-2488 sravan.emany@integralife.com Michael Beaulieu Director, Investor Relations (609) 750-2827 michael.beaulieu@integralife.com Media Contact: Laurene Isip
Read more →IARTIntegra LifeSciences to Host Second Quarter 2019 Earnings Results Conference Call on July 24, 2019
PLAINSBORO, N.J., July 10, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2019 financial results on Wednesday, July 24, 2019, prior to market open. In conjunction with the
Read more →IARTIntegra LifeSciences Announces Promotion of Glenn Coleman to Newly-Created Role of Chief Operating Officer and Appointment of Carrie Anderson as Chief Financial Officer
PLAINSBORO, N.J., June 24, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced the promotion of Glenn Coleman to the newly-created role of chief operating officer (COO) and appointed Carri
Read more →IARTIntegra LifeSciences to participate in the Jefferies Healthcare Conference and the Raymond James Life Sciences and MedTech Conference in June 2019
PLAINSBORO, N.J., May 23, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conferences in June: On Wednesday, June 5, 2019 at 4:30 p.m. ET, Peter Arduini, pres
Read more →IARTIntegra LifeSciences to participate in Bank of America Merrill Lynch 2019 Healthcare Conference in May 2019
PLAINSBORO, N.J., April 30, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conference in May: On Tuesday, May 14, 2019 at 4:20 p.m. PT, Sravan Emany, senior
Read more →IARTIntegra LifeSciences Reports First Quarter 2019 Financial Results
Investor Relations Contacts: Sravan Emany Senior Vice President, Strategy, Treasury & Investor Relations (609) 936-2488 sravan.emany@integralife.com Michael Beaulieu Director, Investor Relations (609) 750-2827 michael.beaulieu@integralife.com Media Contact: Laurene Isip
Read more →IARTIntegra LifeSciences Introduces New Codman Specialty Surgical Products at AANS 2019
PLAINSBORO, N.J., April 11, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, announced today that it will feature its latest innovations at the American Association of Neurological Surgeons (AANS) Annu
Read more →IARTIntegra LifeSciences to Host First Quarter 2019 Earnings Results Conference Call on April 24, 2019
PLAINSBORO, N.J., April 09, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2019 financial results on Wednesday, April 24, 2019, prior to market open. In conjunction with th
Read more →IARTIntegra LifeSciences Announces the Approval of DuraGen in Japan
PLAINSBORO, N.J. and TOKYO, March 14, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a global leader in medical technology, announces the recent approval of DuraGen® Dural Regeneration Matrix in Japan. DuraGen is the first and only non-autologou
Read more →IARTIntegra LifeSciences to participate in Healthcare Conference in March 2019
PLAINSBORO, N.J., March 07, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conference in March: On Tuesday, March 19, 2019 at 8:00 a.m. ET, Glenn Coleman, ch
Read more →IARTIntegra LifeSciences Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides 2019 Financial Guidance
Fourth Quarter 2018 reported revenue increased 4.0% to $383.3 million; organic revenue increased 4.4% Fourth Quarter 2018 GAAP earnings per diluted share were $0.29; adjusted earnings per diluted share were $0.65 The Company provides financial guidance for 2019 including total
Read more →IARTIntegra LifeSciences Launches the Integra Panta 2 TTC Arthrodesis Nail System
PLAINSBORO, N.J., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced the launch of the Integra® Panta® 2 TTC Arthrodesis Nail System for tibio-talo-calcaneal (TTC) fusion of the
Read more →IARTIntegra LifeSciences to Host Fourth Quarter and Full-Year 2018 Earnings Results Conference Call on February 21, 2019
PLAINSBORO, N.J., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full-year 2018 financial results on Thursday, February 21, 2019, prior to market open. In con
Read more →IARTIntegra LifeSciences Launches Integra Titan™ Reverse Shoulder System-S
PLAINSBORO, N.J., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced the full market release of the Integra® Titan™ Reverse Shoulder System-S (RSS-S). This launch includes a new
Read more →IARTIntegra LifeSciences Appoints Rhonda Germany Ballintyn as Director
PLAINSBORO, N.J., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced the appointment of Rhonda Germany Ballintyn to its board of directors, effective today. Ms. Germany Ballintyn
Read more →IARTIntegra LifeSciences Announces Preliminary Fourth Quarter 2018 Financial Results
Preliminary Fourth Quarter 2018 Highlights: Fourth quarter 2018 reported revenue is expected to be at the higher end of the company’s previous guidance range of $378 million to $383 million; Organic revenue growth in the fourth quarter 2018 is expected to be slightly above 4%.
Read more →IARTIntegra LifeSciences Announces Agreement with Consortium of Focused Orthopedists to Develop a Short Stem and Stemless Shoulder System
PLAINSBORO, N.J., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced it has signed a license and development agreement with Consortium of Focused Orthopedists, LLC (CFO), for a sh
Read more →IARTIntegra LifeSciences to Present at the 37th Annual J.P. Morgan Healthcare Conference
PLAINSBORO, N.J., Dec. 18, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced President and Chief Executive Officer Peter Arduini will speak at the 37th Annual J.P. Morgan Healthcare Conf
Read more →IARTIntegra XT Revision Total Ankle Replacement System Offers Innovative Solution to Ankle Arthroplasty Revision Surgery
PLAINSBORO, N.J., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced one of the first surgeries with the Integra® XT Revision Total Ankle Replacement System. “Integra’s new total
Read more →IARTIntegra LifeSciences Appoints Eric Schwartz, Corporate Vice President, General Counsel and Secretary
PLAINSBORO, N.J., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the appointment of Eric Schwartz as corporate vice president, general counsel and secretary. “I am pleased to welcome Eric as our new general counsel and l
Read more →IARTIntegra LifeSciences to participate in Healthcare Conferences in November 2018
PLAINSBORO, N.J., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conference in October: On Thursday, November 15, 2018 at 9:10 a.m. MT, Dan Reuvers,
Read more →IARTIntegra LifeSciences Reports Third Quarter 2018 Financial Results
Investor Relations Contacts: Sravan Emany Senior Vice President, Strategy, Treasury & Investor Relations (609) 936-2488 sravan.emany@integralife.com Michael Beaulieu Director, Investor Relations (609) 750-2827 michael.beaulieu@integralife.com Media Contact: Laurene Isip
Read more →IARTIntegra LifeSciences to Host Third Quarter 2018 Earnings Results Conference Call on October 31, 2018
PLAINSBORO, N.J., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2018 financial results on Wednesday, October 31, 2018, prior to market open. In conjunction with t
Read more →IARTIntegra LifeSciences to participate in the Cantor Global Healthcare Conference
PLAINSBORO, N.J., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conference in October: On Monday, October 1, 2018 at 4:05 p.m. ET, Sravan Emany, v
Read more →IARTIntegra LifeSciences Selected for Healogics iSupply℠ Program
PLAINSBORO, N.J., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced it has been selected as a primary provider for cellular-based tissue products within Healogics® Inc. new iSup
Read more →IARTIntegra LifeSciences to Present at Healthcare Conferences in September 2018
PLAINSBORO, N.J., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conferences in September: On Thursday, September 6, 2018 at 8:35 a.m. ET, Glenn Col
Read more →IARTIntegra LifeSciences Reports Second Quarter 2018 Financial Results
Revenue Increased 29.8% to $366.2 million; Organic Revenue Increased 3.4% Reported EPS of $0.14; Adjusted EPS of $0.60 Raises Low-End of Full-Year Total Revenue and EPS Guidance Successfully Exits First Wave of Codman Transition Services Agreements PLAINSBORO, N.J., July 25,
Read more →IARTIntegra LifeSciences to Host Second Quarter 2018 Earnings Results Conference Call on July 25, 2018
PLAINSBORO, N.J., July 11, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will release second quarter 2018 financial results on Wednesday, July 25, 2018, prior to market open. In conjunction with the
Read more →IARTIntegra LifeSciences to Present at Healthcare Conferences in June 2018
PLAINSBORO, N.J., May 23, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will present at the following healthcare conferences in June: On Wednesday, June 6, 2018 at 3:30 p.m. ET, Peter Arduini, presi
Read more →IARTIntegra LifeSciences Prices Public Offering of Common Stock Plainsboro, New Jersey
Integra LifeSciences Prices Public Offering of Common Stock Plainsboro, New Jersey, May 9, 2018 - Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced that it has priced its previously announced underwritten pub
Read more →IARTIntegra LifeSciences Announces Proposed Public Offering of Common Stock Plainsboro, New Jersey
LifeSciences Announces Proposed Public Offering of Common Stock Plainsboro, New Jersey, May 9, 2018 - Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced that it intends to offer, subject to market conditions an
Read more →IARTIntegra LifeSciences Announces Proposed Public Offering of Common Stock
PLAINSBORO, N.J., May 09, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that it intends to offer, subject to market conditions and other factors, 5,250,000 shares of its common stock
Read more →IARTIntegra LifeSciences Prices Public Offering of Common Stock
PLAINSBORO, N.J., May 09, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that it has priced its previously announced underwritten public offering of 5,250,000 shares of its common stoc
Read more →IARTIntegra LifeSciences Announces Amendment and Extension of Credit Facility
PLAINSBORO, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that it has amended and extended its credit facility with a bank group led by Bank of America, N.A. The overal
Read more →IARTIntegra LifeSciences Announces Amendment and Extension of Credit Facility PLAINSBORO, New Jersey /
LifeSciences Announces Amendment and Extension of Credit Facility PLAINSBORO, New Jersey / May 7, 2018 Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced that it has amended and extended its credit facility wit
Read more →IARTIntegra LifeSciences to Present at Healthcare Conference in May 2018
PLAINSBORO, N.J., April 26, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will present at the following healthcare conferences in May: On Tuesday, May 15, 2018 at 10:40 a.m. PT, Glenn Coleman, chief
Read more →IARTIntegra LifeSciences Reports First Quarter 2018 Financial Results
Revenue Increased 38.1% to $357.1 million; Organic Revenue Increased 3.0% Reported EPS of $0.14; Adjusted EPS of $0.58 Company Raises Full-Year Total Revenue and EPS Guidance PLAINSBORO, N.J., April 25, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ
Read more →IARTIntegra LifeSciences to Host First Quarter 2018 Earnings Results Conference Call on April 25, 2018
PLAINSBORO, N.J., April 11, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will release first quarter 2018 financial results on Wednesday, April 25, 2018, prior to market open. In conjunction with the
Read more →IARTInvestor Relations: Michael Beaulieu (609) 750-2827 michael.beaulieu@integralife.com Media: Laurene Isip (609) 750-7984 laurene.isip@integralife.com Integra LifeSciences Reports Fourth Quarter and F
Contact: Investor Relations: Michael Beaulieu (609) 750-2827 michael.beaulieu@integralife.com Media: Laurene Isip (609) 750-7984 laurene.isip@integralife.com The company reported 2017 fourth quarter revenue of $368.6 million, GAAP earnings per diluted share of $0.56 and
Read more →IARTIntegra LifeSciences Reports Fourth Quarter and Full-Year 2017 Financial Results
PLAINSBORO, N.J., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today reported financial results for the fourth quarter and full-year ended December 31, 2017. The Company completed the acquisition of Codman Neurosurgery, the largest in
Read more →IARTIntegra LifeSciences Appoints Sravan Emany as Vice President, Treasurer and Investor Relations
PLAINSBORO, N.J., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the appointment of Sravan Emany as vice president, treasurer and investor relations. Mr. Emany will be a member of the Integra executive leadership team.
Read more →IARTIntegra LifeSciences to Present at Healthcare Conferences in March 2018
PLAINSBORO, N.J., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will present at the following healthcare conferences in March: On Monday, March 5, 2018 at 4:35 p.m. ET, Glenn Coleman, chief
Read more →IARTIntegra LifeSciences to Host Fourth Quarter 2017 Earnings Results Conference Call on February 27, 2018
PLAINSBORO, N.J., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will release fourth quarter and full year 2017 financial results on Tuesday, February 27, 2018, prior to market open. In conju
Read more →IARTIntegra LifeSciences Announces Preliminary Fourth Quarter 2017 Financial Results
Preliminary Fourth Quarter Highlights: Fourth quarter 2017 reported revenue is expected to be approximately $365 million, exceeding the high-end of the company’s previous implied guidance range of $345 million to $355 million; Organic revenue growth in the fourth quarter is exp
Read more →IARTIntegra LifeSciences to Present at the 36th Annual J.P. Morgan Healthcare Conference
PLAINSBORO, N.J., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced President and Chief Executive Officer Peter Arduini will speak at the 36th Annual J.P. Morgan Healthcare Confe
Read more →IARTIntegra LifeSciences Hosts Investor Day 2017 New York City
PLAINSBORO, N.J., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today will host an Investor Day meeting with analysts and institutional investors in New York City, beginning at 8:00 a.m. EST
Read more →IARTIntegra LifeSciences Reports Third Quarter 2017 Financial Results
Contact: Investor Relations: Michael Beaulieu (609) 750-2827 michael.beaulieu@integralife.com Media: Laurene Isip (609) 750-7984 laurene.isip@integralife.com Integra LifeSciences Reports Third Quarter 2017 Financial Results Revenue Increased 11.4% to $279 million; Organ
Read more →IARTIntegra LifeSciences to Host Third Quarter 2017 Earnings Results Conference Call on October 26, 2017
PLAINSBORO, N.J., Oct. 11, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will release 2017 third quarter financial results on Thursday, October 26, 2017, prior to market open. In conjunction with the
Read more →IARTIntegra LifeSciences launches Revize™/ Revize™-X Collagen Matrix for Plastic and Reconstructive Surgery
PLAINSBORO, N.J., Oct. 06, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced the launch of Revize™ / Revize-X™ Collagen Matrix, its latest offering in tissue-building solutions for plasti
Read more →IARTIntegra LifeSciences Launches Integra SurgiMend™ PRS Meshed Collagen Matrix for Breast Reconstruction in Europe
PLAINSBORO, N.J., Oct. 03, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the expansion of its acellular dermal tissue matrix (ADM) product line for plastic and reconstructive surgery, including breast reconstruction in Europe, wi
Read more →IARTIntegra LifeSciences launches SurgiMend PRS Meshed Collagen Matrix for Plastic and Reconstructive Surgery
PLAINSBORO, N.J., Oct. 03, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced that it has launched SurgiMend® PRS Meshed Collagen Matrix, its latest offering in tissue-building solutions f
Read more →IARTIntegra LifeSciences Completes the Acquisition of Codman Neurosurgery Business from Johnson & Johnson
PLAINSBORO, N.J., Oct. 02, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a global leader in medical technology, announced today that it has completed the previously announced acquisition of the Johnson & Johnson Codman Neurosurgery business for
Read more →IARTIntegra LifeSciences Announces First Patient Enrolled in Cadence Total Ankle System Post-Market Study
PLAINSBORO, N.J., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced the first Cadence® Total Ankle System has been implanted by Dr. David Pedowitz with the Rothman Institute in
Read more →IARTIntegra LifeSciences Announces Definitive Agreement to Sell Certain Neurosurgery Assets to Natus Medical Incorporated Natus Medical to acquire global Camino ICP monitoring product line, U.S. rights to Integra s fixed pre
Integra LifeSciences Announces Definitive Agreement to Sell Certain Neurosurgery Assets to Natus Medical Natus Medical to acquire global Camino ICP monitoring product line, U.S. rights to Integra s fixed pressure shunts, and U.S. rights to Codman s DURAFORM , EVD catheters and
Read more →IARTIntegra LifeSciences to Present at Healthcare Conferences in September 2017
PLAINSBORO, N.J., Aug. 17, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will present at the Wells Fargo Healthcare Conference and the Morgan Stanley Healthcare Conference in September. On Thursday,
Read more →IARTIntegra’s DuraSeal dural sealant saves healthcare costs according to a study recently published in the Journal of Health Economics and Outcomes Research
PLAINSBORO, N.J., Aug. 11, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences (NASDAQ:IART), a leading global medical technology company, has announced the publication of a new economic study, “A cost-benefit analysis of using polyethylene glycol hydrogel sealant versus fibrin glue as
Read more →IARTIntegra LifeSciences Reports Second Quarter 2017 Financial Results
Revenue Increased 13.2% to $282.2 million; Organic Revenue Increased 4.6% Reported EPS of $0.14; Adjusted EPS of $0.45, up 12.5% PLAINSBORO, N.J., July 26, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology comp
Read more →IARTIntegra LifeSciences to Host Its Second Quarter 2017 Earnings Results Conference Call on July 26, 2017
PLAINSBORO, N.J., July 11, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will release its second quarter 2017 financial results on Wednesday, July 26, 2017. In conjunction with the earnings release,
Read more →IARTIntegra LifeSciences to Hold Second International Tissue Technologies Symposium on June 15 - 16, 2017 in Berlin, Germany
PLAINSBORO, N.J., June 15, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it is holding its second International Symposium on Tissue Technologies in Berlin, Germany on June 15 - 16, 2017. Following the success of the first I
Read more →IARTIntegra LifeSciences to Present at Healthcare Conferences in June 2017
PLAINSBORO, N.J., May 24, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that it will present at the following conferences in June: At 4:00PM ET on Wednesday, June 7, 2017, Mr. Peter
Read more →IARTIntegra LifeSciences Announces Agreement with aap to Distribute LOQTEQ Distal Radius System
PLAINSBORO, N.J. and BERLIN, May 23, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, announced today that it has signed an agreement with aap Implantate AG (“aap”) to distribute the LOQTEQ® Distal Radi
Read more →IARTIntegra LifeSciences Announces the European Launch of Integra Dermal Regeneration Template Single Layer “Thin”
PLAINSBORO, N.J., May 17, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced that it has launched in Europe Integra® Dermal Regeneration Template (IDRT) Single Layer “Thin” for dermal repa
Read more →IARTIntegra LifeSciences launches SurgiMend MP Collagen Matrix for Hernia Repair
PLAINSBORO, N.J., May 12, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced the launch of SurgiMend MP, its latest offering in tissue-building solutions for complex abdominal hernia repai
Read more →IARTIntegra LifeSciences to Present at Healthcare Conferences in May 2017
PLAINSBORO, N.J., May 03, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that it will present at the following conferences in May: At 10:40AM PT on Tuesday, May 16, 2017, Mr. Glenn Co
Read more →IARTIntegra LifeSciences Reports First Quarter 2017 Financial Results
Contact: Investor Relations: Angela Steinway (609) 936-2268 angela.steinway@integralife.com Michael Beaulieu (609) 750-2827 michael.beaulieu@integralife.com Media: Laurene Isip (609) 750-7984 laurene.isip@integralife.com Integra LifeSciences Reports First Quarter 2017
Read more →IARTIntegra LifeSciences to Host Its First Quarter 2017 Earnings Results Conference Call on April 26, 2017
PLAINSBORO, N.J., April 12, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will release its first quarter 2017 financial results on Wednesday, April 26, 2017. The company has scheduled a conference ca
Read more →IARTIntegra LifeSciences Holdings Corporation Investor Relations: Angela Steinway (609) 936-2268 angela.steinway@integralife.com Michael Beaulieu (609) 750-2827 michael.beaulieu@integralife.com Integra
Integra LifeSciences Holdings Corporation angela.steinway@integralife.com michael.beaulieu@integralife.com Integra LifeSciences Announces Expansion of Credit Facility to include new $700 million term loan Financing now secured for the planned acquisition of Codman Plainsbor
Read more →IARTIntegra LifeSciences Announces Expansion of Credit Facility to include new $700 million term loan
PLAINSBORO, N.J., April 04, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that it has increased its credit facility with its bank group led by Bank of America, N.A. The expanded cred
Read more →IARTIntegra LifeSciences Announces Commercial Expansion of the Cadence Total Ankle System
PLAINSBORO, N.J., March 28, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced full commercial availability of its Cadence® Total Ankle System, a new ankle prosthesis developed in partners
Read more →IARTIntegra LifeSciences Introduces Next Generation CUSA Clarity Ultrasonic Tissue Ablation System
PLAINSBORO, N.J., March 16, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a global leader in medical technology, announces the launch of its new CUSA® Clarity ultrasonic tissue ablation platform designed to deliver an innovative, integrated sys
Read more →IARTIntegra LifeSciences Launches Press-Fit Reverse Shoulder for Fracture for the Titan™ Modular Shoulder System
PLAINSBORO, N.J., March 15, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, announced the launch of the Titan™ Press-Fit Reverse Shoulder for Fracture. The use of the reverse shoulder to treat humeral
Read more →IARTIntegra LifeSciences to Present at the Barclays Global Healthcare Conference and Oppenheimer’s 27th Annual Healthcare Conference in March 2017
PLAINSBORO, N.J., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conferences in March: At 9:00AM ET on Tuesday, March 14, 2017, Mr. Glenn Coleman, Chief Financial Officer and Corpora
Read more →IARTInvestor Relations: Angela Steinway (609) 936-2268 angela.steinway@integralife.com Michael Beaulieu (609) 750-2827 michael.beaulieu@integralife.com Integra LifeSciences Reports Fourth Quarter and Fu
Contact: Investor Relations: Angela Steinway (609) 936-2268 angela.steinway@integralife.com Michael Beaulieu (609) 750-2827 michael.beaulieu@integralife.com Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidanc
Read more →IARTIntegra LifeSciences Announces Acceptance of Shares Tendered into Offer for Derma Sciences, Inc.
PLAINSBORO, N.J., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (“Integra”) (NASDAQ:IART), a global leader in medical technology, announced today that its tender offer by its wholly-owned subsidiary, Integra Derma, Inc. (“Offeror”), to purchase all o
Read more →IARTIntegra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance
PLAINSBORO, N.J., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today reported its financial results for the fourth quarter and full year ending December 31, 2016. Full-year 2016 revenue increased 12.4% to $992.1 million, while organic
Read more →IARTIntegra LifeSciences Plans to Acquire the Codman Neurosurgery Business from Johnson & Johnson for $1.045 Billion in Cash Enhances global position in neurosurgery by adding a complementary product portfolio and the world-
Integra LifeSciences Plans to Acquire the Codman Neurosurgery Business from Johnson & Johnson for $1.045 Billion in Cash Plainsboro, New Jersey, February 15, 2017 (GLOBE NEWSWIRE) Integra LifeSciences Holdings Corporation (Nasdaq:IART), a global leader in medical technology, t
Read more →IARTIntegra LifeSciences to Host Its Fourth Quarter 2016 Earnings Results Conference Call on February 23, 2017
PLAINSBORO, N.J., Jan. 26, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) will release its fourth quarter 2016 financial results on Thursday, February 23, 2017. The company has scheduled a conference call for 8:30 AM ET the same day to discuss th
Read more →IARTIntegra LifeSciences Commences Previously Announced Cash Tender Offer to Acquire Derma Sciences, Inc.
PLAINSBORO, N.J., Jan. 25, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (“Integra”) (NASDAQ:IART), a global leader in medical technology, announced today that its wholly-owned subsidiary, Integra Derma, Inc. (“Offeror”), is commencing a cash tender offer to
Read more →IARTJan-2017 Integra LifeSciences Holdings Corp. (IART) Acquisition of Derma Sciences, Inc. by Integra LifeSciences Holdings Corporation Call Total Pages: 15 1-877-FACTSET www.callstreet.com Copyright 2001-2017 FactSet CallS
Integra LifeSciences Holdings Corp. Acquisition of Derma Sciences, Inc. by Integra LifeSciences Holdings Corporation Call Total Pages: 15 1-877-FACTSET www.callstreet.com Copyright 2001-2017 FactSet CallStreet, LLC Integra LifeSciences Holdings Corp. (IART) Acquisition of
Read more →IARTIntegra LifeSciences to Acquire Derma Sciences Inc. and Announces Preliminary Fourth Quarter and Full Year 2016 Financial Results and 2017 Outlook Expands regenerative technology capabilities and accelerates advanced wou
Integra LifeSciences to Acquire Derma Sciences Inc. and Announces Preliminary Fourth Quarter and Full Year 2016 Financial Results and 2017 Outlook Plainsboro, New Jersey, January 10, 2016 (GLOBE NEWSWIRE) Integra LifeSciences Holdings Corporation (Nasdaq:IART), a global leader
Read more →IARTIntegra LifeSciences Announces Approval of Two-for-One Stock Split
PLAINSBORO, N.J., Dec. 22, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that its stockholders approved a two-for-one stock split and an increase from 60 million to 240 million authorized shares of the Company’s common stock at a
Read more →IARTIntegra LifeSciences to Present at the 35th Annual J.P. Morgan Healthcare Conference in January 2017
PLAINSBORO, N.J., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conference in January: At 2:30PM PT on Wednesday, January 11, 2017, Mr. Peter Arduini, President and CEO will present
Read more →IARTIntegra LifeSciences to Host Regenerative Technology Investor Day and Webcast Wednesday, December 14, 2016
PLAINSBORO, N.J., Dec. 07, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) - (news) today announced that it will host an institutional investor and analyst meeting on Wednesday, December 14, 2016 from 9:30 a.m. to 1:00 p.m. (ET). A live webcast o
Read more →IARTIntegra LifeSciences Announces Expansion and Extension of Credit Facility to $1.5 Billion
PLAINSBORO, N.J., Dec. 07, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has increased its credit facility with its bank group led by Bank of America, N.A. The expanded and extended credit facility includes the following
Read more →IARTIntegra LifeSciences Announces Key Executive Appointments
PLAINSBORO, N.J., Dec. 05, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced key executive appointments effective December 1, 2016. Robert T. Davis, Jr., corporate vice president and president, Specialty Surgical Solutions (SSS), ha
Read more →IARTIntegra LifeSciences to Present at the 28th Annual Piper Jaffray Healthcare Conference
PLAINSBORO, N.J., Nov. 21, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conference in November: At 10:00M ET on Tuesday, November 29, 2016, Mr. Robert Davis, President Specialty Surgical So
Read more →IARTIntegra LifeSciences Announces Plans for a Two-For-One Stock Split and Increase in Authorized Shares
PLAINSBORO, N.J., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that its Board of Directors has recommended an increase in the number of authorized shares and a two-for-one stock split. “The recommendation from the boar
Read more →IARTIntegra LifeSciences Reports Third Quarter 2016 Financial Results
Revenue Increased 10.6% to $250.3 million; Organic Revenue Increased 9.5% Reported EPS of $0.50; Adjusted EPS of $0.93 PLAINSBORO, N.J., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today reported its financial results for the third
Read more →IARTIntegra LifeSciences Organizes Hands-on Wound Workshop on Best Practices for Omnigraft Dermal Regeneration Matrix and PriMatrix Dermal Repair Scaffold at Symposium on Advanced Wound Care (SAWC) Fall Meeting
PLAINSBORO, N.J., Oct. 17, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) recently organized a hands-on regenerative wound management workshop at the Symposium on Advanced Wound Care (SAWC) Fall meeting in Las Vegas, Nevada. The workshop, led by
Read more →IARTIntegra LifeSciences to Host Its Third Quarter 2016 Earnings Results Conference Call on October 27, 2016
PLAINSBORO, N.J., Oct. 06, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) will release its third quarter 2016 financial results on Thursday, October 27, 2016. The company has scheduled a conference call for 4:30 PM ET the same day to discuss the
Read more →IARTIntegra LifeSciences Announces First Clinical Uses of Cadence™ Total Ankle System in Europe
PLAINSBORO, N.J., Sept. 20, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the first three procedures using the Integra® Cadence™ Total Ankle System in Europe were successfully co
Read more →IARTIntegra LifeSciences to Present at the Wells Fargo 2016 Healthcare Conference and the Morgan Stanley Global Healthcare Conference in September 2016
PLAINSBORO, N.J., Aug. 22, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conferences in September: At 2:20PM ET on Wednesday, September 7, 2016, Mr. Glenn Coleman, Chief Financial Officer, w
Read more →IARTIntegra LifeSciences Announces that Omnigraft™ Dermal Regeneration Matrix was Recognized as a Top Ten Innovation by Podiatry Today
PLAINSBORO, N.J., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that its recently introduced product, Integra® Omnigraft™ Dermal Regeneration Matrix, has been recognized by P
Read more →IARTIntegra LifeSciences Reports Second Quarter 2016 Financial Results
Contact: Investor Relations: Angela Steinway (609) 936-2268 angela.steinway@integralife.com Michael Beaulieu (609) 750-2827 michael.beaulieu@integralife.com Integra LifeSciences Reports Second Quarter 2016 Financial Results Revenue Increased 17.2% to $249.3 million; Organ
Read more →IARTIntegra LifeSciences to Host Its Second Quarter 2016 Earnings Results Conference Call on July 28, 2016
PLAINSBORO, N.J., July 11, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) will release its second quarter 2016 financial results on Thursday, July 28, 2016. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the re
Read more →IARTIntegra LifeSciences Holdings Corporation (Nasdaq: IART) to Ring The Nasdaq Stock Market Closing Bell
ADVISORY, July 05, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, will visit the Nasdaq MarketSite in Times Square. In honor of the occasion, Glenn G. Coleman, Chief Financial Officer will ring the
Read more →IARTIntegra LifeSciences to Hold First International Tissue Technologies Symposium on June 16 - 17, 2016 in Lisbon, Portugal
PLAINSBORO, N.J., June 16, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it is holding its first International Symposium on Tissue Technologies in Lisbon, Portugal, June 16 - 17, 2016. This event-packed, two-day medical tra
Read more →IARTIntegra LifeSciences to Present at the Jefferies 2016 Healthcare Conference in June 2016
PLAINSBORO, N.J., May 25, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conferences in June: At 8:30AM ET on Wednesday, June 8, 2016, Mr. Glenn Coleman, Integra’s Chief Financial Officer, wi
Read more →IARTIntegra LifeSciences launches Integra Fin-Lock™ Glenoid for the Titan™ Modular Shoulder System
PLAINSBORO, N.J., May 23, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced the launch of the Integra® Fin-Lock™ Glenoid. This addition to the Titan™ Modular Shoulder System increases the
Read more →IARTIntegra LifeSciences Receives FDA Approval for Integra Omnigraft™ Dermal Regeneration Matrix, Clearing the Way for Commercial Release
PLAINSBORO, N.J., May 11, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the Company has received approval from the U.S. Food and Drug Administration (FDA) for the packaging of it
Read more →IARTIntegra LifeSciences to Present at the Bank of America Merrill Lynch 2016 Health Care Conference and the UBS Global Healthcare Conference in May 2016
PLAINSBORO, N.J., May 03, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conferences in May: At 1:00PM PT on Tuesday, May 10, 2016, Mr. Glenn Coleman, Integra’s Chief Financial Officer, will
Read more →IARTIntegra LifeSciences Reports First Quarter 2016 Financial Results
Revenue of $236.8 million; Organic Revenue Increased 8.9%; Adjusted Net Income Increased 15.3%; Adjusted EPS of $0.74 PLAINSBORO, N.J., April 27, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today reported its financial results for the first
Read more →IARTIntegra LifeSciences Provides Update for Omnigraft™ Commercialization Plans, Including Expectations for an Earlier Launch
PLAINSBORO, N.J., April 27, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the Company is prepared to launch Omnigraft™ Dermal Regeneration Matrix in June 2016, pending receipt of
Read more →IARTIntegra LifeSciences Announces Initial Clinical Use of the Cadence™ Total Ankle System in the United States
PLAINSBORO, N.J., April 26, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the first ten procedures using the Integra® CadenceTM Total Ankle System were successfully completed by
Read more →IARTIntegra LifeSciences Announces Agreement with AlloSource to Commercialize HuMend™, Human Acellular Dermal Matrix
PLAINSBORO, N.J., April 26, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (NASDAQ:IART), a leading global medical technology company, today announced its entry into an agreement with AlloSource®, one of the nation’s largest providers of cartilage, cellular, bo
Read more →IARTIntegra LifeSciences Announces Agreement with Vomaris Wound Care, Inc. to Commercialize VolTAC™ Antimicrobial Wound Dressing
PLAINSBORO, N.J., April 14, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that its subsidiary, Integra LifeSciences Corporation, has entered into an agreement with Vomaris Wound Care,
Read more →IARTIntegra LifeSciences to Host Its First Quarter 2016 Earnings Results Conference Call on April 27, 2016
PLAINSBORO, N.J., April 06, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) will release its first quarter 2016 financial results on Wednesday, April 27, 2016. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the
Read more →IARTIntegra LifeSciences Awarded $10.3 Million Department of Defense Contract
PLAINSBORO, N.J., March 10, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (NASDAQ:IART), a leading global medical technology company, today announced that through its partnership with Buffalo Supply, it has received a five-year, $10.3 million contract with the
Read more →IARTIntegra LifeSciences to Present at the Canaccord 11th Annual Musculoskeletal Conference, Raymond James & Associates’ 37th Annual Institutional Investors Conference and the Barclays Global Healthcare Conference in March 2016
PLAINSBORO, N.J., Feb. 26, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conference in March: At 4:00PM ET on Tuesday, March 1, 2016, Mr. Mark Augusti, President – Orthopedics & Tissue Techn
Read more →IARTIntegra LifeSciences Announces Service Alliance Agreement With PREZIO Health
PLAINSBORO, N.J., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (NASDAQ:IART) today announced its service alliance agreement with PREZIO Health, a leader in perioperative services, repair, maintenance and management of surgical instruments. Together,
Read more →IARTIntegra LifeSciences Reports Fourth Quarter and Full Year 2015 Financial Results and Issues 2016 Full Year Guidance
Fourth Quarter Revenues Increased 10.1% to $241.2 Million Fourth Quarter Adjusted EPS of $0.87; Reported EPS of $0.39 Full Year Organic Revenues Increased 6.7% PLAINSBORO, N.J., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today rep
Read more →IARTIntegra LifeSciences to Host Its Fourth Quarter 2015 Earnings Results Conference Call on February 25, 2016
PLAINSBORO, N.J., Feb. 01, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) will release its fourth quarter 2015 financial results on Thursday, February 25, 2016. The company has scheduled a conference call for 4:30 PM ET the same day to discuss th
Read more →IARTIntegra LifeSciences Receives FDA Approval of Integra Dermal Regeneration Template (IDRT) for Treatment of Chronic Diabetic Foot Ulcers (DFU)
PLAINSBORO, N.J., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that the United States Food and Drug Administration (FDA) has approved the PMA Supplement for Integra® Dermal Regeneration Template (IDRT) for the treatment
Read more →IARTIntegra LifeSciences to Present at the 34th Annual J.P. Morgan Healthcare Conference In January 2016
PLAINSBORO, N.J., Jan. 04, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the 34th Annual J.P. Morgan Healthcare Conference: At 2:30PM PT on Wednesday, January 13, 2016, Mr. Peter Arduini, President and Ch
Read more →IARTIntegra LifeSciences to Present at the 27th Annual Piper Jaffray Healthcare Conference and the Oppenheimer 26th Annual Healthcare Conference in December 2015
PLAINSBORO, N.J., Nov. 18, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conferences in December: At 9:30AM ET on Tuesday, December 1, 2015, Mr. Peter Arduini, President and Chief Executive
Read more →IARTIntegra LifeSciences Hosts Investor Day Today, November 12, 2015 in New York City
PLAINSBORO, N.J., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it is increasing its 2018 financial outlook in conjunction with its Investor Day meeting on Thursday, November 12, 2015, beginning at 8:30am (ET) in Ne
Read more →IARTIntegra LifeSciences Reports Third Quarter 2015 Financial Results
Revenue Increased 14.6% to $226.4 Million with Adjusted EPS of $0.75 Adjusted Net Income Increased 15.1% Raised Low End of Full Year 2015 Revenue and EPS Guidance PLAINSBORO, N.J., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today
Read more →IARTThis news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties and reflects the
Contact: Investor Relations: Angela Steinway (609) 936-2268 angela.steinway@integralife.com Michael Beaulieu (609) 750-2827 michael.beaulieu@integralife.com Integra LifeSciences Reports Third Quarter 2015 Financial Results Revenue Increased 14.6% to $226.4 Million with Adj
Read more →IARTIntegra LifeSciences to Host Its Third Quarter 2015 Earnings Results Conference Call on November 3, 2015
PLAINSBORO, N.J., Oct. 07, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) will release its third quarter 2015 financial results on Tuesday, November 3, 2015. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the r
Read more →IARTIntegra LifeSciences Completes Acquisition of Salto Talaris(R) Total Ankle Replacement and Futura(TM) Silastic Toe Replacement Product Portfolios from Tornier N.V.
PLAINSBORO, N.J., Oct. 2, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it closed the acquisition of the United States rights to Tornier's Salto Talaris and Salto Talaris XT ankle replacement products and Tornier's Futura si
Read more →IARTIntegra LifeSciences Files Patent Infringement Lawsuit Against HyperBranch Medical Technology, Inc.
PLAINSBORO, N.J., Sept. 15, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Integra filed a lawsuit in the U.S. District Court for the District of Delaware against HyperBranch Medical Technology, Inc. The lawsuit alleges that
Read more →IARTIntegra LifeSciences to Acquire Total Ankle Replacement (Salto Talaris(R)) and Silastic Toe Replacement (Futura(TM)) Product Portfolios From Tornier N.V.
PLAINSBORO, N.J. and AMSTERDAM, The Netherlands, Sept. 3, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) and Tornier N.V. (NASDAQ:TRNX), today announced a definitive agreement under which Integra will acquire the United States rights to Tornier's
Read more →IARTIntegra LifeSciences Announces Expansion of Credit Facility to $1.1 Billion
PLAINSBORO, N.J., Sept. 1, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has increased its credit facility with its bank group led by Bank of America, N.A. "We are pleased to improve our overall capital structure by expa
Read more →IARTIntegra LifeSciences to Present at the Wells Fargo 2015 Healthcare Conference and the 2015 Morgan Stanley Global Healthcare Conference in September
PLAINSBORO, N.J., Aug. 26, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conference in June: At 10:20AM ET on Thursday, September 10, 2015, Mr. Glenn Coleman, Chief Financial Officer, will p
Read more →IARTIntegra LifeSciences Announces FOUNDER Study Results Which Show Increased Rate of Complete Wound Closure and Decreased Time to Complete Wound Closure With Integra(R) Dermal Regeneration Template (IDRT) for Treatment of Chronic Diabetic Foot Ulcers (DFU)
PLAINSBORO, N.J., Aug. 25, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced the online publication of its pivotal clinical trial evaluating Integra Dermal Regeneration Template (IDRT) for the treatment of non-healing diabetic foot u
Read more →IARTIntegra LifeSciences Holdings Corporation Unaudited Pro Forma Consolidated Financial Information On
Integra LifeSciences Holdings Corporation Unaudited Pro Forma Consolidated Financial Information On July 1, 2015, Integra LifeSciences Holdings Corporation ("Integra" or the "Company") completed the previously announced separation (the "Separation") of SeaSpine Holdings Corpora
Read more →IARTIntegra LifeSciences Reports Second Quarter 2015 Financial Results
Revenue Increased 5.5% to $244.1 Million Reported EPS of $0.15; Adjusted EPS Increased 16% to $0.79 Full Year 2015 Revenue and EPS Guidance Updated for SeaSpine Spin-off and TEI Acquisition PLAINSBORO, N.J., July 30, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corpo
Read more →IARTQ2 2015 Earnings Release News Release Contact: Investor Relations: Angela Steinway (609) 936-2268 angela.steinway@integralife.com Michael Beaulieu (609) 750-2827 michael.beaulieu@integralife.com Integra LifeSciences Repo
Contact: Investor Relations: Angela Steinway (609) 936-2268 angela.steinway@integralife.com Michael Beaulieu (609) 750-2827 michael.beaulieu@integralife.com Integra LifeSciences Reports Second Quarter 2015 Financial Results Revenue Increased 5.5% to $244.1 Million Reported
Read more →IARTIntegra LifeSciences Completes Acquisition of TEI Biosciences and TEI Medical
PLAINSBORO, N.J., July 20, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), today announced that it has completed the acquisition of all of the outstanding shares of TEI Biosciences Inc. and TEI Medical Inc. ("TEI"). "We are enthusiastic about th
Read more →IARTIntegra LifeSciences Holdings Corporation Investor Relations: Angela Steinway (609) 936-2268 angela.steinway@integralife.com Michael Beaulieu (609) 750-2827 michael.beaulieu@integralife.com Media:
Integra LifeSciences Holdings Corporation angela.steinway@integralife.com michael.beaulieu@integralife.com gianna.sabella@integralife.com Integra LifeSciences Completes Acquisition of TEI Biosciences and Jersey, July 20, 2015 Integra LifeSciences Holdings Corporation (NASDAQ
Read more →IARTIntegra LifeSciences to Host Its Second Quarter 2015 Earnings Results Conference Call on July 30, 2015
PLAINSBORO, N.J., July 15, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) will release its second quarter 2015 financial results on Thursday, July 30, 2015. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the re
Read more →IARTIntegra LifeSciences Completes Spin-Off of SeaSpine
PLAINSBORO, N.J., July 1, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has completed the previously announced tax-free spin-off of its orthobiologics and spinal fusion hardware business, now known as SeaSpine Holdings Co
Read more →IARTIntegra LifeSciences to Acquire TEI Biosciences and TEI Medical
Broadens Integra's position as a leader in regenerative wound care and tissue repair Adds new selling capabilities to the wound care clinic and enhances current sales channel in both burn centers and Operating Rooms (OR) Management to Host Conference Call Tomorrow PLAINSBORO,
Read more →IARTIntegra to Complete Tax-Free Spin-Off of SeaSpine on July 1, 2015
PLAINSBORO, N.J., June 9, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the Board of Directors of Integra has approved the separation of SeaSpine Holdings Corporation ("SeaSpine") from Integra in the form of a tax-free divid
Read more →IARTIntegra LifeSciences and SeaSpine to Present at the Jefferies 2015 Global Healthcare Conference in June
PLAINSBORO, N.J., May 26, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will make the following presentations at the Jefferies 2015 Global Healthcare Conference in New York City: At 4:00PM ET on Tuesday, June 2, 2015, Mr
Read more →IARTIntegra LifeSciences to Provide Historical Financials Adjusted for Discontinued Operations and Host Conference Call on May 26, 2015
PLAINSBORO, N.J., May 20, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced plans to release historical financial information adjusted for the planned spin-off of its spine business, to become SeaSpine Holdings Corporation. Following
Read more →IARTIntegra LifeSciences Features New MAYFIELD(R) 2 System at the American Association of Neurological Surgeons Annual Scientific Meeting
PLAINSBORO, N.J., May 1, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the introduction of the new MAYFIELD 2 system for rigid cranial fixation. The MAYFIELD 2 system will be featured at the Integra LifeSciences exhibition booth
Read more →IARTKirt Stephenson, future Chairman of SeaSpine's Board of Directors, said, "We are pleased to have a CEO with Keith's background and track record, as well as a proven financial executive in John Bostjancic. We now have the
Integra LifeSciences Holdings Corporation angela.steinway@integralife.com gianna.sabella@integralife.com Integra LifeSciences Names Keith Valentine as Chief Executive Officer of SeaSpine; John Bostjancic Appointed as Chief Financial Officer of SeaSpine Plainsboro, New Jersey
Read more →IARTQ1 2015 Earnings Release News Release Contact: Investor Relations: Angela Steinway (609) 936-2268 angela.steinway@integralife.com Integra LifeSciences Reports First Quarter 2015 Financial Results Revenue Increased 8.7% t
Contact: Investor Relations: Angela Steinway (609) 936-2268 angela.steinway@integralife.com Integra LifeSciences Reports First Quarter 2015 Financial Results Revenue Increased 8.7% to $233.7 Million Reported EPS Increased to $0.25; Adjusted EPS Increased to $0.76 Full Year 2
Read more →IARTIntegra LifeSciences Names Keith Valentine as Chief Executive Officer of SeaSpine; John Bostjancic Appointed as Chief Financial Officer of SeaSpine
PLAINSBORO, N.J., April 30, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the appointment, effective May 1, 2015, of Keith Valentine as Chief Executive Officer of SeaSpine Holdings Corporation, which will be an independent, publi
Read more →IARTIntegra LifeSciences Reports First Quarter 2015 Financial Results
Revenue Increased 8.7% to $233.7 Million Reported EPS Increased to $0.25; Adjusted EPS Increased to $0.76 Full Year 2015 Revenue and EPS Guidance Raised PLAINSBORO, N.J., April 30, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported
Read more →IARTIntegra LifeSciences to Participate in Three Investor Conferences in May
PLAINSBORO, N.J., April 20, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will present at the following conferences in May: At 2:10PM ET on Wednesday, May 6, 2015, Glenn Coleman, Integra's Chief Financial Officer, will p
Read more →IARTHistorical Segment Revenue: New Segments 2012 2014 New Reporting Segments Information 2 In November 2014, Integra announced the strategic decision to spin off the orthobiologics and spinal fusion hardware business into a
Neurosurgery (26%) U.S. Instruments (17%) U.S. Extremities (15%) U.S. Spine Other (19%) International (23%) (%) Shows percentages of 2014 Revenues Integra Prior Segments (% of Total 2014 Revenue) Integra New Revenue Reporting Segments 7 U.S. Neurosurgery (26%) U.S. Instruments (1
Read more →IARTIntegra LifeSciences to Host Its First Quarter 2015 Earnings Results Conference Call on April 30, 2015
PLAINSBORO, N.J., April 10, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its first quarter 2015 financial results on Thursday, April 30, 2015, after the market closes. The company has scheduled a conference call for 4:30 PM ET the
Read more →IARTIntegra LifeSciences Announces the Filing of the Form 10 Registration Statement for the Planned Spin-off of the Orthobiologics and Spinal Fusion Hardware Business, SeaSpine
PLAINSBORO, N.J., April 1, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the filing of an initial Form 10 Registration Statement with the Securities and Exchange Commission ("SEC") in connection with its previously announced plan
Read more →IARTInvestor Relations: Angela Steinway (609) 936-2268 angela.steinway@integralife.com Integra LifeSciences Reports Fourth Quarter 2014 Financial Results Revenues Increased 14.2% to $252.2 Million Organ
Contact: Investor Relations: Angela Steinway (609) 936-2268 angela.steinway@integralife.com Integra LifeSciences Reports Fourth Quarter 2014 Financial Results Revenues Increased 14.2% to $252.2 Million Organic Revenues Increased 5.8% Reported EPS Increased to $0.52; Adjusted
Read more →IARTIntegra LifeSciences Reports Fourth Quarter 2014 Financial Results
Revenues Increased 14.2% to $252.2 Million Organic Revenues Increased 5.8% Reported EPS Increased to $0.52; Adjusted EPS Increased to $0.94 Issues 2015 Full-Year Guidance PLAINSBORO, N.J., Feb. 24, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IAR
Read more →IARTIntegra LifeSciences to Participate in the Raymond James Institutional Investors Conference, Barclays Global Healthcare Conference and the Canaccord Genuity Musculoskeletal Conference in March
PLAINSBORO, N.J., Feb. 20, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will present at the following conferences in March: At 7:30AM ET on Monday, March 2, 2015, Glenn Coleman, Chief Financial Officer, will present at
Read more →IARTIntegra LifeSciences to Participate in the RBC Capital Markets' Global Healthcare Conference
PLAINSBORO, N.J., Feb. 9, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will present at the following conference in February: At 11:30AM ET on Wednesday, February 25, 2015, Mr. Peter Arduini, Integra's President and Chie
Read more →IARTIntegra LifeSciences Announces Submission of a Premarket Approval Supplement Application for the Treatment of Diabetic Foot Ulcers
PLAINSBORO, N.J., Feb. 3, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced it has completed the submission of a Premarket Approval (PMA) Supplement application to the United States Food and Drug Administration (the "FDA") for a new
Read more →IARTIntegra LifeSciences Launches Integra(R) Reinforcement Matrix
PLAINSBORO, N.J., Jan. 21, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the full market release of Integra Reinforcement Matrix, a biological implant composed of porcine dermis that may be used for any type of tendon injury that
Read more →IARTIntegra LifeSciences Announces Resolution of Warning Letter Related to Its Manufacturing Facility in Anasco, Puerto Rico
PLAINSBORO, N.J., Jan. 20, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the United States Food and Drug Administration (the "FDA") has informed the Company that it had addressed the violations in the warning letter relating to i
Read more →IARTFood and Drug Administration 466 Fernandez Juncos Avenue San Juan, Puerto Rico, 00901 Telephone: 787-729-8500 FAX: 787-729-8826
RETURN RECEIPT REQUESTED Integra Life-Sciences Corporation 311 Enterprise Drive, Plainsboro, N.J. 08536 We have completed an evaluation of your firm s corrective actions in response to our Warning Letter 13-SJN-WL-03 dated February 13, 2013. Based on our evaluation, it appea
Read more →IARTIntegra LifeSciences to Host Its Fourth Quarter 2014 Earnings Results Conference Call on February 24, 2015
PLAINSBORO, N.J., Jan. 14, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its fourth quarter 2014 financial results and issue 2015 financial guidance on Tuesday, February 24, 2015. The company has scheduled a conference call for 8:30
Read more →IARTIntegra LifeSciences Acquires Metasurg's Foot and Ankle Product Portfolio
PLAINSBORO, N.J., Jan. 12, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that, in December, it closed on the acquisition of the product portfolio from Metasurg. The addition of the Metasurg product portfolio enhances Integra's l
Read more →IARTIntegra LifeSciences to Participate in the 33rd Annual J.P. Morgan Healthcare Conference in January
PLAINSBORO, N.J., Jan. 5, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will present at the 33rd Annual J.P. Morgan Healthcare Conference. At 4:30PM PT on Wednesday, January 14, 2015, Mr. Peter Arduini, Integra's Preside
Read more →IARTIntegra LifeSciences Launches Integra(R) Meshed Dermal Regeneration Template
PLAINSBORO, N.J., Dec. 17, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the expansion of its skin and wound product line with the introduction of Integra Meshed Dermal Regeneration Template. Integra Meshed Dermal Regeneration Te
Read more →IARTIntegra LifeSciences to Participate in the Piper Jaffray and Oppenheimer Healthcare Conferences in December
PLAINSBORO, N.J., Nov. 20, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will present at the following conferences in December: At 9:30AM ET on Tuesday, December 2, 2014, Mr. Glenn Coleman, Integra's Chief Financial Offi
Read more →IARTIntegra LifeSciences Announces FDA Clearance and Controlled Market Release of Expandable Interbody System for Spinal Surgery
PLAINSBORO, N.J., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the controlled market release of the Integra Expandable Interbody System, in the United States. The system, which received 510(k) clearance from the United
Read more →IARTIntegra LifeSciences Introduces Integra(R) Pocket Strip and Integra(R) Shaped Strip DBM Implants
PLAINSBORO, N.J., Nov. 12, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the limited market release of a new orthobiologic implant. The Demineralized Bone Matrix (DBM) Strip implant is used primarily for posterior lumbar fusion,
Read more →IARTIntegra LifeSciences Announces Strategic Portfolio Alignment and Plans to Create Stand-Alone Spine Business as a Separate Public Company
Plans to Spin Off Spine Business to Create SeaSpine, a New Publicly Traded Company, By Means of Tax-Free Distribution to Integra Shareholders Both Companies Will be Leaders in Providing Regenerative Technologies Integra to Operate as Two Global Divisions in 2015 Upon Completion
Read more →IARTIntegra LifeSciences Reports Third Quarter 2014 Financial Results
Revenue Increased 7.7% to $229.7 Million Adjusted EPS Increased 16% to $0.76 Operating Cash Flow was $31.1 Million PLAINSBORO, N.J., Nov. 3, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the third quar
Read more →IARTIntegra LifeSciences Completes the Acquisition of MicroFrance and Xomed Manual ENT and Laparoscopy Instrumentation Lines From Medtronic
PLAINSBORO, N.J., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has completed the acquisition of the MicroFrance and Xomed manual ear, nose and throat (ENT) and laparoscopy instrumentation lines from Medtronic. I
Read more →IARTIntegra LifeSciences Holdings Corporation Investors: Angela Steinway (609) 936-2268 angela.steinway@integralife.com Media: Gianna Sabella (609) 936-2389 gianna.sabella@integralife.com Integra LifeS
Integra LifeSciences Holdings Corporation angela.steinway@integralife.com gianna.sabella@integralife.com LifeSciences Completes the Acquisition of MicroFrance and Xomed Manual ENT and Laparoscopy Instrumentation Lines from Plainsboro, New Jersey / October 27, 2014 Integra Li
Read more →IARTIntegra LifeSciences to Host Its Third Quarter 2014 Earnings Results Conference Call on November 3, 2014
PLAINSBORO, N.J., Oct. 9, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its third quarter 2014 financial results on Monday, November 3, 2014. The company has scheduled a conference call for 4:30 PM ET the same day to discuss the res
Read more →IARTIntegra LifeSciences Announces Full Market Release for the Integra(R) Freedom Wrist Arthroplasty System
PLAINSBORO, N.J., Sept. 18, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the full commercial release of the Integra Freedom Wrist Arthroplasty System in the United States. The system, which is used in the treatment of wrist arth
Read more →IARTIntegra LifeSciences to Acquire Medtronic's MicroFrance and Xomed Manual ENT and Laparoscopy Instrumentation Lines
PLAINSBORO, N.J., Sept. 17, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) and Medtronic, Inc. today announced an agreement in which Integra will acquire Medtronic's MicroFrance and Xomed manual ENT and laparoscopy instrumentation lines for appro
Read more →IARTIntegra LifeSciences Announces Changes Within Its Orthopedics and Tissue Technologies Business
PLAINSBORO, N.J., Sept. 2, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has made changes to the leadership of its Orthopedics and Tissue Technologies business. The new organization enables Integra to use its resources mo
Read more →IARTIntegra LifeSciences to Participate in the Morgan Stanley Global Healthcare Conference in September
PLAINSBORO, N.J., Aug. 21, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will present at the following conferences next month: - At 10:35AM ET on Tuesday, September 9, 2014, Mr. Peter Arduini, Integra's President and Chi
Read more →IARTto manufacture and ship sufficient quantities of its products to meet its customers' demand; global macroeconomic conditions; continued weakness in sales outside of the U.S.; the C
Contact: Investor Relations: Angela Steinway (609) 936-2268 angela.steinway@integralife.com Integra LifeSciences Reports Second Quarter 2014 Financial Results Revenue Increased 12.6% to a Record of $231 million Adjusted Diluted EPS Increased by 28% Free Cash Flow Increased b
Read more →IARTIntegra LifeSciences Reports Second Quarter 2014 Financial Results
Revenue Increased 12.6% to a Record of $231 million Adjusted Diluted EPS Increased by 28% Free Cash Flow Increased by $17.7 million PLAINSBORO, N.J., Aug. 5, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results f
Read more →IARTIntegra LifeSciences Announces Completion of Its Multicenter Clinical Trial for the Treatment of Diabetic Foot Ulcers
PLAINSBORO, N.J., Aug. 5, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has completed Its multicenter clinical trial evaluating the safety and effectiveness of INTEGRA Dermal Regeneration Template for the Treatment of Dia
Read more →IARTIntegra LifeSciences to Host Its Second Quarter 2014 Earnings Results Conference Call on August 5, 2014
PLAINSBORO, N.J., July 10, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its second quarter 2014 financial results on Tuesday, August 5, 2014. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the re
Read more →IARTIntegra LifeSciences Holdings Corporation Investor Relations: Angela Steinway (609) 936-2268 angela.steinway@integralife.com Integra LifeSciences Announces Renewal and Extension of Credit Facility
Integra LifeSciences Holdings Corporation angela.steinway@integralife.com Integra LifeSciences Announces Renewal and Extension of Credit Facility Plainsboro, New Jersey / July 9, 2014 Integra LifeSciences Holdings Corporation (NASDAQ: IART news) today announced that it has est
Read more →IARTIntegra LifeSciences Announces Renewal and Extension of Credit Facility
PLAINSBORO, N.J., July 9, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has established new terms under its credit facility, including an increase in the size of the facility and an extended maturity date, with its bank g
Read more →IARTPART II ITEM 6. SELECTED FINANCIAL DATA The information set forth below should be read in conjunction with "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations" and our consolida
The information set forth below should be read in conjunction with "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations" and our consolidated financial statements and related notes included elsewhere in this report. We have acquired numer
Read more →IARTIntegra LifeSciences Celebrates 25th Anniversary
PLAINSBORO, N.J., June 19, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a world leader in medical technology, today announced that June 2014 marks the 25th anniversary of its founding. Twenty-five years ago, Richard Caruso, PhD, currently a m
Read more →IARTIntegra LifeSciences Announces Contract with Premier, Inc.
PLAINSBORO, N.J., June 12, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq:IART) today announced that its Orthopedics and Tissue Technologies group signed a three-year group purchasing contract with Premier, Inc., a leading healthcare improvement company
Read more →IARTIntegra LifeSciences to Participate in the Jefferies 2014 Global Healthcare Conference in June
PLAINSBORO, N.J., May 23, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will present at the following conferences next month: - At 8:00AM ET on Tuesday, June 3, 2014, Mr. Peter Arduini, President and Chief Executive Offi
Read more →IARTIntegra LifeSciences Holdings Corporation (NASDAQ:IART) to Ring The NASDAQ Stock Market Closing Bell
ADVISORY, May 5, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a world leader in medical technology, will visit the NASDAQ MarketSite in Times Square. In honor of the occasion, Stuart Essig, Chairman of the Board will ring the Closing Bell.
Read more →IARTIntegra LifeSciences Reports First Quarter 2014 Financial Results
PLAINSBORO, N.J., May 1, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the first quarter ending March 31, 2014. Total revenues for the first quarter were $215.1 million, reflecting an increase of $18.4 mi
Read more →IARTIntegra LifeSciences Announces Chief Financial Officer Transition
PLAINSBORO, N.J., April 29, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that effective May 2, 2014 it has appointed Glenn G. Coleman Corporate Vice President and Chief Financial Officer, reporting to Jack Henneman, who was appo
Read more →IARTIntegra LifeSciences to Participate in the 2014 Deutsche Bank and Bank of America Merrill Lynch 2014 Healthcare Conferences in May
PLAINSBORO, N.J., April 22, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will present at the following conferences next month: At 2:10 PM ET on Wednesday, May 7, 2014, Mr. Jack Henneman, Chief Financial Officer of Integ
Read more →IARTIntegra LifeSciences to Host Its First Quarter 2014 Earnings Results Conference Call on May 1, 2014
PLAINSBORO, N.J., April 11, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its first quarter 2014 financial results on Thursday, May 1, 2014. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the resu
Read more →IARTIntegra LifeSciences to Host Investor Meeting on May 6, 2014
PLAINSBORO, N.J., April 9, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will host an Investor Meeting on Tuesday, May 6, 2014, at 9:00AM ET, in New York City. The meeting will feature presentations by Integra's senior management team focused on
Read more →IARTIntegra LifeSciences Appoints Mark Augusti as Corporate Vice President, President, Orthopedics and Tissue Technologies
PLAINSBORO, N.J., April 7, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Mark Augusti has joined Integra as CVP, President, Orthopedics and Tissue Technologies. Mr. Augusti will be responsible for the management of our Spine
Read more →IARTIntegra LifeSciences Announces Camino(R) Flex Ventricular Catheter Receives FDA Clearance for Use With MRI Scans
PLAINSBORO, N.J., April 4, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the Camino Flex Ventricular Catheter has received clearance from the United States Food and Drug Administration (FDA) for use with magnetic resonance i
Read more →IARTIntegra LifeSciences Launches Integra(R) Wound Matrix (Thin)
PLAINSBORO, N.J., March 25, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the expansion of its skin and wound product line with the introduction of Integra Wound Matrix (Thin). Integra Wound Matrix (Thin) has received 510(k) clea
Read more →IARTIntegra LifeSciences Announces First Implantation of Integra(R) Laminoplasty System
PLAINSBORO, N.J., March 13, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the first implantation of its Integra Laminoplasty System, in the United States. The system, which is used to treat patients with ossification of the poste
Read more →IARTIntegra LifeSciences to Participate in the Barclays Global Healthcare Conference in March
PLAINSBORO, N.J., March 3, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conference next month: At 1:30 PM ET on Tuesday, March 11, 2014, Mr. Jack Henneman, Chief Financial Officer of Integr
Read more →IARTIntegra LifeSciences Receives FDA Clearance for Integra(R) Titanium Bone Wedges
PLAINSBORO, N.J., Feb. 27, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the introduction of the Integra Titanium Bone Wedges, designed for internal fixation for bone fractures or osteotomies in the foot and ankle. The system has
Read more →IARTIntegra LifeSciences Reports Fourth Quarter 2013 Financial Results
Increases Fourth Quarter Revenues 3% to $221 Million Introduces 2014 Full-Year Guidance PLAINSBORO, N.J., Feb. 25, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the fourth quarter ending December 31, 20
Read more →IARTIntegra LifeSciences Appoints Kenneth Burhop, Ph.D., as Corporate Vice President and Chief Scientific Officer
PLAINSBORO, N.J., Feb. 25, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Kenneth Burhop has joined Integra as Corporate Vice President, Chief Scientific Officer. Dr. Burhop will be responsible for setting Integra's strategic
Read more →IARTIntegra LifeSciences to Participate in the 2014 Citi Global and RBC Capital Markets Healthcare Conferences in February
PLAINSBORO, N.J., Feb. 10, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences next month: At 10:30 AM ET on Wednesday, February 26, 2014, Mr. Peter Arduini, President and Chief Execut
Read more →IARTIntegra LifeSciences Completes Acquisition of DuraSeal Product Lines From Covidien
PLAINSBORO, N.J., Jan. 15, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has completed the acquisition of DuraSeal product lines from Covidien. Now, together with our DuraGen family of grafts, Integra offers surgeons the
Read more →IARTIntegra LifeSciences to Host Its Fourth Quarter 2013 Earnings Results Conference Call on February 25, 2014
PLAINSBORO, N.J., Jan. 13, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its fourth quarter 2013 financial results on Tuesday, February 25, 2014. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the
Read more →IARTIntegra LifeSciences to Participate in the 32nd Annual J.P. Morgan Healthcare Conference
PLAINSBORO, N.J., Dec. 30, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that Mr. Peter Arduini, Integra's President and Chief Executive Officer, will present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco,
Read more →IARTIntegra LifeSciences Announces Completion of Patient Enrollment in Clinical Study of Integra(R) Dermal Regeneration Template for the Treatment of Diabetic Foot Ulcers
PLAINSBORO, N.J., Dec. 23, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has completed patient enrollment in a multi-center, randomized, controlled clinical trial comparing the safety and effectiveness of Integra Dermal R
Read more →IARTIntegra LifeSciences Announces NeuraGen(R) Clinical Study Published in Journal of Hand Surgery
PLAINSBORO, N.J., Dec. 12, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the publication of the clinical study, Collagen Conduit Versus Microsurgical Neurorraphy: 2-Year Follow Up of a Prospective, Blinded Clinical and Electrophy
Read more →IARTIntegra LifeSciences to Participate in the Piper Jaffray Healthcare and Oppenheimer Healthcare Conferences in December
PLAINSBORO, N.J., Nov. 18, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences next month: At 12:00 PM ET on Tuesday, December 3, 2013, Mr. Peter Arduini, President and Chief Executive
Read more →IARTIntegra LifeSciences to Acquire DuraSeal(TM) Product Lines From Covidien
PLAINSBORO, N.J., Oct. 28, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today it has entered into a definitive agreement with Covidien to acquire the Confluent Surgical product lines, including surgical sealants, adhesion barrier, and
Read more →IARTIntegra LifeSciences Reports Third Quarter 2013 Financial Results
Revenue In Line with Guidance Cash Flows from Operations of $31 Million PLAINSBORO, N.J., Oct. 28, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the third quarter ending September 30, 2013. Total revenu
Read more →IARTIntegra LifeSciences Announces Update on Optimization Initiatives
Plans Closure of Two Manufacturing Facilities Announces Additional Product Discontinuations Estimates Impairment to Goodwill in Spine Business PLAINSBORO, N.J., Oct. 23, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it pl
Read more →IARTIntegra LifeSciences Introduces Next-Generation Licox(R) Brain Tissue Oxygen Monitoring System
PLAINSBORO, N.J., Oct. 21, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the introduction of the next-generation Licox Brain Tissue Oxygen Monitoring System. The Licox system continually monitors brain oxygen partial pressure (Pt
Read more →IARTIntegra LifeSciences Announces Launch of Integra(R) Proximal Humeral Fracture Plate System in United States
PLAINSBORO, N.J., Oct. 17, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the market release of the Integra Proximal Humeral Fracture Plate System in the United States. The comprehensive system joins a growing portfolio of shoulde
Read more →IARTIntegra LifeSciences to Host Its Third Quarter 2013 Earnings Results Conference Call on October 28, 2013
PLAINSBORO, N.J., Oct. 11, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its third quarter 2013 financial results on Monday, October 28, 2013. The company has scheduled a conference call for 4:30 PM ET the same day to discuss the re
Read more →IARTIntegra LifeSciences Receives FDA Clearance for Integra(R) Laminoplasty System
PLAINSBORO, N.J., Oct. 10, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the introduction of the Integra Laminoplasty System, a comprehensive set of implants and instruments designed for use after open-door laminoplasty procedure
Read more →IARTIntegra LifeSciences Announces Introduction of Integra(R) Hollywood(TM) NanoMetalene(TM) Interbody Device
PLAINSBORO, N.J., Oct. 9, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Integra HollywoodTM NanoMetaleneTM Interbody Device (IBD), and expe
Read more →IARTIntegra LifeSciences Announces Podium Presentation of NeuraGen(R) Nerve Guide Multi-Center Clinical Trial at ASSH
PLAINSBORO, N.J., Oct. 2, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the Podium Presentation of A Collagen Conduit vs. Microsurgical Neurorrhaphy. Two-Year Follow up of a Prospective Blinded Clinical and Electrophysiological M
Read more →IARTIntegra LifeSciences Announces Resolution of Warning Letter Related to Its Plainsboro, NJ, Manufacturing Facility
PLAINSBORO, N.J., Sept. 26, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the United States Food and Drug Administration ("FDA") has informed the Company that it had addressed the violations in the warning letter relating to
Read more →IARTIntegra LifeSciences Announces First Implantation of Titan(TM) Reverse Shoulder System
PLAINSBORO, N.J., Sept. 23, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the first implantation of its Integra Titan Reverse Shoulder System, in the United States. The system, which is used in the treatment of shoulder replaceme
Read more →IARTIntegra LifeSciences to Participate in Investor Conferences in September
PLAINSBORO, N.J., Aug. 29, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences in the next few weeks: - At 11:10 AM ET on Wednesday, September 11, 2013, Mr. Jack Henneman will present
Read more →IARTIntegra LifeSciences Holdings Corporation Appoints Donald E. Morel, Jr., Ph.D. as a Director and Announces Retirement of Neal Moszkowski as a Director
PLAINSBORO, N.J., Aug. 27, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that, effective today, Mr. Neal Moszkowski has retired from the Board of Directors. The Board has appointed Donald Morel as a Director of the Company. "Nea
Read more →IARTIntegra LifeSciences Holdings Corporation [IART] to Ring The NASDAQ Stock Market Closing Bell
ADVISORY, Aug. 20, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation [IART], a world leader in medical technology, will visit the NASDAQ MarketSite in Times Square. In honor of the occasion, Peter J. Arduini, President and CEO of Integra, Linda Brown, Sandy Agr
Read more →IARTIntegra LifeSciences Reports Second Quarter 2013 Financial Results
PLAINSBORO, N.J., Aug. 1, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the second quarter ending June 30, 2013. Total revenues for the second quarter were $205.5 million, reflecting a decrease of $4.7 mi
Read more →IARTIntegra LifeSciences Receives FDA Clearance for Titan(TM) Reverse Shoulder System
PLAINSBORO, N.J., July 31, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the Integra Titan Reverse Shoulder System has received 510k clearance from the U.S. Food and Drug Administration (FDA). Integra expects to begin a limi
Read more →IARTIntegra LifeSciences Offers Surgeons More Foot Fixation Options With Next-Generation Total Foot System
PLAINSBORO, N.J., July 18, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the commercial launch of the Integra Total Foot System 2, which addresses both reconstruction and acute fractures of the forefoot, midfoot and hindfoot. The
Read more →IARTIntegra LifeSciences to Host Its Second Quarter 2013 Earnings Results Conference Call on August 1, 2013
PLAINSBORO, N.J., July 3, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its second quarter 2013 financial results on Thursday, August 1, 2013. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the re
Read more →IARTIntegra LifeSciences Announces CE Mark and European Launch of Integra(R) Smart Cervical Solution
PLAINSBORO, N.J., June 26, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has received European CE Mark for its Integra Smart Cervical Solution, a device approved in the European Union for treating degenerative diseases of
Read more →IARTIntegra LifeSciences to Participate in Investor Conferences in June
PLAINSBORO, N.J., May 29, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences in the next few weeks: At 4:00 PM ET on Tuesday, June 4, 2013, Mr. Peter Arduini, President and Chief Exec
Read more →IARTIntegra LifeSciences to Participate in Investor Conferences in May
PLAINSBORO, N.J., May 7, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences in the next few weeks: - At 3:00 PM PT on Tuesday, May 14, 2013, Jack Henneman, Chief Financial Officer of
Read more →IARTIntegra LifeSciences Reports First Quarter 2013 Financial Results
Results In Line With Preliminary Announcement Revises 2013 Guidance PLAINSBORO, N.J., May 2, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the first quarter ending March 31, 2013. Total revenues for the
Read more →IARTIntegra LifeSciences Introduces Hollywood(TM) VI Spinal Fusion System
PLAINSBORO, N.J., April 30, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the full market release of its HollywoodTM VI intervertebral body fusion device (IBD) system. The Hollywood VI IBD is used primarily in transforaminal lumb
Read more →IARTIntegra LifeSciences Debuts Next-Generation Camino(R) Platform at 2013 American Association of Neurological Surgeons Annual Meeting
PLAINSBORO, N.J., April 29, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the debut of the next generation of the Camino platform, an advanced monitoring system for continuous intracranial pressure (ICP) monitoring and cerebral s
Read more →IARTIntegra LifeSciences Launches Integra(R) Compact Cranial Closure System
PLAINSBORO, N.J., April 29, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the launch of the Integra Compact Cranial Closure System, which provides titanium implants for non-loadbearing (non-facial) operative cranial neurosurgical
Read more →IARTIntegra LifeSciences Issues Voluntary Recall of Certain Products Manufactured in its Anasco, Puerto Rico Facility
PLAINSBORO, N.J., April 10, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that on April 10, 2013 it initiated a voluntary recall of certain products manufactured in its A asco, Puerto Rico facility between December 2010 and May 2
Read more →IARTIntegra LifeSciences to Host Its First Quarter 2013 Earnings Results Conference Call on May 2, 2013
PLAINSBORO, N.J., April 10, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its first quarter 2013 financial results on Thursday, May 2, 2013. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the resu
Read more →IARTIntegra LifeSciences Integra(R) IPP-ON(R) PIP Fusion System Surpasses 4,000 Hammertoe Correction Implants
PLAINSBORO, N.J., March 21, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corp. (Nasdaq:IART) today announced the successful implantation of over 4,000 Integra IPP-ON PIP Fusion Systems. The system is a valuable addition to Integra's broad range of products for orthopedi
Read more →IARTIntegra LifeSciences Expands Its Product Offering for Spinal Deformity
PLAINSBORO, N.J., March 20, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the addition of a second cobalt chrome rod for its Daytona and Malibu Spinal Systems. This new rod, the Enhanced Strength and Stiffness rod, or ESS+ rod, p
Read more →IARTIntegra LifeSciences Expands Shoulder Product Line With the Introduction of a Proximal Humeral Fracture Plate System
PLAINSBORO, N.J., March 20, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the Integra Proximal Humeral Fracture Plate System received 510k clearance from the U.S. Food and Drug Administration (FDA), and expects to begin a co
Read more →IARTIntegra LifeSciences Holdings Corporation Announces Changes to Its Board of Directors
PLAINSBORO, N.J., March 18, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the following changes to its Board composition: The Board of Directors appointed Mr. Lloyd W. Howell, Jr. as a Director of the Company, effective today, w
Read more →IARTIntegra LifeSciences to Participate in Investor Conferences in March
PLAINSBORO, N.J., March 5, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences in the next few weeks: At 1:00 PM ET on Tuesday, March 12, 2013, Ms. Angela Steinway, Head of Investor Re
Read more →IARTIntegra LifeSciences Reports Fourth Quarter 2012 Financial Results
Constant Currency Growth of 5.7% Introduces 2013 Full-Year Guidance PLAINSBORO, N.J., Feb. 21, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the fourth quarter ending December 31, 2012. Total revenues f
Read more →IARTIntegra LifeSciences to Participate in Investor Conferences in February
PLAINSBORO, N.J., Feb. 20, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences in February: - At 8:30 AM ET on Tuesday, February 26, 2013, Mr. Peter Arduini, President and Chief Execut
Read more →IARTIntegra LifeSciences Receives Warning Letter in Anasco, Puerto Rico, Manufacturing Facility
PLAINSBORO, N.J., Feb. 19, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that on February 14, 2013, it received a warning letter from the United States Food and Drug Administration (FDA) related to quality systems issues at its m
Read more →IARTIntegra LifeSciences Announces Three-Year Contract With Premier Healthcare Alliance
PLAINSBORO, N.J., Jan. 31, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it was awarded a three-year group purchasing agreement with the Premier healthcare alliance, one of the largest group purchasing organizations in the U
Read more →IARTIntegra LifeSciences Announces Launch of Integra(R) Flowable Wound Matrix in Europe for Diabetic Foot and Leg Ulcers
PLAINSBORO, N.J., Jan. 18, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has received European CE Mark Certification for its Integra Flowable Wound Matrix, an advanced device approved in the European Union for filling dee
Read more →IARTIntegra LifeSciences to Host Its Fourth Quarter 2012 Earnings Results Conference Call on February 21, 2013
PLAINSBORO, N.J., Jan. 15, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its fourth quarter 2012 financial results on Thursday, February 21, 2013. The company has scheduled a conference call for 8:30 AM ET the same day to discuss th
Read more →IARTIntegra LifeSciences to Participate in 31st Annual J.P. Morgan Healthcare Conference
PLAINSBORO, N.J., Dec. 20, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that at 1:30 PM PT / 4:30 PM ET on Wednesday, January 9, 2013, Mr. Peter Arduini, President and Chief Executive Officer of Integra, will present at the 31st
Read more →IARTIntegra LifeSciences to Participate in the Oppenheimer 23rd Annual Healthcare Conference
PLAINSBORO, N.J., Dec. 3, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that at 10:00 AM ET on Wednesday, December 12, 2012, Mr. Jack Henneman, Chief Financial Officer of Integra, will present at the Oppenheimer 23rd Annual Healt
Read more →IARTIntegra LifeSciences LED Headlight System Receives Top Recognition in Surgical Products Magazine
PLAINSBORO, N.J., Nov. 29, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Surgical Products magazine has awarded Integra's LED Headlight System 1st place in the "Capital Equipment" category of their 2012 "Excellence in Surgic
Read more →IARTIntegra LifeSciences is Honored as One of New Jersey's 2012 Fifty Fastest Growing Companies for Fourth Year in a Row
PLAINSBORO, N.J., Nov. 14, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it was honored for the fourth year in a row as one of New Jersey's Fifty Fastest Growing Companies by NJBIZ, one of New Jersey's leading statewide busi
Read more →IARTIntegra LifeSciences Receives Warning Letter in Andover, England Manufacturing Facility
PLAINSBORO, N.J., Nov. 13, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that on November 5, 2012 it received a warning letter from the United States Food and Drug Administration (FDA) related to quality systems issues at its man
Read more →IARTIntegra LifeSciences to Participate in Investor Conferences in November
PLAINSBORO, N.J., Nov. 8, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences in the next few weeks: At 2:30 PM ET on Wednesday, November 14, 2012, Mr. Jack Henneman, Chief Financial O
Read more →IARTIntegra LifeSciences Now Offers Zero-Profile, Stand-Alone Interbody Devices for Neck and Lumbar Fixation Procedures
PLAINSBORO, N.J., Oct. 24, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the full U.S. market release of the Integra Complete Cervical Intervertebral Body Fusion Device (IBD), expanding Integra's spine product portfolio with the
Read more →IARTIntegra LifeSciences Reports Third Quarter 2012 Financial Results
Raises 2012 Full-Year Earnings Guidance Hosting Investor Day Later Today PLAINSBORO, N.J., Oct. 24, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the third quarter ending September 30, 2012. Total reven
Read more →IARTIntegra LifeSciences Launches New Integra(R) CUSA(R) NXT Bone Tip at 2012 Congress of Neurological Surgeons Annual Meeting
PLAINSBORO, N.J., Oct. 9, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the launch of the Integra CUSA NXT Inferior Forward Bone Tip for Integra's CUSA NXT Ultrasonic Tissue Ablation System. The CUSA NXT system is a well-recogniz
Read more →IARTIntegra LifeSciences Receives FDA Clearance for Expanded Indication for Spinal Device
PLAINSBORO, N.J., Oct. 9, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the Food and Drug Administration (FDA) has approved an expanded indication for use of the Integra Vu aPOD Prime Intervertebral Body Fusion Device (IBD)
Read more →IARTIntegra LifeSciences to Host Its Third Quarter 2012 Earnings Results Conference Call on October 24, 2012
PLAINSBORO, N.J., Oct. 8, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its third quarter 2012 financial results on Wednesday, October 24, 2012. The company has scheduled a conference call for 8:00 AM ET the same day to discuss the
Read more →IARTIntegra LifeSciences Features New MAYFIELD(R) Composite Series Cranial Stabilization Products at the Congress of Neurological Surgeons Annual Meeting
PLAINSBORO, N.J., Oct. 8, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq:IART) today announced that it is featuring its new MAYFIELD Composite Series Cranial Stabilization products at the Congress of Neurological Surgeons (CNS) annual meeting, October 6
Read more →IARTIntegra LifeSciences to Host Investor Meeting on October 24, 2012
PLAINSBORO, N.J., Sept. 20, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will host an Investor Meeting on Wednesday, October 24, 2012, at 9:00AM CT, in Dallas, Texas. The meeting will feature presentations by Integra's senior management team fo
Read more →IARTIntegra LifeSciences Announces Two Key Executive Appointments
PLAINSBORO, N.J., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that John Mooradian and Joseph Vinhais have joined Integra as Senior Vice President, Global Operations and Supply Chain, and Senior Vice President, Global Q
Read more →IARTIntegra LifeSciences Holdings Corporation [IART] and Children's Brain Tumor Foundation to Ring The NASDAQ Stock Market Closing Bell
ADVISORY, Aug. 21, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation [IART], a world leader in medical devices which offers innovative solutions in orthopedics, neurosurgery, spine, reconstructive and general surgery will visit the NASDAQ MarketSite in Times Squ
Read more →IARTIntegra LifeSciences Reports Second Quarter 2012 Financial Results
PLAINSBORO, N.J., July 26, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the second quarter ending June 30, 2012. Total revenues for the second quarter were $210.2 million, reflecting an increase of $16.8
Read more →IARTIntegra LifeSciences to Host Its Second Quarter 2012 Earnings Results Conference Call on July 26, 2012
PLAINSBORO, N.J., July 9, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its second quarter 2012 financial results on Thursday, July 26, 2012. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the res
Read more →IARTIntegra LifeSciences Announces Contract With aap Implantate AG to Provide Stainless Headed Compression Screws for Mid and Hindfoot Reconstruction
PLAINSBORO, N.J. and BERLIN, June 21, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will feature its new Stainless Headed Compression Screw System, manufactured by aap Implantate AG (XETRA:AAQ), at the upcoming Orthopedic
Read more →IARTIntegra LifeSciences Announces Launch of the Integra(R) IPP-ON(R) PIP Fusion System for Extremity Reconstruction
PLAINSBORO, N.J., June 20, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the introduction of Integra IPP-ON PIP Fusion System, for fixation of proximal interphalangeal (PIP) joint arthrodesis. It is indicated for use in the lesse
Read more →IARTIntegra LifeSciences to Present at the Jefferies Global Healthcare and Wells Fargo Securities Healthcare Conferences in June
PLAINSBORO, N.J., May 30, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences next month: At 3:00 PM ET on Tuesday, June 5, 2012, Mr. Peter Arduini, President and Chief Executive Offic
Read more →IARTIntegra LifeSciences to Present at the Deutsche Bank Health Care and Bank of America Merrill Lynch Health Care Conferences in May
PLAINSBORO, N.J., May 2, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences this month: At 4:50 PM ET on Tuesday, May 8, 2012, Mr. Brian Larkin, President, Global Spine & Orthobiologi
Read more →IARTIntegra LifeSciences Reports First Quarter 2012 Financial Results
Revenues $196 Million Raises Bottom End of Adjusted EPS Guidance PLAINSBORO, N.J., April 25, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the first quarter ending March 31, 2012. Total revenues for the
Read more →IARTIntegra LifeSciences Expands Its Spinal Product Portfolio With a Stand-Alone, Zero-Profile Device for ALIF Procedures
PLAINSBORO, N.J., April 17, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the United States full market release of the Integra Vu aPOD Prime Intervertebral Body Fusion Device (IBD), expanding Integra's spine product portfolio wit
Read more →IARTIntegra LifeSciences Launches Integra(R) CUSA(R) NXT Bone Tips at 2012 American Association of Neurological Surgeons Annual Meeting
PLAINSBORO, N.J., April 16, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the launch of the Integra CUSA NXT Bone Tips for Integra's CUSA NXT Ultrasonic Tissue Ablation System. The CUSA NXT system is a well-recognized medical dev
Read more →IARTIntegra LifeSciences to Host Its First Quarter 2012 Earnings Results Conference Call on April 26, 2012
PLAINSBORO, N.J., April 6, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its first quarter 2012 financial results on Thursday, April 26, 2012. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the re
Read more →IARTIntegra LifeSciences Announces Launch of New Jarit(R) Take-Apart Laparoscopic Instruments
PLAINSBORO, N.J., March 26, 2012 (GLOBE NEWSWIRE) -- http://www.integralife.com/">Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its new line of Jarit Take
Read more →IARTIntegra LifeSciences Launches New Shoulder Arthroplasty Device in Italy and Sweden
PLAINSBORO, N.J., March 22, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the first implantation of the PyroTITAN Humeral Resurfacing Implant in patients in Milan, Italy and Stockholm, Sweden. The PyroTITAN implant is used in sho
Read more →IARTIntegra LifeSciences Launches Veterinary Orthopedic Implants
PLAINSBORO, N.J., March 15, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corp (Nasdaq:IART) today announced the launch of the Integra Miltex Veterinary Orthopedic Implant line, which includes plates, screws, lateral suturing products and instruments that aid in the repa
Read more →IARTIntegra LifeSciences to Participate in Upcoming Investor Conferences
PLAINSBORO, N.J., Feb. 24, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences in the next few weeks: On Wednesday, February 29, 2012, Mr. Jack Henneman, Chief Financial Officer of Int
Read more →IARTIntegra LifeSciences Reports Fourth Quarter and Full-Year 2011 Financial Results
Results in Line With Preliminary Announcement Provides 2012 Guidance PLAINSBORO, N.J., Feb. 23, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the fourth quarter and full year ending December 31, 2011. T
Read more →IARTIntegra LifeSciences Announces Launch of the Integra(R) Allograft Wedge System for Extremity Reconstruction
PLAINSBORO, N.J., Feb. 8, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the introduction of Integra Allograft Wedge System, which consists of simple pre-cut allograft wedges for both Evans and Cotton osteotomies and a dedicated i
Read more →IARTIntegra LifeSciences to Present at Three Conferences in February
PLAINSBORO, N.J., Feb. 2, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences this month: At 2:00 PM PT on Tuesday, February 7, 2012, Mr. Brian Larkin, President, Global Spine & Orthob
Read more →IARTIntegra LifeSciences to Host Its Fourth Quarter 2011 Earnings Results Conference Call on February 23, 2012
PLAINSBORO, N.J., Jan. 23, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its fourth quarter 2011 financial results on Thursday, February 23, 2012. The company has scheduled a conference call for 8:30 AM ET the same day to discuss th
Read more →IARTIntegra LifeSciences Reports Preliminary Fourth Quarter and Full-Year 2011 Financial Results and Preliminary 2012 Outlook
Receives Warning Letter Following 483 Observations Arising from Inspection of Plainsboro, NJ Manufacturing Facility Announces Conference Call PLAINSBORO, N.J., Jan. 5, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced it expects to
Read more →IARTIntegra LifeSciences to Present at the 30th Annual J.P. Morgan Healthcare Conference
PLAINSBORO, N.J., Jan. 4, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that Mr. Peter Arduini, President and Chief Executive Officer of Integra, will present at the 30th Annual J.P. Morgan Healthcare Conference. The presentation
Read more →IARTIntegra LifeSciences Announces Appointment of Peter Arduini as President and Chief Executive Officer; Stuart Essig Named Chairman of the Board
PLAINSBORO, N.J., Dec. 21, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that its Board of Directors has made the following changes, all effective January 3, 2012. The Board appointed Peter Arduini as President and Chief Executiv
Read more →IARTIntegra LifeSciences to Present at the Oppenheimer Healthcare Conference
PLAINSBORO, N.J., Dec. 8, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the Oppenheimer Healthcare Conference in New York City. At 1:30 PM ET on Wednesday, December 14, 2011, Ms. Angela Steinway, Head of I
Read more →IARTIntegra LifeSciences Establishes First Office in Shanghai, China
PLAINSBORO, N.J. and SHANGHAI, China, Dec. 5, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the opening of its first Asia business office in Shanghai, China, part of an ongoing expansion to serve one of the world's fastest develo
Read more →IARTIntegra LifeSciences to Present at the Lazard Capital Markets Healthcare and Piper Jaffray Health Care Conferences in November
PLAINSBORO, N.J., Nov. 7, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences this month: At 11:30 AM ET on Tuesday, November 15, 2011, Mr. Stuart Essig, Chief Executive Officer of Int
Read more →IARTIntegra LifeSciences Highlights New LED Headlight System at North American Spine Society Annual Meeting
PLAINSBORO, N.J., Nov. 3, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corp. (Nasdaq:IART) today announced that it is featuring the new Integra LED Headlight System at the North American Spine Society (NASS) Annual Meeting in Chicago, Illinois, November 2-5, 2011. The
Read more →IARTIntegra LifeSciences Grows Its Presence in the Spinal Deformity Market
PLAINSBORO, N.J., Nov. 2, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the expanded market introduction of the Daytona Deformity Spinal System, which was previously released on a limited basis in 2010, and the limited market int
Read more →IARTIntegra LifeSciences Launches a Zero-Profile, Stand-Alone Interbody Device for Neck Surgery
PLAINSBORO, N.J., Nov. 2, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the U.S. controlled market release of the Integra Complete Cervical Intervertebral Body Fusion Device (IBD), expanding Integra's spine product portfolio with
Read more →IARTIntegra LifeSciences to Host Analyst Forum on November 14, 2011
PLAINSBORO, N.J., Oct. 31, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will host the annual Analyst Forum on Monday, November 14, 2011 from 2:00 PM to 5:00 PM ET at the New York Millennium Broadway Hotel in New York Cit
Read more →IARTIntegra LifeSciences Reports Third Quarter 2011 Financial Results
PLAINSBORO, N.J., Oct. 31, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the third quarter ending September 30, 2011. Total revenues for the third quarter were $202.2 million, reflecting an increase of $1
Read more →IARTIntegra LifeSciences Features New LED Headlight System at American College of Surgeons Congress
PLAINSBORO, N.J., Oct. 24, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corp (Nasdaq:IART) today announced the launch of its new Integra LED Headlight System, a surgical headlight system that is designed to deliver the cool brightness and color surgeons need for visibil
Read more →IARTIntegra LifeSciences to Host Its Third Quarter 2011 Earnings Results Conference Call on October 31, 2011
PLAINSBORO, N.J., Oct. 7, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its third quarter 2011 financial results on Monday, October 31, 2011. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the res
Read more →IARTIntegra LifeSciences Launches an Anterior Cervical Plating System
PLAINSBORO, N.J., Oct. 4, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the U.S. commercial market introduction of the Cordant Anterior Cervical Plating System, expanding Integra's spine product portfolio to include three anterio
Read more →IARTIntegra LifeSciences Meets Surgeon Demand for User-Friendly Minimally Invasive Spinal Solutions
PLAINSBORO, N.J., Oct. 3, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences (Nasdaq:IART) today announced the global market introduction of the NewPort Minimally Invasive Spinal System (MIS) and the limited release of the Integra Steerable Intervertebral Body Fusion Device (IBD). The
Read more →IARTIntegra LifeSciences Launches Integra(TM) CUSA NXT(TM) Extended Length Tip at 2011 Congress of Neurological Surgeons Annual Meeting
PLAINSBORO, N.J., Oct. 3, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the launch of the IntegraTM CUSA NXT Extended Length Tip for Integra's CUSA NXT and CUSA Selector Ultrasonic Tissue Ablation Systems. The IntegraTM CUSA NXT
Read more →IARTIntegra LifeSciences Completes Acquisition of Ascension Orthopedics
PLAINSBORO, N.J., Sept. 26, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the closing of its previously announced acquisition of Ascension Orthopedics, Inc. ("Ascension.") Ascension, based in Austin, Texas, develops and distribut
Read more →IARTIntegra LifeSciences Announces Agreement to Acquire Ascension Orthopedics
Integra Extremity Reconstruction to Expand in Foot, Hand and Shoulder Markets Company to Gain Access to PyroCarbon Technology PLAINSBORO, N.J. and AUSTIN, Texas, Sept. 12, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) and Ascension Orthopedics
Read more →IARTIntegra LifeSciences Announces Multi-Year Agreement With Premier Purchasing Partners to Provide Neurosurgical Products
PLAINSBORO, N.J., Sept. 1, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has signed a new multi-year contract with Premier Purchasing Partners, L.P., the group purchasing unit of the Premier healthcare alliance, to provid
Read more →IARTIntegra LifeSciences to Present at Three Conferences in September
PLAINSBORO, N.J., Aug. 31, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences in the next month: At 9:45 AM ET on Friday, September 9, 2011, Mr. Brian Larkin, President, Global Spine
Read more →IARTIntegra LifeSciences Launches an Integrated Plate and Cervical Interbody Fixation System
PLAINSBORO, N.J., Aug. 9, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the global market introduction of the Zuma-CTM Anterior Cervical Fixation System, expanding Integra's spine product portfolio with the addition of its first
Read more →IARTIntegra LifeSciences to Present at the Canaccord Genuity Global Growth Conference in August
PLAINSBORO, N.J., Aug. 2, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the Canaccord Genuity Global Growth Conference in Boston. At 11:30 AM ET on Tuesday, August 9, 2011, Mr. Peter Arduini, President and
Read more →IARTIntegra LifeSciences Reports Second Quarter 2011 Financial Results
PLAINSBORO, N.J., July 28, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the second quarter ending June 30, 2011. Total revenues for the second quarter were $193.3 million, reflecting an increase of $14.7
Read more →IARTIntegra LifeSciences Expands Uni-CP(TM) Compression System Product Range for Mid and Hindfoot Reconstruction
PLAINSBORO, N.J., July 13, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will release a line extension for its Uni-CP Compression System. The Uni-CP Compression System provides a comprehensive solution for arthrodesis and
Read more →IARTIntegra LifeSciences to Host Its Second Quarter 2011 Earnings Results Conference Call on July 28, 2011
PLAINSBORO, N.J., July 6, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its second quarter 2011 financial results on Thursday, July 28, 2011. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the res
Read more →IARTIntegra Announces Pricing of Convertible Senior Notes
PLAINSBORO, N.J., June 10, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the pricing of $200,000,000 aggregate principal amount of 1.625% convertible senior notes due 2016 (the "notes"). The notes were offered and sold in a priva
Read more →IARTIntegra Announces Private Placement of Convertible Senior Notes
PLAINSBORO, N.J., June 9, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has commenced a private offering, subject to market conditions, of $200,000,000 aggregate principal amount of convertible senior notes due 2016. Inte
Read more →IARTIntegra LifeSciences Lowers Costs and Extends Term of Its $600 Million Credit Facility
PLAINSBORO, N.J., June 8, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has established new terms under its credit facility, including lower pricing and an extended maturity date, with its bank group led by Bank of Americ
Read more →IARTIntegra LifeSciences to Present at Three Conferences in June
PLAINSBORO, N.J., May 31, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at three conferences in June as follows: On Tuesday, June 7, 2011 - At 10:00 AM ET, Mr. Stuart Essig, CEO of Integra, will present at
Read more →IARTIntegra LifeSciences Acquires SeaSpine
Integra Spine Doubles Its Distribution Network and Revenue Base in Spinal Hardware Kirt Stephenson Joins Integra as President, U.S. Spine PLAINSBORO, N.J., May 24, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acqui
Read more →IARTIntegra LifeSciences Announces Three-Year Contract With Novation to Provide Luxtec(R) Surgical Headlights
PLAINSBORO, N.J., May 4, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has signed a three-year contract with Novation, the leading healthcare supply contracting company, to provide Luxtec surgical headlights, light source
Read more →IARTIntegra LifeSciences to Present at the Deutsche Bank Health Care and the Bank of America Merrill Lynch Health Care Conferences
PLAINSBORO, N.J., April 28, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at two conferences in May as follows: On Monday, May 2, 2011 at 1:30 PM ET., Mr. Brian Larkin, President, Global Spine and Orthobiolo
Read more →IARTIntegra LifeSciences Reports First Quarter 2011 Financial Results
PLAINSBORO, N.J., April 28, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the first quarter ending March 31, 2011. Total revenues for the first quarter were $181.0 million, reflecting an increase of $8.3
Read more →IARTIntegra LifeSciences CFO Jack Henneman Selected as a 2011 SmartCXO Winner by Philadelphia SmartCEO Magazine
PLAINSBORO, N.J., April 18, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corp (Nasdaq:IART) today announced that John B. Henneman, III, Integra's Executive Vice President, Finance and Administration, and Chief Financial Officer, has been selected as one of ten winners i
Read more →IARTIntegra LifeSciences Announces Instrument Repair Partnership With InstruMedics
PLAINSBORO, N.J., April 14, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corp (Nasdaq:IART) today announced a partnership with InstruMedics LLC., a national provider of service and repair for surgical instruments and equipment. The relationship will allow Integra's Surg
Read more →IARTIntegra LifeSciences Announces FDA Clearance for New Indication for Accell Evo3(R) Demineralized Bone Matrix
PLAINSBORO, N.J., April 12, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market Accell Evo3 Demineralized Bone Matrix as a bone v
Read more →IARTIntegra LifeSciences Receives FDA Approvals for Three Spinal Fixation Devices
PLAINSBORO, N.J., April 11, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has received 510k clearance from the United States Food and Drug Administration (FDA) for three new spinal intervertebral body fusion devices (IBD)
Read more →IARTIntegra LifeSciences Opens New Facility in Medina, Ohio
PLAINSBORO, N.J., April 8, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has opened a new facility in Medina, Ohio, to house its growing spinal implant business. The facility is equipped with the latest video and communic
Read more →IARTIntegra LifeSciences to Host Its First Quarter 2011 Earnings Results Conference Call on April 28, 2011
PLAINSBORO, N.J., April 5, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its first quarter 2011 financial results on Thursday, April 28, 2011. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the re
Read more →IARTIntegra LifeSciences Announces Three-Year Contract With Novation to Provide Jarit(R) Sterilization Containers
PLAINSBORO, N.J., April 4, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has signed a three-year contract with Novation, the leading healthcare supply contracting company, to provide Jarit sterilization containers to the
Read more →IARTIntegra LifeSciences Features the Integra(TM) Endoscopic Gastroc Release System (EGR) Product Line at the Annual ACFAS Meeting
PLAINSBORO, N.J., March 9, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is featuring the Integra(TM) Endoscopic Gastroc Release System (EGR) product line at the Annual Meeting of the American College of Foot and Ankle Su
Read more →IARTIntegra LifeSciences to Present at the Following Four Conferences in March:
Citi Global Healthcare Conference RBC Capital Markets' Healthcare Conference Raymond James' Institutional Investors Conference Barclays Capital Global Healthcare Conference PLAINSBORO, N.J., Feb. 24, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:I
Read more →IARTIntegra LifeSciences Reports Fourth Quarter and Full Year 2010 Financial Results
PLAINSBORO, N.J., Feb. 24, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the fourth quarter and full year ending December 31, 2010. Total revenues for the fourth quarter were $194.1 million, reflecting an
Read more →IARTIntegra LifeSciences Acquires an Exclusive Worldwide License for Novel Minimally Invasive Expandable Interbody Fusion Technology
PLAINSBORO, N.J., Feb. 17, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has entered into an exclusive worldwide license and development agreement with Stout Medical Group, LP to develop and commercialize an expandable in
Read more →IARTIntegra LifeSciences Introduces Advanced Orthobiologics for Extremity Reconstruction
PLAINSBORO, N.J., Feb. 16, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the launch of Trel-XPress Demineralized Bone Matrix, expanding its portfolio of bone grafting substitutes for the orthopedic extremity reconstruction surgeo
Read more →IARTIntegra LifeSciences to Present at the Canaccord Genuity Musculoskeletal Conference
PLAINSBORO, N.J., Feb. 7, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that Mr. Brian Larkin, President, Global Spine, and Head of Strategic Development of Integra, will present at the Canaccord Genuity Musculoskeletal Conferenc
Read more →IARTIntegra LifeSciences Introduces Allograft Cancellous Sponge
PLAINSBORO, N.J., Feb. 7, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corp (Nasdaq:IART) announced today the launch of Integra Allograft Cancellous Sponge, a compressible bone graft composed of 100% cancellous bone. The sponge-like handling characteristics of Integra A
Read more →IARTIntegra LifeSciences to Host Its Fourth Quarter 2010 Earnings Results Conference Call on February 24, 2011
PLAINSBORO, N.J., Jan. 10, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its fourth quarter 2010 financial results on Thursday, February 24th, 2011. The company has scheduled a conference call for 8:30 AM ET the same day to discuss
Read more →IARTIntegra LifeSciences to Present at the 29th Annual J.P. Morgan Healthcare Conference
PLAINSBORO, N.J., Jan. 4, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that Mr. Stuart Essig, Chief Executive Officer of Integra, will present at the 29th Annual J.P. Morgan Healthcare Conference. The presentation will take plac
Read more →IARTIntegra LifeSciences Expands Integra(TM) Endoscopic Gastroc Release System (EGR) Product Line
PLAINSBORO, N.J., Dec. 14, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the launch of a second size of the Integra Endoscopic Gastroc Release (EGR) System in the United States. Integra's EGR System is a disposable device with a
Read more →IARTIntegra LifeSciences to Present at Piper Jaffray's Healthcare and the J.P. Morgan Small and Mid Cap Conferences
PLAINSBORO, N.J., Nov. 19, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at two upcoming conferences. Mr. John B. Henneman, III, Executive Vice President and Chief Financial Officer of Integra, will present
Read more →IARTIntegra LifeSciences Introduces XKnife(R) 5 Stereotactic Radiosurgery and Radiotherapy Treatment Planning Software
PLAINSBORO, N.J., Nov. 3, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the launch of its XKnife 5 Stereotactic Radiosurgery and Radiotherapy Treatment Planning Software. The XKnife 5 Stereotactic Radiosurgery and Radiotherapy Tr
Read more →IARTIntegra LifeSciences Awarded Three Contracts With The Broadlane Group to Provide Dural Substitute, Neuro Trauma and Hydrocephalus Products
PLAINSBORO, N.J., Nov. 1, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has signed a multi-year contract with The Broadlane Group to provide dural repair, neuro trauma (neuro critical care), and hydrocephalus products and
Read more →IARTIntegra LifeSciences to Present at Four Investor Conferences in November
PLAINSBORO, N.J., Oct. 28, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at four conferences next month. Mr. John B. Henneman, III, Executive Vice President and Chief Financial Officer of Integra, will prese
Read more →IARTIntegra LifeSciences Reports Third Quarter 2010 Financial Results
PLAINSBORO, N.J., Oct. 28, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) reported its financial results for the third quarter ending September 30, 2010. Total revenues for the third quarter were $186.6 million, reflecting an increase of $14.4 mi
Read more →IARTIntegra LifeSciences Featured in Forbes 2010 List of America's 100 Best Small Companies
PLAINSBORO, N.J., Oct. 26, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has made Forbes magazine's 2010 list of "America's 100 Best Small Companies." This is the third consecutive year and the sixth time in the last seve
Read more →IARTIntegra LifeSciences Features Integra(TM) Flow Regulating Valve, Mini at Congress of Neurological Surgeons Annual Meeting
PLAINSBORO, N.J., Oct. 19, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corp (Nasdaq:IART) will feature the new Integra Flow Regulating Valve, Mini, a smaller version of the Integra NPH Low Flow Valve, at the 2010 Congress of Neurological Surgeons Annual Meeting in San
Read more →IARTIntegra LifeSciences Introduces the CRW Precision(TM) Arc Stereotactic System for Use in Stereotactic Frame-Based Neurosurgery
PLAINSBORO, N.J., Oct. 18, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the launch of the CRW Precision Arc Stereotactic System, a multi-purpose stereotactic system used for localizing intra-cranial targets and precisely directi
Read more →IARTIntegra LifeSciences to Host Analyst Forum on November 15, 2010
PLAINSBORO, N.J., Oct. 15, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will host the annual Analyst Forum on Monday, November 15, 2010 from 2:00 PM to 5:00 PM ET at the New York Millennium Broadway Hotel in New York Cit
Read more →IARTIntegra LifeSciences Launches New Corporate Identity
PLAINSBORO, N.J., Oct. 14, 2010 (GLOBE NEWSWIRE) -- http://www.integralife.com/">Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that it will officially unveil its new corporate identity at the 2010 Congress of Neurological Surgeons Annual Meeting, October 16-21
Read more →IARTIntegra LifeSciences Appoints Peter J. Arduini as President and Chief Operating Officer
Gerard S. Carlozzi to Retire at End of 2010 John B. Henneman, III Extends Employment Agreement Through 2012 PLAINSBORO, N.J., Oct. 12, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation's (Nasdaq:IART) Chief Executive Officer, Stuart Essig, announced today the a
Read more →IARTIntegra LifeSciences Features the Inforce(R) Reinforcement Matrix at the 65th Annual ASSH Meeting
PLAINSBORO, N.J., Oct. 8, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is featuring the Inforce Reinforcement Matrix at the 65th Annual Meeting of the American Society for Surgery of the Hand (ASSH) on October 7-9, in Bo
Read more →IARTIntegra LifeSciences Announces the Completion of the Randomized, Blind, Multi-Center Human Clinical Study Demonstrating Equal Short Gap Entubulation Repair Results with NeuraGen(R) Nerve Guide in Comparison to Conventional End-to-End Repair
PLAINSBORO, N.J., Oct. 7, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that the results of the multi-center human clinical trial comparing NeuraGen Nerve Guide with direct suture repair have been accepted, in abstract form, for
Read more →IARTIntegra LifeSciences Features the Integra(TM) Total Wrist Fusion System at the 65th Annual ASSH Meeting
PLAINSBORO, N.J., Oct. 7, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is featuring the IntegraTM Total Wrist Fusion System at the 65th Annual Meeting of the American Society for Surgery of the Hand (ASSH) on October 7-9
Read more →IARTIntegra LifeSciences Receives FDA Clearance for Multiple Fixation Options for Vu aPOD(TM) Prime ALIF Device
PLAINSBORO, N.J., Oct. 6, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences (Nasdaq:IART) announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Vu aPOD Prime anterior lumbar interbody fusion (ALIF) device. ALIF is a p
Read more →IARTIntegra LifeSciences Launches Integra(TM) Endoscopic Gastroc Release System (EGR)
PLAINSBORO, N.J., Oct. 4, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the launch of the Integra Endoscopic Gastroc Release (EGR) System in the United States. Integra's EGR System is a disposable device with a unique articulatin
Read more →IARTIntegra LifeSciences to Host Its Third Quarter 2010 Earnings Results Conference Call on October 28, 2010
PLAINSBORO, N.J., Sept. 27, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its third quarter 2010 financial results on Thursday, October 28, 2010. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the
Read more →IARTIntegra LifeSciences Announces Launch of New Surgical Spine Instruments
PLAINSBORO, N.J., Sept. 15, 2010 (GLOBE NEWSWIRE) -- http://www.integralife.com/">Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced the introduction of a new line of extended length and "detachable" Ruggles kerrison rongeurs, which are key instruments used in a va
Read more →IARTIntegra LifeSciences to Present at Five Investor Conferences in September
PLAINSBORO, N.J., Sept. 1, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at five conferences this month. Mr. Stuart Essig, President and CEO of Integra, will present at the following three conferences in New
Read more →IARTIntegra LifeSciences Opens State-of-the-Art Center for Research, Education and Training in Irvine, California
PLAINSBORO, N.J., Aug. 20, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the opening of its state-of-the art Center for Research, Education and Training in Irvine, California. The new facility is designed to accommodate hands-on
Read more →IARTIntegra LifeSciences Introduces the iPASSAGE(TM) Retractor for Minimally Invasive Spine Surgery
PLAINSBORO, N.J., Aug. 13, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the addition of the iPASSAGETM Retractor for Minimally Invasive Surgery (MIS) of the lumbar spine. The iPASSAGETM Retractor is a tissue sparing retraction s
Read more →IARTIntegra LifeSciences Announces Three-Year Contract with GPO Amerinet to Provide JARIT(R) Surgical Instruments
PLAINSBORO, N.J., Aug. 12, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it signed a three-year contract for JARIT surgical instruments with Amerinet, a leading national healthcare group purchasing organization (GPO). "We a
Read more →IARTIntegra LifeSciences Establishes New $600 Million Senior Secured Credit Facility
Integra Establishes a $450 Million 5-Year Revolver and a $150 Million 5-Year Term Loan A Integra Reiterates Earnings Per Share Guidance for 2010 PLAINSBORO, N.J., Aug. 10, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it h
Read more →IARTIntegra LifeSciences to Present at BMO Capital Markets 10th Annual Focus on Healthcare Conference and Canaccord Genuity Global Healthcare Conference
PLAINSBORO, N.J., July 30, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at two conferences in August. On Thursday, August 5th, 2010 at 8:30 am ET, Mr. Gerry Carlozzi, Executive Vice President and Chief Oper
Read more →IARTIntegra LifeSciences Reports Second Quarter 2010 Financial Results
PLAINSBORO, N.J., July 29, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the second quarter ending June 30, 2010. Total revenues for the second quarter were $178.6 million, reflecting an increase of $12.9
Read more →IARTIntegra LifeSciences Introduces DuraGen Plus(R) Dural Regeneration Matrix - Spinal Matrix, for Repair of the Dura
PLAINSBORO, N.J., July 9, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the launch of DuraGen Plus Dural Regeneration Matrix - Spinal Matrix, an absorbable and sutureless collagen onlay indicated as a dura substitute for the repa
Read more →IARTIntegra LifeSciences to Host Its Second Quarter 2010 Earnings Results Conference Call on July 29, 2010
PLAINSBORO, N.J., July 6, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its second quarter 2010 financial results on Thursday, July 29, 2010. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the res
Read more →IARTIntegra LifeSciences Reaches Milestone of Over 800 Implanted Vu a-POD(TM) Devices
PLAINSBORO, N.J., June 8, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences (Nasdaq:IART) announced today a major milestone in the commercialization of the Vu a-POD anterior lumbar intervertebral body fusion (ALIF) device. Launched in the U.S. in early 2009, the Vu a-Pod fusion devic
Read more →IARTIntegra LifeSciences to Present at the Morgan Joseph 2010 Best Ideas Conference and the Goldman Sachs 31st Annual Global Healthcare Conference in June
PLAINSBORO, N.J., June 4, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at two conferences in June. On Wednesday, June 9th, 2010 at 12:30 pm ET, Mr. John B. Henneman, III, Executive Vice President and Chief
Read more →IARTIntegra LifeSciences Will Feature the Newest Additions to Its Portfolio of Hydrocephalus Management Products at the American Association of Neurological Surgeons Annual Meeting
PLAINSBORO, N.J., May 4, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will showcase its new valve systems for the treatment of hydrocephalus, the OSV II Lumbar and the OSV II Low Flow Lumbar Valve Systems, at the 2010 American Association of Ne
Read more →IARTIntegra LifeSciences Features CUSA ShearTip(TM) for Fibrous Tissue at the AANS 2010 Annual Meeting
PLAINSBORO, N.J., May 3, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will feature the CUSA ShearTip at the 2010 American Association of Neurological Surgeons (AANS) annual meeting, May 1-5, 2010 in Philadelphia, Pennsylvania. The CUSA ShearTip
Read more →IARTIntegra LifeSciences Reports First Quarter 2010 Financial Results
PLAINSBORO, N.J., May 3, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the first quarter ending March 31, 2010. Total revenues for the first quarter were $172.7 million, reflecting an increase of $11.7 mi
Read more →IARTIntegra LifeSciences to Present at the Deutsche Bank 35th Annual Health Care, Bank of America Merrill Lynch Health Care and Citi Investment Research's 2010 Global Healthcare Conferences in May
PLAINSBORO, N.J., April 27, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at three conferences in May. On Monday, May 3th, 2010 at 11:20 am ET, Mr. Gerry Carlozzi, Executive Vice President and Chief Operatin
Read more →IARTIntegra LifeSciences to Host First Quarter 2010 Earnings Results Conference Call on May 3, 2010
PLAINSBORO, N.J., April 5, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its first quarter 2010 financial results on Monday, May 3, 2010. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results
Read more →IARTIntegra LifeSciences Introduces Four New Products at the Association of periOperative Registered Nurses (AORN) Conference
PLAINSBORO, N.J., March 15, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences (Nasdaq:IART) introduced four new products today at the AORN conference in Denver, Colorado. The products include Secure-Cut Reposable Endoscopic Scissors, Ruggles Bayonet Curettes, Jarit Disposable Bi-pola
Read more →IARTIntegra LifeSciences Announces Commercial Launch of Paramount(R) Pedicle Screw (PS) System for Minimally Invasive Spine Surgery
PLAINSBORO, N.J., March 12, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences (Nasdaq:IART) announced today the U.S. commercial launch of Integra Spine's Paramount Pedicle Screw (PS) Fixation System for minimally invasive spine surgery. Previously, the Paramount PS system was availab
Read more →IARTIntegra LifeSciences Announces the Release of the Integra(TM) Total Wrist Fusion System
PLAINSBORO, N.J., March 10, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the release of the Integra Total Wrist Fusion System, a solution for wrist arthrodesis that is designed to provide fixation of the wrist while decreasing s
Read more →IARTIntegra LifeSciences Launches Integra Mozaik(TM) Moldable Morsels for Bone Grafting Procedures
PLAINSBORO, N.J., March 10, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the introduction of Integra Mozaik Moldable Morsels bone void filler, which will be available in four sizes. Integra Mozaik Moldable Morsels expands the su
Read more →IARTIntegra LifeSciences Launches Portfolio of Advanced Orthobiologics for Spine Surgery
PLAINSBORO, N.J., March 9, 2010 (GLOBE NEWSWIRE) -- Integra Lifesciences Holdings Corporation (Nasdaq:IART) announced today that it has created a portfolio of advanced bone grafting products, which will be sold in conjunction with its Integra Spine implants, providing spine surge
Read more →IARTIntegra LifeSciences to Present at Three Conferences in March
Raymond James Institutional Investors Conference Canaccord Adams Musculoskeletal Conference Barclays Capital Healthcare Conference PLAINSBORO, N.J., March 1, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present a
Read more →IARTIntegra LifeSciences Announces the Newest Additions to its Portfolio of Hydrocephalus Management Products: The OSV II(R) Lumbar and OSV II(R) Low Flow Lumbar Self-Adjusting Valves
PLAINSBORO, N.J., March 1, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the introduction of two new valve systems for the treatment of hydrocephalus, the OSV II Lumbar and the OSV II Low Flow Lumbar Valve Systems. The new line
Read more →IARTIntegra LifeSciences Reports Fourth Quarter and Full Year 2009 Financial Results
Revenues for the Fourth Quarter and Full Year Increased to $184 Million and $682 Million Cash Flow From Operations for the Fourth Quarter and Full Year Increased to $47 Million and $143 Million PLAINSBORO, N.J., March 1, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Co
Read more →IARTIntegra LifeSciences Donates Over $300,000 Worth of Medical Instruments to Haiti Earthquake Relief Efforts
PLAINSBORO, N.J., Feb. 2, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has donated over $300,000 worth of Jarit and Miltex surgical instruments to Direct Relief International, a non-profit, non-sectarian humanitarian ass
Read more →IARTIntegra LifeSciences to Present at the Deutsche Bank 2010 Small and Mid Cap Conference
PLAINSBORO, N.J., Feb. 1, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the Deutsche Bank 2010 Small and Mid Cap Conference in Naples, Florida. Mr. John B. Hennenman, III, Executive Vice President and Chi
Read more →IARTIntegra LifeSciences Announces First Two-Level Surgery With Paramount(R) Pedicle Screw System for Minimally Invasive Spine Surgery
PLAINSBORO, N.J., Jan. 25, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences (Nasdaq:IART) announced today that the first two-level surgery using the Paramount Pedicle Screw System for minimally invasive spine surgery under Integra Spine's ownership was performed by Dr. Ali Araghi of
Read more →IARTIntegra LifeSciences Announces First Surgery With Coral Spinal System for Minimally Invasive Spine Surgery
PLAINSBORO, N.J., Jan. 22, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences (Nasdaq:IART) announced today that the first clinical application of the Coral Spinal System for minimally invasive spine surgery was performed by Dr. Morteza Farr from Santa Cruz, California. Dr. Farr is th
Read more →IARTIntegra LifeSciences to Host Fourth Quarter 2009 Earnings Results Conference Call on March 1, 2010
PLAINSBORO, N.J., Jan. 19, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its fourth quarter and full year 2009 financial results and update its financial guidance for 2010 on Monday, March 1, 2010. The company has scheduled a confer
Read more →IARTIntegra LifeSciences Awarded Contract With HealthTrust Purchasing Group to Provide Luxtec(R) Surgical Illumination Products
PLAINSBORO, N.J., Jan. 19, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that its subsidiary, Integra Luxtec, Inc., has signed a three-year contract with HealthTrust Purchasing Group to provide Luxtec(R) surgical headlights, ligh
Read more →IARTIntegra LifeSciences Announces First Surgery With Paramount(R) Pedicle Screw System for Minimally Invasive Spine Surgery
PLAINSBORO, N.J., Jan. 11, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences (Nasdaq:IART) announced today that the first surgery using Integra Spine's Paramount(R) Pedicle Screw System for minimally invasive spine surgery was performed by Dr. Andrew Parkinson, of Orthopedic Associat
Read more →IARTIntegra LifeSciences to Present at the 28th Annual J.P. Morgan Healthcare Conference
PLAINSBORO, N.J., Jan. 5, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco. Mr. Stuart Essig, President and Chief Executive Officer of Integ
Read more →IARTIntegra LifeSciences Announces New Three-Year Agreement With Premier
PLAINSBORO, N.J., Dec. 21, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has signed a new three-year contract for Jarit(R) surgical and laparoscopic instruments with Premier Purchasing Partners, LP, the group purchasing u
Read more →IARTIntegra LifeSciences Announces Contract With Premier Purchasing Partners
PLAINSBORO, N.J., Dec. 7, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has signed a three-year contract for Luxtec(R) surgical headlights, light sources and accessories with Premier Purchasing Partners, LLP (Premier), th
Read more →IARTIntegra LifeSciences Names Ken Yamada Director of Sales for Asia
PLAINSBORO, N.J., Dec. 3, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the appointment of Ken Yamada as Director of Sales, Asia for Integra LifeSciences, effective immediately. Mr. Yamada has a wealth of senior sales and market
Read more →IARTIntegra LifeSciences to Present at the Piper Jaffray Health Care and JP Morgan SMid Cap Conferences in December
PLAINSBORO, N.J., Nov. 20, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at two conferences in December. Stuart Essig, President and Chief Executive Officer of Integra, will present at both conferences in Ne
Read more →IARTIntegra Spine Launches the Paramount(R) Minimally Invasive System at the North American Spine Society Meeting
PLAINSBORO, N.J., Nov. 11, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences (Nasdaq:IART) announced today that it is featuring the Paramount(R) Pedicle Screw Fixation System for minimally invasive spine surgery at the annual North American Spine Society (NASS) Meeting, held November
Read more →IARTIntegra LifeSciences Reports Third Quarter 2009 Financial Results
Revenues for the Third Quarter Increased to $172 Million Outstanding Debt Reduced by $58 million PLAINSBORO, N.J., Nov. 4, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the third quarter ending Septembe
Read more →IARTIntegra LifeSciences to Present at the Oppenheimer 20th Annual Healthcare Conference
PLAINSBORO, N.J., Oct. 28, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the Oppenheimer 20th Annual Healthcare Conference. On Wednesday, November 4th, 2009 at 1:35 PM, Gerry Carlozzi, Executive Vice Pres
Read more →IARTIntegra LifeSciences Featured in Forbes 2009 List of 200 Best Small Companies
PLAINSBORO, N.J., Oct. 27, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a world leader in regenerative medicine, announced today that it has made Forbes magazine's 2009 list of "200 Best Small Companies." "We're honored to have been named to
Read more →IARTIntegra LifeSciences Features Auragen(TM) Electrodes at Congress of Neurological Surgeons
PLAINSBORO, N.J., Oct. 27, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will feature the Auragen(TM) line of cortical electrodes for brain mapping at the 2009 Congress of Neurological Surgeons, held October 24 - October 29, 2009 in New Orleans,
Read more →IARTIntegra LifeSciences Launches CUSA ShearTip(TM) for Fibrous Tissue at 2009 Congress of Neurological Surgeons Meeting
PLAINSBORO, N.J., Oct. 26, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the launch of the CUSA ShearTip(TM) for its CUSA EXcel(R) Ultrasonic Surgical Tissue Ablation platform that includes the CUSA EXcel(R) and the CUSA EXcel(R)
Read more →IARTIntegra LifeSciences to Host Analyst Forum On November 16, 2009
PLAINSBORO, N.J., Oct. 15, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will host the annual Analyst Forum on Monday, November 16, 2009 from 2:00 to 5:00 PM EST at the New York Marriott East Side Hotel in New York City.
Read more →IARTIntegra LifeSciences to Host Third Quarter 2009 Earnings Results Conference Call On November 4th, 2009
PLAINSBORO, N.J., Oct. 5, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its 2009 third quarter financial results and update its financial guidance for 2009 on Wednesday, November 4, 2009, before regular market trading hours. The com
Read more →IARTIntegra LifeSciences to Present At the JMP 4th Annual Healthcare Focus Conference
PLAINSBORO, N.J., Sept. 30, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today it will present at JMP Securities 4th Annual Healthcare Focus Conference. On Monday, October 5th 2009 at 9:30 AM, Stuart Essig, President and Chief Execut
Read more →IARTIntegra LifeSciences Expands Accell Evo3 Product Line
PLAINSBORO, N.J., Sept. 29, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the release of a smaller configuration of the innovative Accell Evo3(R) Demineralized Bone Matrix. Originally introduced as a bone void filler for large or
Read more →IARTIntegra LifeSciences Acquires the Assets of Innovative Spinal Technologies, Inc.
PLAINSBORO, N.J., Sept. 14, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that Integra Spine has acquired substantially all of the assets of Innovative Spinal Technologies, Inc. (IST) for $9.25 million in cash. IST designed, dev
Read more →IARTIntegra LifeSciences Announces First Clinical Implant of INTEGRA(R) Dermal Regeneration Template for Life-Threatening Burns in Japan
PLAINSBORO, N.J., Sept. 3, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the first clinical implant of INTEGRA(R) Dermal Regeneration Template in Japan. The operation was performed by Dr. Hajime Matsumura of Tokyo Medical Univers
Read more →IARTIntegra LifeSciences Launches Coral Cobalt Chrome Rods
PLAINSBORO, N.J., Sept. 1, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the launch of 5.5mm Coral(TM) cobalt chrome rods in a range of lengths for use in spinal correction and fusion procedures. With the addition of cobalt chrom
Read more →IARTIntegra NeuroSciences Features New MAYFIELD(R) Infinity XR2 Radiolucent Cranial Stabilization System At World Congress of Neurological Surgery
PLAINSBORO, N.J., Aug. 31, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) is featuring the MAYFIELD(R) Infinity XR2 Radiolucent Cranial Stabilization System at the XIV World Congress of Neurological Surgery in Boston, Massachusetts, August 30 - S
Read more →IARTIntegra LifeSciences to Present At the Thomas Weisel Partners Healthcare and Morgan Stanley Global Healthcare Unplugged Conferences in September
PLAINSBORO, N.J., Aug. 28, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today it will present at two Conferences. On Wednesday, September 9, 2009 at 2:05 PM, Gerry Carlozzi, Integra's Executive Vice President and Chief Operating Offi
Read more →IARTIntegra LifeSciences Announces the Release of the PANTA XL Arthrodesis Nail
PLAINSBORO, N.J., Aug. 7, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the release of the Panta(R) XL Arthrodesis Nail, a solution for tibiotalocalcaneal (TTC) arthrodesis. The Panta(R) XL Nail has received clearance from the U.
Read more →IARTIntegra LifeSciences Reports Second Quarter 2009 Financial Results
Revenues for the Second Quarter Increased to $166 Million Outstanding Debt Reduced by $79 Million PLAINSBORO, N.J., Aug. 6, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the second quarter ending June 3
Read more →IARTIntegra LifeSciences to Present At Canaccord Adams Global Growth Conference in August
PLAINSBORO, N.J., Aug. 3, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today it will present at Canaccord Adams Global Growth Conference. On Thursday, August 13th at 8:00 AM, Gerry Carlozzi, Integra's Executive Vice President and Chi
Read more →IARTIntegra LifeSciences Announces Launch of HALLU-LOCK MTP Arthrodesis System
PLAINSBORO, N.J., July 17, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE Mark Certification from the European Union for the HALLU(R)-LO
Read more →IARTIntegra LifeSciences Expands Uni-CP Compression System Product Range for Mid and Hindfoot Reconstruction
PLAINSBORO, N.J., July 16, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will release multiple product line extensions to the Uni-CP(TM) Compression System. The Uni-CP(TM) Compression System has U.S. Food and Drug Adminis
Read more →IARTIntegra LifeSciences Holdings Corporation Signs Licensing Agreement With Organogenesis, Inc. for Distribution of Inforce(TM) Reinforcement Matrix
PLAINSBORO, N.J. and CANTON, Mass., July 15, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has signed an agreement with Organogenesis, Inc., to distribute Organogensis' FortaFlex(R) Technology as Inforce(TM) Reinforcement
Read more →IARTIntegra LifeSciences Expands OrthoBiologics Product Line
PLAINSBORO, N.J., July 13, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that Integra Mozaik(TM) Osteoconductive Scaffold strip is now available in a smaller configuration, broadening Integra's OrthoBiologics portfolio and provid
Read more →IARTIntegra LifeSciences to Host Second Quarter 2009 Earnings Results Conference Call On August 6
PLAINSBORO, N.J., July 6, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its 2009 second quarter financial results and update its financial guidance for 2009 on Thursday, August 6, 2009, before regular market trading hours. The compa
Read more →IARTIntegra LifeSciences Celebrates 20th Anniversary
PLAINSBORO, N.J., June 19, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) is celebrating its 20th anniversary. Officially founded on June 19, 1989, Integra began with two employees and a vision to use collagen based products to regenerate body pa
Read more →IARTIntegra LifeSciences to Present At the Following Conferences in June: Goldman Sachs Global Healthcare Conference, Needham Life Sciences Conference, Jefferies Healthcare Conference, and Piper Jaffray Europe Conference
PLAINSBORO, N.J., June 3, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at four conferences in June. On Tuesday, June 9, 2009 at 2:35 PM John B. Henneman III, Integra's Executive Vice President, F
Read more →IARTIntegra LifeSciences Appoints Deborah Leonetti as President of Integra Surgical
PLAINSBORO, N.J., May 12, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced the promotion of Deborah Leonetti to President of Integra Surgical, which is part of Integra's Medical Instrument business. "Debbie will be a definite asset to th
Read more →IARTIntegra LifeSciences Announces Launch of LUXTEC UltraLite Pro Headlight
PLAINSBORO, N.J., May 11, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the introduction of the LUXTEC(R) UltraLite(R) Pro headlight for use in surgical procedures, the latest addition to Luxtec's extensive line of illumination s
Read more →IARTIntegra LifeSciences Reports First Quarter 2009 Financial Results
Revenues for the First Quarter Increase to $161 Million Operating Cash Flow Increases to $37 Million Repurchased $32 Million of 2.75 Percent 2010 Convertible Notes PLAINSBORO, N.J., May 6, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today r
Read more →IARTIntegra LifeSciences Launches Coral(TM) Extended Tab Spinal Screw Series
PLAINSBORO, N.J., May 5, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the launch the Coral(TM) Extended Tab Spinal Screw series, a range of polyaxial pedicle screws designed to be used with the Coral(TM) Spinal System. The Coral
Read more →IARTIntegra LifeSciences Launches Atoll Occipital-Cervical-Thoracic System
PLAINSBORO, N.J., May 4, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the launch of the Atoll(TM) Occipital-Cervical-Thoracic (OCT) System, a posterior cervical spinal fixation system. With the addition of the Atoll(TM) OCT Syst
Read more →IARTIntegra LifeSciences Features CUSA NXT System At American Association of Neurological Surgeons Annual Meeting
PLAINSBORO, N.J., May 3, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) is featuring the CUSA NXT(TM) ultrasonic tissue ablation system at the 2009 American Association of Neurological Surgeons Annual Meeting in San Diego, California, May 2-6, 20
Read more →IARTIntegra LifeSciences Will Feature the New LimiTorr Volume Limiting CSF Drainage System At AANS
PLAINSBORO, N.J., May 1, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will feature the LimiTorr(TM) Volume Limiting CSF Drainage System at the upcoming 2009 American Association of Neurological Surgeons Annual Meeting in
Read more →IARTIntegra LifeSciences to Feature the OSVII Low Pro Flow-Regulating Shunt At the American Association of Neurological Surgeons Annual Meeting
PLAINSBORO, N.J., May 1, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will feature the OSVII Low Pro(TM) Valve, a low profile version of the OSVII(R) Flow-Controlled Hydrocephalus Valve, at the American Association of Neurological Surgeons Annu
Read more →IARTIntegra LifeSciences to Present At Two Conferences in May
PLAINSBORO, N.J., April 30, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at two conferences in May. On Wednesday, May 13, 2009 at 8:40 AM, Stuart Essig, Integra's President and Chief Executive Of
Read more →IARTIntegra LifeSciences Will Feature the CUSA EXcel+ Ultrasonic Tissue Ablation System At the American Association of Neurological Surgeons Annual Meeting
PLAINSBORO, N.J., April 30, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will showcase its new CUSA EXcel(R)+ ultrasonic tissue ablation system at the 2009 American Association of Neurological Surgeons (AANS) meeting in San Diego, California, M
Read more →IARTIntegra LifeSciences Will Feature the INTEGRA Meshed Bilayer Wound Matrix At the 22nd Annual Symposium On Advanced Wound Care and Wound Healing Society Meeting
PLAINSBORO, N.J., April 27, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the introduction of INTEGRA(TM) Meshed Bilayer Wound Matrix, and will feature the product at the upcoming 22nd Annual Symposium on Advanced Wound Care and
Read more →IARTINTEGRA Dermal Regeneration Template Launched in Japan
PLAINSBORO, N.J., April 15, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today its plan to launch INTEGRA(R) Dermal Regeneration Template in Japan with its long-time distributor, Century Medical, Inc. "We have been working very close
Read more →IARTIntegra LifeSciences Holdings Corporation Appoints Raymond G. Murphy to Its Board of Directors
PLAINSBORO, N.J., April 13, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that Raymond G. Murphy will join its board of directors on April 17, 2009. "I am very pleased that Ray has agreed to join our board of directors as our ninth me
Read more →IARTIntegra LifeSciences to Host First Quarter 2009 Earnings Results Conference Call On May 6
PLAINSBORO, N.J., April 7, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its 2009 first quarter financial results and update its financial guidance for 2009 on Wednesday, May 6, 2009, before regular market trading hours. The company
Read more →IARTIntegra LifeSciences Names Christopher Thatcher President of Integra NeuroSciences
PLAINSBORO, N.J., March 3, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the appointment of Christopher A. Thatcher as President of Integra NeuroSciences, effective immediately. Mr. Thatcher brings to Integra more than 14 years
Read more →IARTIntegra LifeSciences to Present At Two Conferences in March
PLAINSBORO, N.J., March 2, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at two conferences in March. On Wednesday, March 11, 2009 at 7:30 AM ET, John B. Henneman III, Executive Vice President, Fi
Read more →IARTIntegra LifeSciences Reports 2008 Financial Results
PLAINSBORO, N.J., March 2, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the fourth quarter and full year ending December 31, 2008. Total revenues in the fourth quarter of 2008 were $174.4 million, reflec
Read more →IARTIntegra LifeSciences Announces In-Kind Donation of Over $1 Million in Medical Instruments to Direct Relief International
PLAINSBORO, N.J., Feb. 18, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) completed an in-kind donation of over $1 million worth of medical instruments and devices to Direct Relief International, a non-profit, non-sectarian humanitarian assistanc
Read more →IARTIntegra LifeSciences to Present At Two Conferences in February
PLAINSBORO, N.J., Jan. 29, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at two conferences in February. On Thursday, February 12, 2009 at 8:00 AM, Gerry Carlozzi, Executive Vice President and Chi
Read more →IARTIntegra LifeSciences Launches a Series of PEEK-Optima(R) Interbody Spinal Implants
PLAINSBORO, N.J., Jan. 9, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the launch of a series of intervertebral body fusion devices (IBD), the Vu e-POD(TM) and Vu L-POD(TM) through the newly formed Integra Spine. The Vu e-POD a
Read more →IARTIntegra LifeSciences Announces Acquisition of Omni-Tract Surgical
PLAINSBORO, N.J., Jan. 9, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has acquired Minnesota Scientific, Inc. (d/b/a Omni-Tract Surgical). Omni-Tract Surgical, based in St. Paul, MN, is a global leader in the developme
Read more →IARTIntegra LifeSciences Expects 2008 Revenues to be 1 Percent Below Prior Guidance
PLAINSBORO, N.J., Jan. 9, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that its 2008 and 2009 revenues and GAAP and adjusted diluted earnings per share results are expected to be below the guidance previously provided and that i
Read more →IARTIntegra LifeSciences to Present At the 27th Annual JPMorgan Healthcare Conference
PLAINSBORO, N.J., Dec. 29, 2008 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at the 27th Annual JPMorgan Healthcare Conference on January 14, 2009 at 3:30 p.m. at the Westin St. Francis Hotel in San Fr
Read more →IARTIntegra LifeSciences to Present At Three Conferences in December
PLAINSBORO, N.J., Nov. 26, 2008 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at three conferences in December. On Wednesday, December 3, 2008 at 9:30 AM, Stuart Essig, President and CEO of Integra, wi
Read more →IARTIntegra LifeSciences Reports Third Quarter 2008 Financial Results
Revenues for the Third Quarter Increase 24% to $167 Million Cash Flow From Operations Increases to $27 Million Announces Acquisition of Its Australian and New Zealand Distributor PLAINSBORO, N.J., Nov. 7, 2008 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasd
Read more →IARTIntegra LifeSciences to Present At Two Conferences in November
PLAINSBORO, N.J., Oct. 31, 2008 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at two conferences in November. On Monday, November 3, 2008 at 8:40 AM, Stuart Essig, President and CEO of Integra will be
Read more →IARTIntegra LifeSciences Featured in Forbes 2008 List of 200 Best Small Companies
PLAINSBORO, N.J., Oct. 24, 2008 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a world leader in regenerative medicine, announced today that it has made Forbes magazine's 2008 list of "200 Best Small Companies." The Forbes 200 Best Small Companies r
Read more →IARTIntegra LifeSciences Launches Accell Evo3, the Next Generation Accell Technology
PLAINSBORO, N.J., Oct. 15, 2008 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has received 510(k) clearance from the United States Food and Drug Administration to market Accell Evo3(TM) in the US. Accell Evo3(TM) is the lates
Read more →IARTIntegra LifeSciences Announces Theken Products Will be Marketed as Integra Spine
PLAINSBORO, N.J., Oct. 14, 2008 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that the Theken products will now be marketed under the name Integra Spine(TM), and will be featured at the upcoming North American Spine Society annual mee
Read more →IARTIntegra LifeSciences Announces Launch of Luxtec MLX 300W Xenon Light Source
PLAINSBORO, N.J., Oct. 13, 2008 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the introduction of the Luxtec(R) MLX 300W Xenon light source for use in surgical procedures, the latest addition to Luxtec's extensive line of illumination
Read more →IARTIntegra LifeSciences to Host Third Quarter 2008 Earnings Results Conference Call On November 10
PLAINSBORO, N.J., Oct. 8, 2008 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference call for 9:00 AM ET on Monday, November 10, 2008 to discuss financial results for the third quarter of 2008 and to update forward-looking financia
Read more →IARTIntegra LifeSciences to Host Analyst Forum On November 17, 2008
PLAINSBORO, N.J., Oct. 7, 2008 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will host the annual Analyst Forum on Monday, November 17, 2008 from 2:00 to 5:00 PM Eastern Time at the New York Marriott East Side Hotel in New Yor
Read more →IARTIntegra LifeSciences to Present At Two Conferences in October
PLAINSBORO, N.J., Oct. 2, 2008 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at two conferences in October. On Tuesday, October 7, 2008 at 1:00 PM, Gerry Carlozzi, Chief Operating Officer of Integra, w
Read more →IARTIntegra LifeSciences Announces Contract With Novation
PLAINSBORO, N.J., Sept. 24, 2008 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq:IART) announced today that Integra OrthoBiologics has signed a three-year contract with Novation, one of the industry's leading contracting services companies, to supply Integra
Read more →IARTIntegra LifeSciences Will Feature the New LimiTorr Volume Limiting CSF Drainage System At Congress of Neurological Surgeons Annual Meeting
PLAINSBORO, N.J., Sept. 23, 2008 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will feature the LimiTorr(TM) Volume Limiting CSF Drainage System at the upcoming Congress of Neurological Surgeons Annual Meeting in Orlando, FL,
Read more →IARTIntegra Announces the Addition of a Low Profile Shunt to the OSVII Flow-Regulating Shunts
PLAINSBORO, N.J., Sept. 22, 2008 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the introduction of the OSVII Low Pro(TM) Valve, a low profile version of the OSVII(R) Flow-Controlled Hydrocephalus Valve. The OSVII Low Pro(TM) Valve wil
Read more →IARTIntegra LifeSciences Announces $700,000 In-Kind Donation of Medical Devices to Boston University School of Medicine
PLAINSBORO, N.J., Sept. 22, 2008 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today an in-kind donation of over $700,000 worth of neurosurgical medical devices to the Boston University School of Medicine (BUSM) -- Armenia Medical Partnersh
Read more →IARTIntegra LifeSciences Will Feature Its New EndoRelease Endoscopic Cubital Tunnel Release System At American Society for Surgery of the Hand Annual Meeting
PLAINSBORO, N.J., Sept. 17, 2008 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the introduction of the EndoRelease(TM) Endoscopic Cubital Tunnel Release System. The EndoRelease(TM) System will initially be marketed in the United State
Read more →IARTIntegra LifeSciences to Present At Two Conferences in September
PLAINSBORO, N.J., Sept. 1, 2008 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at two conferences in September. On Thursday, September 4 at 10:20 AM, John B Henneman III, Executive Vice President, Finan
Read more →IARTIntegra LifeSciences Names Gabrielle Wolfson Chief Information Officer
PLAINSBORO, N.J., Aug. 18, 2008 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the appointment of Gabrielle Wolfson as Chief Information Officer, effective immediately. Ms. Wolfson brings to Integra over 20 years of experience in Info
Read more →IARTIntegra LifeSciences Reports Second Quarter 2008 Financial Results
Revenues for the Second Quarter Increase 17% to $157.2 Million Integra Enters the Fast Growing Spine Market PLAINSBORO, N.J., Aug. 11, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the quarter ended Jun
Read more →IARTIntegra LifeSciences Acquires Theken Spine
PLAINSBORO, N.J., Aug. 4, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has acquired Theken Spine, LLC, Theken Disc, LLC and Therics, LLC (together "Theken") for $75 million in cash, subject to certain adjustments, and up
Read more →IARTIntegra LifeSciences to Present At Two Conferences in August
PLAINSBORO, N.J., Aug. 3, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at two conferences in August. On Tuesday, August 5th, 2008 at 9:30 a.m., Gerry Carlozzi, Chief Operating Officer of Integra,
Read more →IARTIntegra LifeSciences Announces Agreement to Acquire Theken Spine
PLAINSBORO, N.J., July 24, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has agreed to acquire Theken Spine, LLC, Theken Disc, LLC and Therics, LLC (together "Theken") for $75 million in cash at closing, subject to certai
Read more →IARTIntegra LifeSciences to Host Second Quarter 2008 Earnings Results Conference Call On August 12
PLAINSBORO, N.J., July 23, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference call for 9:00 AM EST on Tuesday, August 12, 2008 to discuss financial results for the second quarter of 2008 and to update forward-looking financ
Read more →IARTIntegra LifeSciences Announces the Launch of the Tibiaxys Plating System
PLAINSBORO, N.J., June 26, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the introduction of the Tibiaxys(TM) Plating System. The Tibiaxys(TM) Plating System has received clearance from the United States Food and Drug Administrat
Read more →IARTIntegra LifeSciences Features Large Qwix Fixation and Positioning Screw System At American Orthopaedic Foot & Ankle Society Meeting
PLAINSBORO, N.J., June 25, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will feature the Large Qwix(TM) Fixation and Positioning Screw System at the 24th Annual American Orthopaedic Foot & Ankle Society Meeting, June 25-28, 2008, Denver, Colora
Read more →IARTIntegra LifeSciences to Present At the Piper Jaffray Europe Conference
PLAINSBORO, N.J., June 24, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it is scheduled to present at the Piper Jaffray Europe Conference on Wednesday, June 25, 2008. John B Henneman III, Executive Vice President, Finance a
Read more →IARTIntegra LifeSciences Receives NASDAQ Notice of Compliance
PLAINSBORO, N.J., June 6, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that The NASDAQ Stock Market has formally notified the Company that, following the filing of the Company's Quarterly Report on Form 10-Q for the period ended
Read more →IARTIntegra LifeSciences Reports First Quarter 2008 Financial Results
PLAINSBORO, N.J., June 4, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the first quarter ending March 31, 2008. Total revenues were approximately $156.0 million, reflecting an increase of $33.0 million,
Read more →IARTIntegra LifeSciences Launches Smaller Size of Accell Total Bone Matrix
PLAINSBORO, N.J., June 4, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that Accell TBM(R) (Total Bone Matrix) is now available in a smaller size configuration. The addition of the smaller size configuration allows clinicians to
Read more →IARTIntegra LifeSciences to Host First Quarter 2008 Financial Results Conference Call on June 5, 2008
PLAINSBORO, N.J., June 3, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference call for 9:00 AM ET on Thursday, June 5, 2008 to discuss financial results for the first quarter ended March 31, 2008 and to update forward-lookin
Read more →IARTIntegra LifeSciences Receives NASDAQ Notice of Non-compliance Due to Delayed Form 10-Q
PLAINSBORO, N.J., May 23, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that, as expected, on May 20, 2008, the Company received a notice of non-compliance from The NASDAQ Stock Market LLC due to the Company's failure to timely f
Read more →IARTIntegra LifeSciences to Present At Citi Investment Research Health Care Conference
PLAINSBORO, N.J., May 20, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is to present at the 2008 Citi Investment Research Health Care Conference at the Hilton New York in New York City on May 22nd at 2:00 PM. Integra Li
Read more →IARTIntegra LifeSciences Reports 2007 Financial Results and Appointment of Chief Financial Officer
Revenues for the Fourth Quarter Increase 26% to $157.6 Million First Quarter Revenues Expected Above Consensus PLAINSBORO, N.J., May 16, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the fourth quarter
Read more →IARTIntegra LifeSciences to Host 2007 Financial Results Conference Call On May 19
PLAINSBORO, N.J., May 16, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference call for 9:00 AM EDT on Monday, May 19, 2008 to discuss financial results for the fourth quarter and full year ended December 31, 2007 and to upda
Read more →IARTIntegra LifeSciences Announces Launch of the LimiTorr Volume Limiting CSF Drainage System
PLAINSBORO, N.J., April 25, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the release of the LimiTorr(TM) Volume Limiting CSF Drainage System, the latest addition to Integra's cerebral spinal fluid (CSF) drainage product line and
Read more →IARTIntegra LifeSciences Announces the Addition of a New Size for Its Integra Mozaik Moldable Putty
PLAINSBORO, N.J., April 24, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that the moldable putty configuration of Integra Mozaik(TM) Osteoconductive Scaffold is now available in a smaller configuration. The addition of the small
Read more →IARTIntegra LifeSciences Announces $2.8 Million In-Kind Donation of Medical Devices to CURE International
PLAINSBORO, N.J., April 21, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today an in-kind donation of almost $3.0 million worth of neurosurgical medical devices to three CURE International hospitals located in the Dominican Republic,
Read more →IARTIntegra LifeSciences Receives NASDAQ Notice of Non-Compliance Due to Delayed Form 10-K
PLAINSBORO, N.J., March 24, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that on March 18, 2008, it received notice from the Listing Qualifications Staff of The NASDAQ Stock Market that it is not in compliance with NASDAQ Market
Read more →IARTIntegra LifeSciences Will Feature Its New Osteobiologics Line for Reconstructive Surgery At AAOS
PLAINSBORO, N.J., March 7, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the introduction of Integra OS(TM) Osteoconductive Scaffold and the Trel-X(TM) and Trel-XC(TM) Demineralized Bone Matrix products through the Integra Extrem
Read more →IARTIntegra LifeSciences Introduces the Large Qwix Fixation and Positioning Screws
PLAINSBORO, N.J., March 6, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the introduction of the Large Qwix(TM) Fixation and Positioning Screw System. The Large Qwix(TM) system has received clearance to be marketed in the United
Read more →IARTIntegra LifeSciences Introduces New MAYFIELD Pediatric Radiolucent Horseshoe Headrest
PLAINSBORO, N.J., Feb. 29, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the introduction of its new MAYFIELD(R) Pediatric Radiolucent Horseshoe Headrest, for use with the MAYFIELD(R) Radiolucent Cranial Stabilization System. The
Read more →IARTIntegra LifeSciences Announces 2007 Revenues
PLAINSBORO, N.J., Feb. 29, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced its revenues for the fourth quarter ending December 31, 2007. Total revenues in the fourth quarter of 2007 were approximately $157.6 million, reflecting an
Read more →IARTIntegra LifeSciences Introduces InterFix Radiosurgery Kit for Use With TomoTherapy Radiation Treatment Systems
PLAINSBORO, N.J., Feb. 28, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that its subsidiary, Integra Radionics, Inc., has launched the InterFix(TM) Radiosurgery Kit for use with TomoTherapy(R) radiation treatment systems. The In
Read more →IARTIntegra LifeSciences Introduces Titanium Skull Pins for Intra-Operative Brain Surgery
PLAINSBORO, N.J., Feb. 27, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the introduction of the next generation of MAYFIELD(R) skull pins. Manufactured from high grade titanium, the new MAYFIELD(R) skull pins are specifically de
Read more →IARTIntegra LifeSciences to Present At Five Conferences in March
PLAINSBORO, N.J., Feb. 20, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at five conferences in March. On March 4, 2008 at 9:30 AM, Gerard Carlozzi, Chief Operating Officer of Integra, will be pre
Read more →IARTIntegra LifeSciences Announces Determination of Entitlement to Contingent Interest On Convertible Notes Due 2008
PLAINSBORO, N.J., Feb. 20, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has determined that holders of its 2 1/2% Contingent Convertible Subordinated Notes due 2008 ("Notes") shall be entitled to receive contingent inter
Read more →IARTIntegra LifeSciences to Present At the Upcoming Wachovia Healthcare Conference
PLAINSBORO, N.J., Jan. 17, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at the Wachovia Healthcare Conference at the Langham Hotel in Boston on Wednesday, January 30, 2008 at 9:00 am (ET). The pr
Read more →IARTIntegra LifeSciences Names James Oti Senior Vice President of Global Operations
PLAINSBORO, N.J., Jan. 11, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the appointment of James A. Oti as Senior Vice President of Global Operations, effective immediately. Mr. Oti brings to Integra more than 14 years of medic
Read more →IARTIntegra LifeSciences to Host 2007 Financial Results Conference Call On February 29
PLAINSBORO, N.J., Jan. 4, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference call for 9:00 AM EST on Friday, February 29, 2008 to discuss financial results for the fourth quarter and full year ended December 31, 2007 and to
Read more →IARTIntegra LifeSciences to Present At the Upcoming JPMorgan Healthcare Conference
PLAINSBORO, N.J., Dec. 20, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at the JPMorgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on January 7, 2008. The presentation
Read more →IARTIntegra LifeSciences Launches Flowable Wound Matrix
PLAINSBORO, N.J., Dec. 13, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the launch of Integra(TM) Flowable Wound Matrix. Integra has received 510(k) clearance from the United States Food and Drug Administration to market Integra
Read more →IARTIntegra LifeSciences Launches Radionics CRW BiopsyPlus Kit
PLAINSBORO, N.J., Dec. 7, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has launched the Radionics CRW(TM) BiopsyPlus Kit, which is designed to simplify the use of the Nashold Biopsy Needle when used with the Radionics CR
Read more →IARTIntegra LifeSciences Announces $4 Million In-Kind Donation of Medical Devices to FIENS
PLAINSBORO, N.J., Dec. 5, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today an in-kind donation of over $4 million worth of neurosurgical medical devices to the Foundation for International Education in Neurological Surgery (FIENS).
Read more →IARTIntegra LifeSciences Announces Acquisition of Dental Businesses
PLAINSBORO, N.J., Dec. 3, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has acquired the Precise Dental family of companies for approximately $10 million in cash, subject to certain adjustments. The Precise Dental family
Read more →IARTIntegra LifeSciences to Present At the BMO Capital Markets Focus On Healthcare Conference and RBC Capital Markets Healthcare Conference
PLAINSBORO, N.J., Nov. 29, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at two conferences in New York City next month. On Wednesday, December 5, 2007, the company will present at the BMO Capital
Read more →IARTIntegra LifeSciences to Host Analyst Forum Today
PLAINSBORO, N.J,, Nov. 20, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will host an Analyst Forum today, Tuesday, November 20, 2007 at 3:00 PM Eastern Time at the New York Marriott East Side Hotel at 525 Lexington Avenue in New York City. The
Read more →IARTIntegra LifeSciences Honored as 2007 Medical Device Manufacturer of the Year by Medical Device & Diagnostic Industry Magazine
PLAINSBORO, N.J., Nov. 14, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a world leader in regenerative medicine, announced today that it has been selected by Medical Device & Diagnostic Industry (MD&DI) magazine as a "2007 Medical Device Manuf
Read more →IARTIntegra LifeSciences Reports Third Quarter 2007 Financial Results
PLAINSBORO, N.J., Nov. 9, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the third quarter ending September 30, 2007. Total revenues in the third quarter of 2007 were $135.0 million, reflecting an increase
Read more →IARTIntegra LifeSciences Acquires IsoTis Creating a Global Leader in Orthobiologics
PLAINSBORO, N.J., Oct. 29, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today it has acquired the shares of IsoTis, Inc. for $7.25 in cash per share of IsoTis common stock, representing total consideration to IsoTis stockholders of ap
Read more →IARTIntegra LifeSciences to Present At the CIBC World Markets 18th Annual Healthcare Conference, Lazard Capital Markets 4th Annual Healthcare Conference and the 19th Annual Piper Jaffray Health Care Conference
PLAINSBORO, N.J., Oct. 29, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at three conferences in New York City next month. On Monday, November 5th, the company will present at CIBC World Markets 18
Read more →IARTIntegra LifeSciences to Host Analyst Forum On November 20, 2007
PLAINSBORO, N.J., Oct. 15, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will host an Analyst Forum on Tuesday, November 20, 2007 at 3:00 PM Eastern Time at the New York Marriott East Side Hotel in New York City. The meet
Read more →IARTIntegra LifeSciences Partners With TomoTherapy to Deliver Image-Guided Stereotactic Radiosurgery
PLAINSBORO, N.J., Oct. 11, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that its subsidiary, Integra Radionics, Inc., has entered into a strategic alliance with TomoTherapy Incorporated (Nasdaq:TTPY). The companies will develop
Read more →IARTIntegra LifeSciences Schedules Conference Call for Friday, November 9, 2007 to Discuss Third Quarter 2007 Financial Results and Update Forward-Looking Financial Guidance
PLAINSBORO, N.J., Oct. 2, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference call for 9:00 AM EST on Friday, November 9, 2007 to discuss financial results for the third quarter ended September 30, 2007 and to update forward
Read more →IARTIntegra LifeSciences Announces Launch of New Cortical Stimulator for Mapping Brain Functions in Cancer and Epilepsy Patients
PLAINSBORO, N.J., Sept. 21, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced the release of the OCS2 Ojemann Cortical Stimulator at this week's annual meeting of the Congress of Neurological Surgeons in San Diego, CA. The OCS2 Ojemann Cor
Read more →IARTIntegra LifeSciences to Present At the UBS Global Life Sciences Conference and Natixis Bleichroeder's Hidden Gems Conference
PLAINSBORO, N.J., Sept. 17, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at the UBS Global Life Sciences Conference at the Grand Hyatt New York on Wednesday, September 26, 2007, and at Natixis Ble
Read more →IARTIntegra LifeSciences Announces Poster Presentation 'Periradicular Lumbar Fibrosis: What to Do?' At 2007 Congress of Neurological Surgeons Annual Meeting
PLAINSBORO, N.J., Sept. 17, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq:IART) is pleased to announce the poster presentation "Periradicular Lumbar Fibrosis: What to Do?" by Dr. Inaki Arrotegui, of the Department of Neurosurgery, University of Valenci
Read more →IARTIntegra LifeSciences Launches Bone-Cutting Selector SaberTip At 2007 Congress of Neurological Surgeons Meeting
PLAINSBORO, N.J., Sept. 17, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the launch of the Selector SaberTip(TM) for the CUSA Selector(TM) ultrasonic surgical aspirator system, and will feature the Selector SaberTip(TM) at the 2
Read more →IARTIntegra NeuroSciences Launches DuraGen XS Dural Regeneration Matrix
PLAINSBORO, N.J., Sept. 16, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Integra NeuroSciences has received 510(k) clearance from the United States Food and Drug Administration to market the DuraGen XS(TM) Dural Regeneratio
Read more →IARTIntegra LifeSciences Announces Launch of the Camino Advanced Monitor, a State of the Art Monitoring System for Traumatic Brain Injury Patients
PLAINSBORO, N.J., Sept. 11, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the release of the Camino(R) Advanced Monitor (CAM), the latest addition to Integra's neuromonitoring product line. Camino(R) Advanced Monitor is the newe
Read more →IARTIntegra LifeSciences Announces Resignation of Chief Financial Officer
PLAINSBORO, N.J., Sept. 7, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Maureen B. Bellantoni has resigned as the Executive Vice President and Chief Financial Officer of the Company, effective September 6, 2007. Ms. Bellant
Read more →IARTIntegra LifeSciences to Present at the Bear Stearns 20th Annual Healthcare Conference and the First Albany Regenerative Technologies Conference
PLAINSBORO, N.J., Sept. 4, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at the Bear Stearns 20th Annual Healthcare Conference at The Grand Hyatt New York on Monday, September 10, 2007, and at the
Read more →IARTIntegra LifeSciences Launches AEON Shape Memory Implant at 2007 American Podiatric Medical Association Annual Scientific Meeting in Philadelphia, Pennsylvania
PLAINSBORO, N.J., Aug. 16, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has signed an agreement with InteliFUSE, Inc. to distribute its patented shape memory implant and activation system in the U.S. and Canada and will
Read more →IARTIntegra LifeSciences and IsoTis to Combine Creating a Global Leader in Orthobiologics
PLAINSBORO, N.J. and IRVINE, Calif., Aug. 7, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) ("Integra") and IsoTis, Inc. (Nasdaq:ISOT) ("IsoTis") announced today a definitive agreement whereby Integra would acquire IsoTis in an all cash transacti
Read more →IARTIntegra LifeSciences Reports Second Quarter 2007 Financial Results
PLAINSBORO, N.J., Aug. 7, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the second quarter ending June 30, 2007. Total revenues in the second quarter of 2007 were $134.8 million, reflecting an increase of
Read more →IARTIntegra LifeSciences to Present At Canaccord Adams 27th Annual Global Growth Conference
PLAINSBORO, N.J., July 24, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at the Canaccord Adams 27th Annual Global Growth Conference at the InterContinental Boston Hotel in Boston at 8:00 AM ET on
Read more →IARTIntegra LifeSciences Announces Creation of Medical Instrument Selling Organization, Formation of Integra Pain Management, and Elimination of Bimeco Operations
PLAINSBORO, N.J., July 13, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the formation of its Medical Instrument selling organization. The Medical Instrument selling organization consists of Miltex(R) instruments, Jarit(R) instru
Read more →IARTIntegra LifeSciences Announces Launch of the Uni-CP Compression Plate
PLAINSBORO, N.J., July 12, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it released the Uni-CP(TM) Compression Plating system, the latest addition to its extremity fixation product line. The Uni-CP(TM) Plating System has an
Read more →IARTIntegra LifeSciences Features the Advansys Mid and Hind Foot Plating Systems At Upcoming American Orthopaedic Foot and Ankle Society Meeting, July 13-15, 2007
PLAINSBORO, N.J., July 11, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that it will be featuring the Advansys(TM) Mid and Hind Foot Plating Systems at the 23rd Annual Summer Meeting of the American Orthopaedic Foot and Ankle Society
Read more →IARTIntegra LifeSciences Schedules Conference Call for Tuesday, August 7, 2007 to Discuss Second Quarter 2007 Financial Results and Update Forward-Looking Financial Guidance
PLAINSBORO, N.J., July 3, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference call for 9:00 AM EST on Tuesday, August 7 to discuss financial results for the second quarter ended June 30, 2007 and to update forward-looking fi
Read more →IARTIntegra LifeSciences Supports Newest Edition of Brain Trauma Foundation's Guidelines for the Management of Severe Traumatic Brain Injury
PLAINSBORO, N.J., June 28, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today its support for the third edition of the Brain Trauma Foundation's Guidelines for the Management of Severe Traumatic Brain Injury (Guidelines). The Guidelin
Read more →IARTIntegra LifeSciences Announces Launch of the Integra Brain Retractor System
PLAINSBORO, N.J., June 15, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has launched the Integra Brain Retractor System. This new line extension, combined with the existing BUDDE(R) Halo System, allows Integra to offer n
Read more →IARTIntegra LifeSciences to Present At the NASDAQ 19th Investor Program and the Second Annual Piper Jaffray London Health Care Conference
PLAINSBORO, N.J., June 12, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at the NASDAQ 19th Investor Program at the Renaissance Chancery Court Hotel on Tuesday, June 19, 2007, and at the Second Ann
Read more →IARTIntegra Lifesciences Holdings Corporation Announces Closing of Private Sale of $165,000,000 2.75 Percent Senior Convertible Notes Due 2010 and $165,000,000 2.375 Percent Senior Convertible Notes Due 2012
PLAINSBORO, N.J., June 11, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the closing of the private sale $165 million aggregate principal amount of senior convertible notes due 2010 (the "2010 notes") and $165 million aggregate p
Read more →IARTIntegra LifeSciences to Present at the Goldman Sachs 28th Annual Healthcare Conference and the Jefferies Healthcare Conference
PLAINSBORO, N.J., June 6, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it is scheduled to present at the Goldman Sachs 28th Annual Healthcare Conference at the Ritz Carlton Laguna Niguel in Dana Point, CA on Wednesday, June
Read more →IARTIntegra LifeSciences Holdings Corporation Announces Pricing of Private Offering of $150,000,000 2.75 Percent Senior Convertible Notes Due 2010 and $150,000,000 2.375 Percent Senior Convertible Notes Due 2012
PLAINSBORO, N.J., June 6, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the pricing of $150 million aggregate principal amount of senior convertible notes due 2010 (the "2010 notes") and $150 million aggregate principal amount of
Read more →IARTIntegra LifeSciences Holdings Corporation Announces Private Offering of $125,000,000 Senior Convertible Notes Due 2010 and $125,000,000 Senior Convertible Notes Due 2012
PLAINSBORO, N.J., June 4, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has commenced a private offering, subject to market conditions, of $125 million aggregate principal amount of senior convertible notes due 2010 and $
Read more →IARTIntegra Mozaik Osteoconductive Scaffold Now Available in 5 cc Size
PLAINSBORO, N.J., June 1, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that Integra Mozaik(TM) Osteoconductive Scaffold moldable putty is now available in a 5 cc package. The addition of the 5 cc enables clinicians to use Integr
Read more →IARTIntegra LifeSciences Announces CUSA Ultrasonic Aspirator Distribution Agreement With AMCO, Inc. for Japan
PLAINSBORO, N.J., May 24, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq:IART) announced today that it has signed a five-year contract with AMCO, Inc. to promote and sell the CUSA(R) Excel ultrasonic surgical aspirator family of products in Japan. AMCO
Read more →IARTIntegra LifeSciences Announces Contract With MedAssets Supply Chain Systems, LLC.
PLAINSBORO, N.J., May 23, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq:IART) announced today that its Jarit Surgical Instruments subsidiary has signed a three-year contract to supply Jarit(R) surgical and laparoscopic instruments to members of MedAsse
Read more →IARTIntegra LifeSciences to Present At Citigroup's 2007 Healthcare Conference and the Bank of America 2007 Health Care Conference
PLAINSBORO, N.J., May 15, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at Citigroup's 2007 Healthcare Conference at the Hilton Hotel in New York on May 22 and the Bank of America 2007 Health Care
Read more →IARTIntegra LifeSciences Announces Acquisition of the Pain Management Business from Physician Industries
PLAINSBORO, N.J., May 11, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has acquired certain assets of the pain management business of Physician Industries, Inc. for $4.0 million in cash, subject to certain adjustments.
Read more →IARTIntegra LifeSciences Reports First Quarter 2007 Financial Results
PLAINSBORO, N.J., May 9, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the first quarter ending March 31, 2007. Total revenues in the first quarter of 2007 were $123.0 million, reflecting an increase of $
Read more →IARTIntegra LifeSciences Closes its Acquisition of LXU Healthcare, Inc.
PLAINSBORO, N.J., May 8, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has closed its acquisition of LXU Healthcare, Inc. (LXU) for $30.0 million, subject to certain adjustments. LXU employs approximately 140 employees. L
Read more →IARTIntegra LifeSciences to Present At Deutsche Bank's 32nd Annual Health Care Conference and the Morgan Stanley Global Healthcare Unplugged Conference
PLAINSBORO, N.J., April 20, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at Deutsche Bank's 32nd Annual Health Care Conference at The Mayflower Hotel in Washington, D.C. and at the Morgan Stanley
Read more →IARTIntegra LifeSciences Releases New Brain Mapping Software to Treat Parkinson's Disease
PLAINSBORO, N.J., April 17, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that its subsidiary, Integra Radionics, released a major upgrade for the NeuroSight(R) Arc module of the OmniSight(R) EXcel image-guided system. Developed
Read more →IARTIntegra LifeSciences Announces New Proposed Tracking Codes for Intracranial Monitoring
PLAINSBORO, N.J., April 16, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that new tracking codes for Intracranial Monitoring Systems have been proposed in the April 13th Federal Register. The Federal Register is the daily public
Read more →IARTIntegra LifeSciences Showcases Its New Accuracy Catheter At the 2007 American Association of Neurological Surgeons Meeting in Washington, D.C.
PLAINSBORO, N.J., April 13, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will showcase its new Accuracy(TM) Catheter at the AANS Annual Meeting in Washington D.C., April 14-19, 2007. The ventricular catheter was designed with the help of David
Read more →IARTIntegra LifeSciences Schedules Conference Call for Wednesday, May 9 to Discuss First Quarter 2007 Financial Results and Update Forward-Looking Financial Guidance
PLAINSBORO, N.J. , April 3, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference call for 9:00 AM EST on Wednesday, May 9 to discuss financial results for the first quarter ended March 31, 2007 and to update forward-looking f
Read more →IARTIntegra LifeSciences Announces Agreement to Acquire LXU Healthcare, Inc.
PLAINSBORO, N.J., March 23, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has agreed to acquire LXU Healthcare, Inc. (LXU) for $30 million in cash, subject to certain adjustments. LXU employs approximately 140 employees.
Read more →IARTIntegra LifeSciences to Host Analyst Forum on April 16, 2007 at American Association of Neurological Surgeons Annual Meeting in Washington, D.C.
PLAINSBORO, N.J., March 12, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will host an Analyst Forum on Monday, April 16, 2007 at 10:00 AM Eastern Time at the Hilton Garden Inn in Washington, D.C. The meeting will be host
Read more →IARTIntegra LifeSciences Showcases Integra Mozaik Osteoconductive Scaffold At the American Association of Neurological Surgeons Spine Section Meeting
PLAINSBORO, N.J., March 8, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will showcase Integra Mozaik(TM) Osteoconductive Scaffold at the AANS Spine Section meeting in Phoenix, Arizona March 7-10, 2007. Integra Mozaik(TM) Osteoconductive Scaffol
Read more →IARTIntegra LifeSciences Reports 2006 Financial Results
PLAINSBORO, N.J., Feb. 28, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the fourth quarter ending December 31, 2006. Total revenues in the fourth quarter of 2006 were $125.4 million, reflecting an increa
Read more →IARTIntegra LifeSciences Expands Credit Facility
PLAINSBORO, N.J., Feb. 26, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has amended its senior secured revolving credit facility to increase its size to $300 million, to extend the term by one year and to modify certain
Read more →IARTIntegra LifeSciences Holdings Corporation Appoints Thomas J. Baltimore, Jr. to Its Board of Directors
PLAINSBORO, N.J., Feb. 22, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that Thomas J. Baltimore, Jr. will join its board of directors on March 5, 2007. Mr. Baltimore is Co-Founder and President of RLJ Development, LLC (RLJ), a priva
Read more →IARTIntegra LifeSciences Launches TenoGlide Tendon Protector Sheet
PLAINSBORO, N.J., Feb. 14, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the launch of TenoGlide(TM) Tendon Protector Sheet. Integra has received 510(k) clearance from the United States Food and Drug Administration to market Teno
Read more →IARTIntegra LifeSciences Announces the Launch of the Mid and Hind Foot Plating Systems
PLAINSBORO, N.J., Feb. 13, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the introduction of the Mid and Hind Foot Plating Systems. The Mid and Hind Foot Plating Systems have received clearance from the United States Food and Dru
Read more →IARTIntegra LifeSciences Announces the Launch of Integra Mozaik Osteoconductive Scaffold
PLAINSBORO, N.J., Feb. 12, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it had received 510 K Clearance from the United States Food and Drug Administration for Integra Mozaik(TM) Osteoconductive Scaffold. This new bone void
Read more →IARTIntegra LifeSciences Adds PET Imaging to Its Cancer Fighting XKnife System
PLAINSBORO, N.J., Feb. 9, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that its subsidiary, Integra Radionics, released its latest image registration software, ImageFusion(TM) 3. The software was originally developed in collabor
Read more →IARTIntegra LifeSciences to Present At Upcoming Merrill Lynch and First Albany Healthcare Conferences
PLAINSBORO, N.J., Feb. 1, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference at the Grand Hyatt Hotel in New York
Read more →IARTIntegra LifeSciences to Present at Upcoming Healthcare Conferences
PLAINSBORO, N.J., Jan. 24, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at the Wachovia Small and Mid-Cap Healthcare Conference at the Langham Hotel in Boston on Tuesday, January 30, 2007 and at t
Read more →IARTIntegra LifeSciences Schedules Conference Call for Wednesday, February 28 to Discuss Fourth Quarter 2006 Financial Results and Update Forward-Looking Financial Guidance
PLAINSBORO, N.J., Jan. 22, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference call for 9:00 AM EST on Wednesday, February 28 to discuss financial results for the fourth quarter ended December 31, 2006 and to update forward-
Read more →IARTIntegra LifeSciences' Miltex Business Acquires DenLite Product Line From Welch Allyn
PLAINSBORO, N.J., Jan. 3, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that its Miltex Dental business has acquired the assets of the DenLite illuminated mirror product from Welch Allyn, Inc. The DenLite mirror is designed to g
Read more →IARTIntegra LifeSciences to Present At JPMorgan Healthcare Conference
PLAINSBORO, N.J., Jan. 2, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at the JPMorgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco at 9:00 AM PST on Monday, January 8, 2
Read more →IARTIntegra LifeSciences Announces the First Patient Surgery in the DuraGen Plus Adhesion Barrier Matrix Clinical Trial
PLAINSBORO, N.J., Dec. 4, 2006 (PRIME NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq:IART) announced the first patient surgery as part of the FDA approved Investigational Device Exemption (IDE), to conduct a clinical trial designed to evaluate the safety and effect
Read more →IARTIntegra LifeSciences to Host Analyst Forum On November 21, 2006
PLAINSBORO, N.J., Nov. 17, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will host an Analyst Forum on Tuesday, November 21, 2006 at 3:00 PM Eastern Time at the New York Marriott East Side Hotel in New York City. The meeting w
Read more →IARTIntegra LifeSciences Names Jerry Corbin to Role of Principal Accounting Officer
PLAINSBORO, N.J., Nov. 9, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that Jerry E. Corbin has been named principal accounting officer, replacing David B. Holtz in that role. Mr. Corbin joined the company earlier this year as Vice P
Read more →IARTIntegra LifeSciences Partners With Siemens to Deliver Stereotactic Radiosurgery Solutions
PLAINSBORO, N.J., Nov. 4, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), today announced that its Radionics business has entered into a preferred partnership with Siemens Medical Solutions Oncology Care Systems, a division of Siemens USA, Inc. (NYSE:
Read more →IARTIntegra LifeSciences Launches XKnife RT 4 Radiosurgery Software at ASTRO
PLAINSBORO, N.J., Nov. 4, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that its subsidiary Integra Radionics launched its latest radiosurgery software, XKnife(TM) version RT 4.0, at the annual meeting of the American Society for Ther
Read more →IARTIntegra LifeSciences Reports Third Quarter 2006 Financial Results
PLAINSBORO, N.J., Nov. 2, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its third quarter financial results. Total revenues in the third quarter of 2006 were $116.6 million, reflecting an increase of $47.3 million, or 68%, over the thi
Read more →IARTIntegra LifeSciences to Present At Upcoming Healthcare Conferences
PLAINSBORO, N.J., Oct. 30, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at the Cowen and Company 7th Annual Global Health Care Conference in London and at the CIBC World Markets 17th Annual Healthcare
Read more →IARTIntegra LifeSciences Announces Launch of the MAYFIELD Ultra 360 Patient Positioning System
PLAINSBORO, N.J., Oct. 10, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has launched the MAYFIELD(R) Ultra 360 Patient Positioning System for improved cranial stabilization. MAYFIELD products are sold throughout the world and
Read more →IARTIntegra LifeSciences Announces Launch of the Mobius(TM) Multi Modality Monitoring System
PLAINSBORO, N.J., Oct. 9, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the launch of the Mobius(TM) Multi Modality Monitoring System as the latest addition to Integra's neuromonitoring product line. The Mobius system has received 510
Read more →IARTIntegra LifeSciences Announces Termination of Interest Rate Swap and Financial Impact of Completed Exchange Offer for its 2 1/2 Percent Contingent Convertible Subordinated Notes
PLAINSBORO, N.J., Oct. 3, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has terminated its $50.0 million notional amount interest rate swap and is providing information regarding the financial impact of its recently completed
Read more →IARTIntegra LifeSciences Announces Completion of Exchange Offer for its 2-1/2 Percent Contingent Convertible Subordinated Notes Due 2008
PLAINSBORO, N.J., Oct. 2, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it completed its offer to exchange up to $120 million principal amount of new notes with a "net share settlement" mechanism for its currently outstanding 2-1
Read more →IARTIntegra LifeSciences Launches the LumbarTrak Lumbar Retraction System
PLAINSBORO, N.J., Sept. 27, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the launch of the LumbarTrak(TM) Lumbar Retraction System, the latest addition to the R&B Redmond(TM) line. Integra is featuring the LumbarTrak system at the 21
Read more →IARTIntegra LifeSciences Announces Amendment to Exchange Offer for Its 2-1/2 Percent Contingent Convertible Subordinated Notes Due 2008
PLAINSBORO, N.J., Aug. 28, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has extended the expiration date and modified the terms of its offer to exchange up to $120 million principal amount of new notes with a "net share settl
Read more →IARTIntegra LifeSciences Announces Amendment to Exchange Offer for its 2 1/2 Percent Contingent Convertible Subordinated Notes Due 2008
PLAINSBORO, N.J., Aug. 14, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has waived a condition and extended the expiration date of its offer to exchange up to $120 million principal amount of new notes with a "net share settl
Read more →IARTIntegra LifeSciences Reports Second Quarter 2006 Financial Results
PLAINSBORO, N.J., Aug. 2, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its second quarter financial results. Total revenues in the second quarter of 2006 were $100.1 million, reflecting an increase of $30.3 million, or 43%, over the s
Read more →IARTIntegra LifeSciences Closes its Acquisition of Kinetikos Medical, Inc.
PLAINSBORO, N.J., Aug. 2, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has acquired the shares of Kinetikos Medical, Inc. ("KMI") for approximately $40 million in cash, subject to certain adjustments, including future payment
Read more →IARTIntegra LifeSciences Holdings Corporation Appoints Neal Moszkowski to its Board of Directors
PLAINSBORO, N.J., Aug. 1, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that effective immediately it has increased the size of its Board of Directors to eight and appointed Neal Moszkowski to fill the newly created vacancy. Mr. Moszk
Read more →IARTIntegra LifeSciences Announces Exchange Offer for Its 2 1/2 Percent Contingent Convertible Subordinated Notes Due 2008
PLAINSBORO, N.J., July 17, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has commenced an offer to exchange up to $120 million principal amount of new notes with a "net share settlement" mechanism for its currently outstanding
Read more →IARTIntegra LifeSciences Releases the Large Uni-Clip and 2.7mm Spin Snap-off Screw
PLAINSBORO, N.J., July 13, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the release of the Large Uni-Clip(R) and the 2.7mm Spin(R) Snap-off Screw as the latest additions to Integra's extremity fixation product line. The products have
Read more →IARTIntegra LifeSciences Introduces the Qwix Compression Screw
PLAINSBORO, N.J., July 13, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the release of the 3.0mm and 4.3mm Qwix(TM) Compression Screw, the latest addition to Integra's extensive extremity fixation product line. The Qwix Screw has rec
Read more →IARTIntegra LifeSciences Announces Direct Sales Strategy in Canada
PLAINSBORO, N.J., July 11, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is launching a direct sales force in Canada through the acquisition of its longstanding distributor, Canada Microsurgical Ltd. Canada Microsurgical has e
Read more →IARTIntegra LifeSciences Announces Agreement to Acquire Kinetikos Medical, Inc.
PLAINSBORO, N.J., June 30, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has agreed to acquire the shares of Kinetikos Medical, Inc. ("KMI") for approximately $40 million in cash, subject to certain adjustments, including futu
Read more →IARTIntegra LifeSciences Closes its Acquisition of the Miltex Companies
PLAINSBORO, N.J., May 12, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has acquired the shares of Miltex, Inc. ("Miltex") for approximately $101 million in cash, subject to certain adjustments, and revised its 2006 and 2007 f
Read more →IARTIntegra LifeSciences Reports First Quarter 2006 Financial Results
PLAINSBORO, N.J., May 8, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its first quarter financial results. Total revenues in the first quarter of 2006 were $77.1 million, reflecting an increase of $11.3 million, or 17%, over the first
Read more →IARTIntegra Announces Increased Use of NeuraGen Nerve Guide in Complex Peripheral Nerve Injuries
PLAINSBORO, N.J., April 26, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the NeuraGen(R) Nerve Guide is increasingly used in a wide variety of peripheral nerve repair applications. NeuraGen has been used successfully to repair p
Read more →IARTIntegra LifeSciences and University of Pennsylvania To Present Results of LICOX Brain Tissue Oxygen Monitoring Clinical Experience At the 2006 American Association of Neurological Surgeons -- AANS -- Annual Meeting in San Francisco
PLAINSBORO, N.J., April 25, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the Department of Neurosurgery and Surgery, University of Pennsylvania will present the results of seven clinical studies on the application of the LICOX(R
Read more →IARTIntegra LifeSciences Welcomes the CUSA EXcel
Integra Announces the Release of CUSA SaberTip Bone-Cutting Tips PLAINSBORO, N.J., April 24, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) proudly welcomes the CUSA(R) brand to our ultrasonic aspirator product family. By acquiring Radionics and addi
Read more →IARTIntegra LifeSciences Announces Agreement to Acquire the Miltex Companies
PLAINSBORO, N.J., April 20, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has agreed to acquire the shares of Miltex, Inc. ("Miltex") for approximately $101 million in cash, subject to certain adjustments. Miltex, based in Yo
Read more →IARTIntegra LifeSciences Introduces the Panta Arthrodesis Nail
PLAINSBORO, N.J., March 22, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the release of the Panta(R) Arthrodesis Nail, an innovative solution for tibiotalocalcaneal fusion. The Panta Nail has received clearance from the Food and Drug
Read more →IARTIntegra LifeSciences Announces the Release of the B-BOP Basal Osteotomy Plating System
PLAINSBORO, N.J., March 21, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the release of the B-BOP(R) Basal Osteotomy Plating System, a unique fixation solution for hallux-valgus correction. The B-BOP Plating System has received clear
Read more →IARTIntegra LifeSciences Reports Record Revenues for the Fourth Quarter and Full Year 2005
PLAINSBORO, N.J., March 5, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its fourth quarter and full year 2005 revenues and earnings. Total revenues in the fourth quarter of 2005 were $73.0 million, reflecting an increase of $11.2 mill
Read more →IARTIntegra LifeSciences Closes its Acquisition of the Radionics Division of Tyco Healthcare Group LP
PLAINSBORO, N.J., March 5, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has acquired the assets of the Radionics Division of Tyco Healthcare Group LP for $80 million in cash, subject to certain adjustments. Radionics, based
Read more →IARTIntegra LifeSciences Names Maureen Bellantoni Chief Financial Officer
PLAINSBORO, N.J., Jan. 10, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that Maureen Blanchfield Bellantoni will join the Company as Executive Vice President and Chief Financial Officer, effective immediately. Ms. Bellantoni joins In
Read more →IARTIntegra LifeSciences Establishes New $200 Million Credit Facility
PLAINSBORO, N.J., Dec. 22, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has established a $200 million, five-year, senior secured revolving credit facility. The credit facility was arranged and managed by Banc of America Secu
Read more →IARTIntegra LifeSciences' Proposed Acquisition of the Radionics Division of Tyco Healthcare Group, L.P. Clears Antitrust Review
PLAINSBORO, N.J., Dec. 12, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, relating to its pending acquisition of the assets of the Radi
Read more →IARTIntegra LifeSciences to Host Analyst Forum on November 21, 2005
PLAINSBORO, N.J., Nov. 2, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will host an Analyst Forum on Monday, November 21, 2005 at 3:00 PM Eastern Time at the New York Marriott East Side Hotel in New York City. The meeting, wh
Read more →IARTIntegra LifeSciences Reports Record Operating Earnings for the Third Quarter 2005
PLAINSBORO, N.J., Oct. 30, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its third quarter financial results. Total revenues in the third quarter of 2005 were $69.3 million, reflecting an increase of $10.2 million, or 17%, over the thi
Read more →IARTIntegra NeuroSciences Features AccuDrain External CSF Drainage System at the Congress of Neurological Surgeons Annual Meeting
PLAINSBORO, N.J., Oct. 12, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that it is featuring the AccuDrain(TM) External CSF Drainage System at the 55th Annual Meeting of the Congress of Neurological Surgeons in Boston Massachusetts this we
Read more →IARTIntegra NeuroSciences Launches New Non-Stick Bipolar Forceps
PLAINSBORO, N.J., Oct. 11, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will market and sell the Integra BUZZ(TM) non-stick bipolar forceps. Bipolar forceps are an essential part of neurosurgery. The Integra BUZZ(TM) non-stic
Read more →IARTIntegra Foundation Donates $130,000 for Hurricane Katrina Relief Effort
PLAINSBORO, N.J., Oct. 11, 2005 (PRIMEZONE) -- In response to the overwhelming devastation of Hurricane Katrina, the Integra Foundation, the philanthropic arm of Integra LifeSciences Holdings Corporation (Nasdaq:IART), has made grants to the Congress of Neurological Surgeons ($10
Read more →IARTIntegra NeuroSciences Features the Integra NPH Low Flow Hydrocephalus Valve at the Congress of Neurological Surgeons Annual Meeting
PLAINSBORO, N.J., Oct. 10, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) is featuring the Integra NPH(TM) Low Flow Hydrocephalus Valve (Integra NPH(TM) Valve) this week at the 55th Annual Meeting of the Congress of Neurological Surgeons in Boston. In
Read more →IARTIntegra LifeSciences Acquires Eunoe Inc.'s Intellectual Property Estate
PLAINSBORO, N.J., Sept. 29, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has acquired the intellectual property estate of Eunoe, Inc. Prior to ceasing operations, Eunoe, Inc. was engaged in the development of its innovative C
Read more →IARTIntegra Introduces Line Extension for Nerve Injury Products
PLAINSBORO, N.J., Sept. 23, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Integra NeuroSciences has enhanced its product offering for the treatment of peripheral nerve injuries. Integra LifeSciences introduced a new 3 cm length o
Read more →IARTIntegra LifeSciences Announces Agreement to Acquire Radionics Division of Tyco Healthcare Group, L.P.
PLAINSBORO, N.J., Sept. 7, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has agreed to acquire the assets of the Radionics Division of Tyco Healthcare Group, L.P. for $80 million in cash, subject to certain adjustments. Radio
Read more →IARTIntegra LifeSciences Reports Record Revenues for the Second Quarter 2005
PLAINSBORO, N.J., Aug. 7, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its second quarter financial results. Total revenues in the second quarter of 2005 were $69.8 million, reflecting an increase of $13.3 million, or 24% over the sec
Read more →IARTIntegra LifeSciences Announces Planned Restructuring of its European Operations
PLAINSBORO, N.J., June 1, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the planned reorganization of its European operations. "We recently began to review our European manufacturing and distribution operations for possible restructu
Read more →IARTIntegra LifeSciences Announces Results of Stockholders' Vote at Annual Meeting
PLAINSBORO, N.J., May 17, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced at the annual meeting of stockholders today that David C. Auth, Ph.D., Keith Bradley, Ph.D., Richard E. Caruso, Ph.D., Stuart M. Essig, James M. Sullivan, and Anne M. V
Read more →IARTIntegra LifeSciences Reports Record Revenues for the First Quarter 2005
PLAINSBORO, N.J., May 8, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its first quarter financial results. Total revenues in the first quarter of 2005 were $65.8 million, reflecting an increase of $13.4 million, or 26%, over the first
Read more →IARTIntegra NeuroSciences Launches New State-of-the-Art External CSF Drainage System
PLAINSBORO, N.J., April 18, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will market and sell the AccuDrain(TM) External CSF Drainage System. This new external ventricular and lumbar drainage (EDS) system is used to drain cer
Read more →IARTIntegra NeuroSciences Launches Suturable DuraGen Dural Regeneration Matrix
PLAINSBORO, N.J., April 17, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced it has received 510(k) clearance from the United States Food and Drug Administration to market the Suturable DuraGen(TM) Dural Regeneration Matrix in the United
Read more →IARTIntegra LifeSciences Reports Fourth Quarter and Full Year 2004 Financial Results
PLAINSBORO, N.J., March 13, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its fourth quarter and full year 2004 revenues and earnings. Product revenues in the fourth quarter of 2004 were $61.8 million, reflecting an increase of $14.9 m
Read more →IARTIntegra LifeSciences Announces Launch of Newdeal Foot and Ankle Implants and United States Introduction of the CALCANEA(R) Plate
PLAINSBORO, N.J., Feb. 16, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has begun selling Newdeal(R) foot and ankle products in the United States through its Reconstructive Surgery sales force. Integra LifeSciences also annou
Read more →IARTIntegra LifeSciences Announces First Implantation of the HINTEGRA(R) Total Ankle Prosthesis in Brazil
PLAINSBORO, N.J., Feb. 10, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that the first three HINTEGRA(R) Total Ankle Prostheses, a product of Newdeal SA, have been implanted in Brazil. Brazil is the largest market for foot and ankle
Read more →IARTIntegra LifeSciences Closes Acquisition of Newdeal Technologies
PLAINSBORO, N.J., Jan. 3, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has acquired the Newdeal group of companies ("Newdeal") for EUR 39.5 million (approximately $53 million at today's exchange rate) in cash, subject to cert
Read more →IARTIntegra LifeSciences Holdings Corporation Appoints Anne M. VanLent to its Board of Directors
PLAINSBORO, N.J., Dec. 20, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that effective immediately it has increased the size of its Board of Directors to seven and appointed Anne M. VanLent to fill the newly created vacancy. Ms. VanL
Read more →IARTIntegra LifeSciences Announces Agreement to Acquire Newdeal Technologies
PLAINSBORO, N.J., Nov. 14, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has agreed to acquire the Newdeal group of companies ("Newdeal") for EUR 38.5 million (approximately $50 million at today's exchange rate) in cash, subje
Read more →IARTIntegra LifeSciences Announces Third Quarter 2004 Financial Results
PLAINSBORO, N.J., Nov. 7, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its third quarter revenues and earnings. Total revenues in the third quarter of 2004 increased by $12.1 million to $59.1 million, a 26% increase over the third qua
Read more →IARTIntegra LifeSciences to Host Analyst Forum on November 15, 2004
PLAINSBORO, N.J., Nov. 2, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will host an Analyst Forum on Monday, November 15, 2004 at 3:00 PM Eastern Time at the Hilton Times Square Hotel in New York City. The meeting, which will
Read more →IARTIntegra NeuroSciences(TM) Launches MAYFIELD(R) Infinity Support System
PLAINSBORO, N.J., Oct. 19, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced plans to market and sell the MAYFIELD(R) Infinity Support System in the United States through its Integra NeuroSciences(TM) sales force. The new MAYFIELD Infinit
Read more →IARTIntegra Epilepsy(TM) Products Receive CE Mark For Distribution in the European Union
PLAINSBORO, New Jersey, Oct. 19, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it was awarded the CE Mark required for commercial distribution of the Integra Epilepsy(TM) line in the European Union. Integra LifeSciences, which cu
Read more →IARTIntegra LifeSciences and University of Pennsylvania to Present Results of Brain Tissue Oxygen Monitoring Clinical Experience at 2004 Congress of Neurological Surgeons Annual Meeting in San Francisco
PLAINSBORO, N.J., Oct. 18, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the Department of Neurosurgery and Surgery, University of Pennsylvania is presenting the results of four clinical studies on the application of the LICOX(R)
Read more →IARTIntegra LifeSciences Announces CE Mark for DuraGen Plus(TM) Adhesion Barrier Matrix
PLAINSBORO, N.J., Oct. 18, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has received CE Mark Certification for the DuraGen Plus(TM) Adhesion Barrier Matrix. The product is approved as a barrier against adhesions following spi
Read more →IARTIntegra NeuroSciences Launches NPH(TM) Low Flow Hydrocephalus Valve
PLAINSBORO, N.J., Oct. 15, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced plans to market and sell the NPH(TM) Low Flow Hydrocephalus Valve (NPH(TM) Valve) through its direct Integra NeuroSciences(TM) sales force. Integra NeuroSciences
Read more →IARTIntegra NeuroSciences Launches NeuroSensor Cerebral Blood Flow and Intracranial Pressure System
PLAINSBORO, N.J., Oct. 15, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it plans to market and sell the NeuroSensor Cerebral Blood Flow and Intracranial Pressure System (NeuroSensor), a neuro-monitoring system used to measure bo
Read more →IARTIntegra LifeSciences Launches INTEGRA(TM) Matrix Wound Dressing at Plastic Surgery 2004 in Philadelphia
PLAINSBORO, N.J., Oct. 12, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the launch of the INTEGRA(TM) Matrix Wound Dressing, a single layer version of its advanced wound care product line that can be used for the management of partia
Read more →IARTIntegra LifeSciences Receives FDA Approval and CE Mark for INTEGRA(R) Dermal Regeneration Template - Terminally Sterilized
PLAINSBORO, N.J., Oct. 11, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Integra LifeSciences has received approval from the United States Food and Drug Administration (FDA) and CE Mark Certification in the European Union from TU
Read more →IARTIntegra LifeSciences Launches New Web Site For Physician Information and Training
PLAINSBORO, N.J., Oct. 8, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has launched a new website for physicians that provides information and training on the use of its two tissue regenerative products, the INTEGRA(R) Dermal
Read more →IARTIntegra LifeSciences Announces Neuromonitoring Strategic Alliance with CNS Technology, LLC and Moberg Research, Inc.
PLAINSBORO, N.J., Oct. 1, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has entered into a development agreement pursuant to which CNS Technology, LLC has agreed to perform a variety of development and other activities related
Read more →IARTIntegra LifeSciences Announces Achievement of Product Development Milestone by Novus Monitoring Limited
PLAINSBORO, N.J., Oct. 1, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it paid $1.4 million to Novus Monitoring Limited for the achievement of a product development milestone. In September of 2002, Integra LifeSciences acquired
Read more →IARTIntegra NeuroSciences Launches NeuraWrap(TM) Nerve Protector
PLAINSBORO, N.J., Sept. 8, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Integra NeuroSciences has received 510(k) clearance from the United States Food and Drug Administration to market the NeuraWrap(TM) Nerve Protector in the U
Read more →IARTIntegra LifeSciences Launches KraniOS(TM) Cranial Closure System
PLAINSBORO, N.J., July 27, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it plans to market and sell the KraniOS(TM) Cranial Closure System, a complete set of implants and tools necessary to perform successful cranial flap closur
Read more →IARTIntegra LifeSciences Announces Second Quarter 2004 Financial Results
PLAINSBORO, N.J., July 27, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported net income of $7.5 million, or $0.24 per share, for the second quarter of 2004, compared to net income of $5.4 million, or $0.18 per share, in the second quarter
Read more →IARTIntegra LifeSciences Extends Employment Agreement of Chief Executive Officer
PLAINSBORO, N.J., July 27, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Stuart M. Essig, Integra's President and Chief Executive Officer, has renewed his employment agreement with the Company through December 31, 2009. In makin
Read more →IARTIntegra Epilepsy(TM) Products Featured at the 2004 National Teaching Institute & Critical Care Exposition
PLAINSBORO, N.J., May 18, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it is featuring its recently launched Integra Epilepsy(TM) products at the 2004 National Teaching Institute & Critical Care Exposition in Orlando, Florida th
Read more →IARTIntegra LifeSciences Announces Acquisition of MAYFIELD(R) and BUDDE(R) Cranial Stabilization Product Lines
PLAINSBORO, N.J., May 10, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acquired the MAYFIELD(R) Cranial Stabilization and Positioning Systems and the BUDDE(R) Halo Retractor System from Schaerer Mayfield USA, Inc. (former
Read more →IARTIntegra NeuroSciences(TM) Launches 5 by 7-inch DuraGen Plus(TM) Dural Graft Matrix
PLAINSBORO, N.J., May 4, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Integra NeuroSciences has launched a new 5 by 7-inch size of the DuraGen Plus(TM) Dural Graft Matrix in the United States. The new 5 by 7-inch size of DuraGen
Read more →IARTIntegra LifeSciences Announces Acquisition of Berchtold Medizin-Elektronik GmbH
PLAINSBORO, N.J., May 4, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acquired Berchtold Medizin-Elektronik GmbH from Berchtold Holding GmbH. Based in Tuttlingen, Germany, Berchtold Medizin-Elektronik manufactures and mar
Read more →IARTIntegra LifeSciences Launches LICOX(R) PMO Catheter
PLAINSBORO, N.J., May 3, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it plans to market and sell the LICOX(R) PMO, a next-generation catheter and introducer for use with the Integra LICOX(R) Brain Tissue Oxygen Monitoring Syste
Read more →IARTIntegra LifeSciences Announces First Quarter 2004 Financial Results
PLAINSBORO, N.J., April 27, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported net income of $7.4 million, or $0.24 per share, for the first quarter of 2004, compared to net income of $5.4 million, or $0.18 per share, in the first quarter o
Read more →IARTIntegra LifeSciences Supports Study On Spinal Cord Injuries
PLAINSBORO, N.J., April 2, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced its participation in a study published last month in the European Journal of Neuroscience. The study concluded that infusing a naturally occurring anti-scarring
Read more →IARTIntegra LifeSciences Features Recently Launched INTEGRA(TM) Bilayer Matrix Wound Dressing At American Burn Association Meeting
PLAINSBORO, N.J., March 25, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it is featuring its recently launched INTEGRA(TM) Bilayer Matrix Wound Dressing product at the American Burn Association Meeting in Vancouver, British Colu
Read more →IARTIntegra LifeSciences' JARIT Surgical Instruments Launches Redmond/R&B Instruments at 2004 AORN Congress
PLAINSBORO, N.J., March 23, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that JARIT(R) Surgical Instruments launched the Redmond/R&B Surgical Instrument line at AORN's 51st Congress in San Diego, California. The Redmond/R&B catalog i
Read more →IARTIntegra LifeSciences Reports Record Operating Earnings and Revenues for the Fourth Quarter and Full Year 2003
PLAINSBORO, N.J., Feb. 27, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported net income of $9.2 million, or $0.30 per share, for the fourth quarter of 2003, compared to $25.4 million, or $0.83 per share, for the prior year period. Net inco
Read more →IARTIntegra LifeSciences Announces Acquisition of Fleetwood Medical's Sparta Implants, Disposables and Instruments
PLAINSBORO, N.J., Feb. 3, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acquired the Sparta line of disposable critical care devices and surgical instruments from Fleetwood Medical, Inc. for approximately $1.5 million in c
Read more →IARTIntegra LifeSciences' JARIT Surgical Instruments Awarded Surgical Instrument Agreements by Premier, Inc.
PLAINSBORO, N.J., Jan. 16, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Premier Inc. (Premier) has selected JARIT(R) Surgical Instruments as a national supplier under two surgical instrument contracts. These 36-month contracts,
Read more →IARTIntegra LifeSciences Announces Acquisition of Reconstructive Technologies, Inc.
PLAINSBORO, N.J., Jan. 15, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acquired the assets of Reconstructive Technologies, Inc. (RTI), the developer of the Automated Cyclic Expansion System (ACE System(TM)), a tissue exp
Read more →IARTIntegra LifeSciences Announces Acquisition of R&B Surgical Solutions' Line of Neurosurgical Instruments
PLAINSBORO, N.J., Jan. 14, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that JARIT Surgical Instruments has acquired the R&B instrument line from R&B Surgical Solutions, LLC for approximately $2.0 million in cash. The R&B instrument
Read more →IARTIntegra LifeSciences' JARIT(R) Surgical Instruments Awarded Surgical Instrument Agreement by HealthTrust Purchasing Group, L.P.
PLAINSBORO, N.J., Nov. 13, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that JARIT(R) Surgical Instruments has been selected as a national supplier for HealthTrust Purchasing Group's (HPG) surgical instrument contract. Effective Janu
Read more →IARTIntegra LifeSciences Reports Record Operating Earnings and Revenues for the Third Quarter 2003
PLAINSBORO, N.J., Oct. 31, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported net income of $6.8 million, or $0.23 per share, for the third quarter of 2003, as compared to net income of $1.6 million, or $0.05 per share, in the third quarter
Read more →IARTIntegra LifeSciences Agrees to Acquire Spinal Specialties from I-Flow Corporation
PLAINSBORO, N.J., Oct. 28, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has agreed to acquire Spinal Specialties, Inc. from I-Flow Corporation (Nasdaq:IFLO) on October 31, 2003 for approximately $6.0 million in cash, subject
Read more →IARTIntegra LifeSciences Launches New Padgett Model S Dermatome
PLAINSBORO, N.J., Oct. 27, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced plans to market and sell the Model S Dermatome through its plastic and reconstructive sales force. The Model S, now one of three electric dermatomes offered by I
Read more →IARTIntegra NeuroSciences Launches DuraGen Plus(TM) Dural Graft Matrix
PLAINSBORO, N.J., Oct. 20, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Integra NeuroSciences has received 510(k) clearance from the United States Food and Drug Administration to market the DuraGen Plus(TM) Dural Graft Matrix in
Read more →IARTIntegra NeuroSciences Launches EnDura No-React Dural Substitute
PLAINSBORO, N.J., Oct. 20, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced plans to market and sell EnDura(TM) No-React(R) Dural Substitute, a new suturable product for repair of the dura mater. Integra is featuring the EnDura product a
Read more →IARTIntegra NeuroSciences Donates Camino Monitoring Systems and LICOX Brain Tissue Oxygen Monitoring System to U.S. Army Hospital in Iraq
PLAINSBORO, N.J., Oct. 13, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today responded to a request from the 207th Neurosurgery Team at the 28th Combat Support Hospital in Baghdad, Iraq to donate medical equipment for the treatment of severe head i
Read more →IARTIntegra LifeSciences Announces Plans to Market INTEGRA Dermal Regeneration Template through its Direct Sales Force
PLAINSBORO, N.J., Oct. 6, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has reached agreement with ETHICON Inc. for the return to Integra of the exclusive right to sell, market and distribute the INTEGRA Dermal Regeneration Te
Read more →IARTIntegra LifeSciences Appoints Gerard S. Carlozzi as Executive Vice President and Chief Operating Officer
PLAINSBORO, N.J., Sept. 25, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has appointed Gerard S. Carlozzi to the position of Executive Vice President and Chief Operating Officer. In this capacity Mr. Carlozzi will direct the
Read more →IARTIntegra LifeSciences Announces Acquisition of Neuron Therapeutics' Patent Estate
PLAINSBORO, N.J., September 3, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has acquired the patent estate of Neuron Therapeutics, Inc. Prior to its dissolution, Neuron Therapeutics, Inc. was engaged in the development of inn
Read more →IARTIntegra NeuroSciences Reports Positive Clinical Results from a Five-Year Study of the OSVII Smart Valve for the Treatment of Hydrocephalus
PLAINSBORO, N.J., August 5, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the results of a five-year prospective, multicenter study of the OSVII(R) Smart Valve(TM), a flow-regulating shunt used for the treatment of hydrocephalus. The
Read more →IARTIntegra LifeSciences Reports Record Operating Earnings and Revenues for the Second Quarter 2003
PLAINSBORO, NJ, July 31, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported net income of $5.4 million, or $0.18 per share, for the second quarter of 2003, as compared to net income of $4.2 million, or $0.14 per share, in the second quarter
Read more →IARTIntegra LifeSciences Schedules Conference Call for Thursday, July 31 to Discuss Second Quarter 2003 Financial Results and Update Forward-Looking Financial Guidance
PLAINSBORO, N.J., July 22, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that it has scheduled a conference call for 9:00 AM EST on Thursday, July 31 to discuss financial results for the second quarter ended June 30, 2003 and to update forw
Read more →IARTIntegra LifeSciences Announces Launch of New and Improved External Ventricular Drainage System
PLAINSBORO, N.J., May 1, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the release of a new and improved Hermetic Plus(TM) external ventricular drainage system (EVD). EVD systems are used to drain cerebral spinal fluid (CSF) from pati
Read more →IARTIntegra LifeSciences Announces 1,000th Implant of NeuraGen Nerve Guide for Peripheral Nerve Repair
PLAINSBORO, N.J., April 29, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported that more than 1,000 NeuraGen(TM) Nerve Guides have been implanted in patients in the United States in nearly 200 hospitals and surgery centers since the introdu
Read more →IARTIntegra LifeSciences Reports Record Pre-Tax Earnings and Revenues for the First Quarter 2003
PLAINSBORO, N.J., April 25, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported net income of $5.4 million, or $0.18 per share, for the first quarter of 2003, as compared to net income of $4.1 million, or $0.13 per share, in the first quarte
Read more →IARTIntegra LifeSciences Holdings Corporation to Sell Additional $20 Million of Contingent Convertible Subordinated Notes
PLAINSBORO, N.J., April 11, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that the initial purchasers of its 2.5% Contingent Convertible Subordinated Notes due 2008 have elected to exercise their option to purchase an additional $20 million
Read more →IARTIntegra LifeSciences Schedules Conference Call for Friday, April 25 to Discuss First Quarter 2003 Financial Results and Update Forward-Looking Financial Guidance
PLAINSBORO, N.J., April 9, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that it has scheduled a conference call for 9:00 AM EST on Friday, April 25 to discuss financial results for the first quarter ended March 31, 2003 and to update forwa
Read more →IARTIntegra LifeSciences Confirms Earnings Guidance
PLAINSBORO, N.J., March 26, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that the Company's guidance for earnings per share of $0.16 for the first quarter of 2003 remains unchanged. Excluding a potential in-process research and devel
Read more →IARTIntegra LifeSciences Holdings Corporation to Sell $100 Million of Contingent Convertible Subordinated Notes
PLAINSBORO, N.J., March 26, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that it has agreed to sell $100 million principal amount of its 2.5% contingent convertible subordinated notes due 2008. Integra has agreed to grant the initial purch
Read more →IARTIntegra LifeSciences Holdings Corporation Announces Proposed $100 Million Contingent Convertible Subordinated Notes Offering
PLAINSBORO, N.J., March 26, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it intends to offer $100 million of contingent convertible subordinated notes in a private placement. Integra may raise up to an additional $20 million upo
Read more →IARTIntegra LifeSciences Announces Acquisition of JARIT Surgical Instruments; Raises Revenue and Earnings Guidance
PLAINSBORO, N.J., March 18, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has acquired JARIT(R) Surgical Instruments for approximately $44.5 million in cash, subject to certain adjustments. JARIT, based in Hawthorne, New York,
Read more →IARTIntegra LifeSciences Reports Record Earnings and Revenues for the Fourth Quarter and Full Year 2002
PLAINSBORO, N.J., Feb. 27, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported record revenues and net income for the fourth quarter and full year 2002. Total revenues in the fourth quarter of 2002 increased $10.2 million, or 41%, over the f
Read more →IARTIntegra LifeSciences Schedules Conference Call for Thursday, February 27 to Discuss Fourth Quarter and Full Year 2002 Financial Results and Update Forward-Looking Financial Guidance
PLAINSBORO, N.J., Feb. 19, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that it has scheduled a conference call for 9:00 AM EST on Thursday, February 27 to discuss financial results for the fourth quarter and year ended December 31, 2002 a
Read more →IARTIntegra LifeSciences Announces CE Mark for the NeuraGen Nerve Guide for Repair of Severed Peripheral Nerves
PLAINSBORO, N.J., Feb. 6, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has received the CE mark for the NeuraGen(TM) Nerve Guide, an absorbable implant for the repair of severed peripheral nerves. Integra NeuroSciences, the n
Read more →IARTIntegra NeuroSciences Awarded Neurosurgery Agreement by Premier, Inc.
PLAINSBORO, N.J., Jan. 2, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported that it has been selected as a national supplier for Premier's neurosurgical products contract. Effective January 1, 2003, this 24-month contract gives Integra Neu
Read more →IARTIntegra LifeSciences Reports Record Revenues of $30.2 Million
PLAINSBORO, N.J., Nov. 4, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported record revenues of $30.2 million for the third quarter ended September 30, 2002, a 27% increase over the prior year quarter, and net income of $1.6 million, or $0.
Read more →IARTIntegra LifeSciences Schedules Conference Call for Monday, November 4 to Discuss Third Quarter 2002 Financial Results and Update Forward-Looking Financial Guidance
PLAINSBORO, N.J., Oct. 28, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that it has scheduled a conference call for 9:00 a.m. EST on Monday, November 4 to discuss financial results for the third quarter ended September 30, 2002 and to upda
Read more →IARTIntegra LifeSciences Announces Acquisition of Padgett Instruments, Inc.
PLAINSBORO, N.J., Oct. 22, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has acquired Padgett Instruments, Inc., a marketer of instruments used in reconstructive and plastic surgery, for $9.7 million in cash. Padgett, which is
Read more →IARTIntegra NeuroSciences Direct Salesforce Begins Marketing Helitene Hemostatic Agent in a Pad Form
PLAINSBORO, N.J., Sept. 24, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that its Integra NeuroSciences division has begun marketing the Helitene(R) Absorbable Collagen Hemostatic Agent in a 35mm X 70mm pad form. The product received
Read more →IARTIntegra NeuroSciences Announces Launch of Camino Single Parameter Monitor in Europe and Other International Markets
PLAINSBORO, N.J., Sept. 24, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Integra NeuroSciences has launched the Camino(R) Single Parameter Monitor ("SPM-1") for the measurement of intracranial pressure into Europe and certain ot
Read more →IARTIntegra LifeSciences Announces Acquisition of the NeuroSensor Monitor and Related Technology from Novus Monitoring Limited
PLAINSBORO, N.J., Sept. 23, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acquired certain assets, including the NeuroSensor(TM) monitor and rights to certain intellectual property from Novus Monitoring Limited of the Unit
Read more →IARTIntegra NeuroSciences Announces FDA Clearance to Market the Selector Integra Ultrasonic Surgical Aspirator for Use in Additional Surgical Procedures
PLAINSBORO, N.J., Sept. 20, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Integra NeuroSciences has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market the Selector(R) Integra Ultrasonic
Read more →IARTIntegra LifeSciences Holdings Corporation Appoints David C. Auth to Board of Directors
PLAINSBORO, N.J., Sept. 18, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that effective October 31, 2002 it will increase the size of its Board of Directors to six and appoint David C. Auth to fill the newly created vacancy. Stuart
Read more →IARTIntegra LifeSciences and REVA Medical Announce Agreement for REVA Medical to Evaluate Integra's Tyrosine-Derived Polycarbonates for Use in Cardiovascular Stents
PLAINSBORO, N.J., Aug. 6, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) and REVA Medical, Inc. of San Diego, California today announced that they entered into an agreement for REVA to evaluate Integra's tyrosine-derived polycarbonate biomaterials for
Read more →IARTIntegra LifeSciences Reports Second Quarter Earnings Per Share of $0.14 on Record Revenues of $26.4 Million
PLAINSBORO, N.J., Aug. 1, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported record revenues of $26.4 million and net income of $0.14 per share for the second quarter ended June 30, 2002. Total revenues increased $3.5 million to $26.4 milli
Read more →IARTIntegra LifeSciences Announces Acquisition of Signature Technologies, a Specialty Manufacturer of Neurosurgical and Spinal Implants
PLAINSBORO, N.J. and Pembroke, Mass., Aug. 1, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acquired the assets of Signature Technologies, Inc., a specialty manufacturer of titanium and stainless steel implants for the neu
Read more →IARTIntegra LifeSciences Acquires Neurosciences Division of NMT Medical
PLAINSBORO, N.J., Aug. 1, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acquired the neurosciences division of NMT Medical, Inc. (Nasdaq:NMTI) for $5.4 million in cash. Through this acquisition, Integra NeuroSciences, the
Read more →IARTIntegra LifeSciences Schedules Conference Call for Tuesday, August 6 to Discuss Second Quarter 2002 Financial Results and Update Forward-Looking Financial Guidance
PLAINSBORO, N.J., July 29, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that it has scheduled a conference call for 9:00 a.m. EST on Tuesday, August 6 to discuss financial results for the second quarter ended June 30, 2002 and to update fo
Read more →IARTIntegra LifeSciences Reports First Quarter Earnings Per Share of $0.13 on Record Revenues of $25.9 Million
PLAINSBORO, N.J., May 8, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported record revenues of $25.9 million and net income of $0.13 per share for the quarter ended March 31, 2002. Total revenues increased $4.2 million to $25.9 million, a 2
Read more →IARTIntegra LifeSciences Schedules Conference Call for Wednesday, May 8 to Discuss First Quarter 2002 Financial Results and Update Forward-Looking Financial Guidance
PLAINSBORO, N.J., April 25, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that it has scheduled a conference call for 9 a.m. EST on Wednesday, May 8 to discuss financial results for the first quarter ended March 31, 2002 and to update forwa
Read more →IARTIntegra LifeSciences Announces FDA Approval to Market INTEGRA Dermal Regeneration Template for the Repair of Scar Contractures
PLAINSBORO, N.J., April 23, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the U.S. Food and Drug Administration (FDA) has approved its pre-market approval application ("PMA") supplement to market INTEGRA(R) Dermal Regeneration Te
Read more →IARTIntegra NeuroSciences Announces FDA Clearance to Market a Tunneled Catheter for the LICOX Brain Tissue Oxygen Monitoring System
PLAINSBORO, N.J., April 9, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Integra NeuroSciences has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market the LICOX(R) Tunneling Catheter in t
Read more →IARTIntegra LifeSciences Reports Preliminary First Quarter 2002 Revenues; Forward-Looking Earnings Guidance Unchanged
PLAINSBORO, N.J., April 5, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported preliminary revenues for the first quarter ended March 31, 2002. The Company expects to report total revenue of approximately $25.7 million in the first quarter o
Read more →IARTIntegra LifeSciences Announces Investor Forum at the American Association of Neurological Surgeons Meeting on April 9, 2002
PLAINSBORO, N.J., March 8, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has scheduled an Investor Forum at the American Association of Neurological Surgeons meeting on Tuesday, April 9, 2002 at 8:30 AM Eastern Time (7:30 AM C
Read more →IARTIntegra LifeSciences Reports Record Fourth Quarter and Full Year 2001 Earnings on a 'Fully Taxed' Basis
PLAINSBORO, N.J., Feb. 27, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported record revenues and net income for the fourth quarter and full year 2001. Total revenues in the fourth quarter of 2001 increased $4.8 million, or 24%, over the fo
Read more →IARTIntegra LifeSciences Schedules Conference Call for Wednesday, February 27 to Discuss Fourth Quarter and Full Year 2001 Financial Results and Update Forward-Looking Financial Guidance
PLAINSBORO, N.J. Feb. 20, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that it has scheduled a conference call for 9:00 a.m. EST on Wednesday, February 27 to discuss financial results for the fourth quarter and year ended December 31, 2001
Read more →IARTIntegra LifeSciences Reports Preliminary Fourth Quarter 2001 Revenues -- Product Sales Increase 26%
PLAINSBORO, N.J., Jan. 29, 2002 (PRIMEZONE) -- Led by strong growth in product sales, Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported preliminary revenues for the fourth quarter and year ended December 31, 2001. The Company expects to report revenues of $25
Read more →Competitive Position
How IART ranks across every disease it competes inCompetitive Position is a premium feature
See how IART ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial